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General introductionChapter 1
1The immune systemThe immune system defends us against the invasion of pathogens, like bacteria 
and viruses, and cancer. The first line of response is quick and non-specific and 
this so-called innate immune system will attack everything that is non self-
based following the detection of structural features of pathogens, including 
bacterial nucleic acids or cell wall components, called pathogen-associated 
molecular patterns (PAMPs)1. The innate immune system will also respond to 
tissue damage, dying necrotic cells or cancer cells in the absence of pathogens 
by recognition of endogenous stress signals known as damage-associated 
molecular patterns (DAMPs)1. PAMPs and DAMPs are recognized by pattern-
recognition receptors (PRRs) of the innate immune system that recognize a 
limited number of structural motifs that could harm the host. Toll-like receptors 
(TLRs) are the most well-known type of PRRs. Activation of the TLRs at the 
plasma membrane, organellar membranes, or in the cytosol initiates a signaling 
cascade that induces activation of the innate immune response, resulting in 
synthesis of cytokines, chemokines, adhesion molecules and immune-related 
receptors. This activates natural killer cells and phagocytes, neutrophils and 
macrophages, which clear dying cells, cancer cells and/or infections by ingesting 
them. In addition, PRR-mediated signaling is important for induction of the 
second wave of the immune response, the adaptive immune system. 
This adaptive system is more specific and involved in the development of 
immunological memory. The specificity occurs by somatic rearrangements 
of genes coding for T and B cell receptors (TCR and BCR). Because of these 
rearrangements there are millions of different T and B cell receptors that 
recognize a specific antigen presented on the surface of an antigen-presenting 
(innate immune) cell. When an antigen is recognized, the T-cell with the matching 
TCR undergoes clonal expansion to generate a large number of this specific T-cell. 
The two main types of T cells are CD4+ T helper lymphocytes and CD8+ cytotoxic T 
lymphocytes (CTLs). T helper  (Th) cells are able to induce isotype class switching 
in antigen-specific B cells and subsequent antibody production in plasma cells 2. 
In addition, interaction with CD4+ T cells enables CTLs to fully carry out their 
cytotoxic effector functions. When a pathogen infects the body a second time, 
memory T and B cells that originated from the first inflammatory response are 
able to respond quicker and more vigorously to attack the invader. This is called 
immunological memory 3. The innate and the adaptive immune system do not 
work independently but need each other to successfully protect against infections 
and cancer cells.  This link is provided by dendritic cells, as these innate immune 
cells play a central role in the initiation of specific immunity by presenting antigen 
to specific T cells (Figure 1). In addition, they are important for the maintenance of 
immune tolerance by preventing T cell expansion upon self-antigen encounter 4. 
Figure 1. Initiation of the adaptive immune response by dendritic cells. Dendritic cells (pink) 
orchestrate the immune response against tumor cells (and pathogens) via CD4+ T helper cells 
(blue) that are able to activate B cells (green) to differentiate into antibody-producing plasma cells. 
Antibodies are able to bind tumor cells and enable phagocytic cells to engulf tumor cells (purple). 
Dendritic cells, together with T helper cells are also able to activate CD8+ cytotoxic T cells (yellow) that 
proliferate and gain cytolytic capacity for tumor cell killing. 
 
Immature dendritic cells reside in peripheral tissues of the body. They sample their 
environment for pathogens and cancer cells. When they encounter potentially 
hazardous molecules, these can directly activate dendritic cells via their PRRs, 
or they are first phagocytosed and subsequently encounter a PRR within the 
phagosomal lumen or the cytosol. In macrophages, another innate immune cell 
capable of antigen presentation, most of the ingested material is directed to 
the lysosomal compartment where it will be completely degraded. Dendritic 
cells do not directly send pathogens and tumor material to their lysosomes, 
but instead traffic them to major histocompatibility complex (MHC) class II-rich 
compartments. These late-endosomal compartments are specialized in loading 
antigen peptides to MHC class II molecules, which are then transported to the 
cell surface for presentation 5.  In addition, dendritic cells have the capability 
to route exogenous antigen peptides to the MHC class I pathway in a process 
called cross-presentation. This process is specific for dendritic cells, as normally 
cells are only able to present endogenous proteins on MHC class I molecules 6. 
Cross-presentation is very important in the immune response against viruses 
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1and cancer and makes dendritic cells the most potent antigen presenting cell of the immune system.  Activation decreases the capability of dendritic cells to 
take up antigens, but increases their motility 7. This enables them to traffic to 
the spleen or through the lymphatic system to the lymph nodes, where naive 
and memory T cells are located. 
In the lymph node naive T cells scan antigen-loaded MHC molecules on the 
dendritic cell with their TCR by forming short-lived interaction platforms. When 
the T cell finds a matching dendritic cell, a stable interaction is formed, called 
the immunological synapse 8. This synapse integrates and segregates signals 
necessary for T cell activation and clonal expansion of the antigen-specific T 
cell 9,10(See chapter 2 of this thesis for a more detailed discussion). Three types 
of signals are necessary for optimal activation. The first is the interaction of 
the MHC-peptide complex on the dendritic cell with the TCR of the T cell. The 
second signal necessary for T cell activation is the engagement of co-stimulatory 
receptor CD28, which binds to CD80 or CD86 on the dendritic cell. When this 
signal is not available the T cells become anergic, possibly leading to immune 
tolerance. The third signal comprises the secretion of cytokines. This increases T 
cell potentiation, but is mostly responsible for giving direction to CD4+ T helper 
cell development 11. 
Cytokines in the immune response
Depending on which cytokines are secreted by the dendritic cell and sensed by 
the CD4+ T cell in the microenvironment during antigen recognition, cytokines 
induce differentiation of CD4+ T cells into Th1, Th2, Th17 or T regulatory cells 
(Tregs) by activation of specific gene transcription pathways. Th1 differentiation 
occurs when naive T cells are exposed to IFNγ and IL-12, which is secreted by 
dendritic cells. They are mainly involved in the immune response against 
intracellular pathogens, like viruses, and cancer, where they help in fully activating 
CD8+ cytotoxic T cells and natural killer (NK) cells 12. When differentiated, Th1 
cells mainly secrete IFNγ, Lymphotoxin α and large amounts of IL-2. Th2 cells 
develop upon exposure to high levels of IL-4 and help with the differentiation 
of B cells and antibody production. They secrete IL-4, IL-5, IL-10, IL-13 and IL-6 
and are mainly involved in clearance of exogenous pathogens like bacteria and 
large parasites. Treg development in the periphery is induced by high levels of 
TGFβ in combination with IL-2. Their function is essential in the maintenance 
of tolerance to nonpathogenic foreign antigens in the body, like commensal 
bacteria in the gut. Th17 cells are a relatively new discovered subtype, which 
arises when naive T cells are exposed to high levels of TGFβ in combination 
with IL-6. Th17 cells are known for their role in the development of autoimmune 
diseases, but they have a clear function in the host defense against bacteria and 
fungi, as they attract high numbers of neutrophils and macrophages. 
Next to cytokine production for T cell activation, dendritic cells also secrete 
TNFα, IL-1β and IL-6 upon inflammation and TLR stimulation. These cytokines 
induce an acute phase response and mobilize a massive infiltration of innate 
immune cells at the site of inflammation 13. Furthermore, a distinct subset of 
dendritic cells is capable of secreting IFNα during viral infections, which activates 
the anti-viral immune response of macrophages and natural killer cells 14. When 
the inflammation or infection is eradicated, the immune response is abrogated 
by secretion of anti-inflammatory cytokines IL-10 and TGFβ that suppress Th1 
and Th2 activation while inducing regulatory T cell differentiation 13.
The focus of this thesis is on the production and intracellular trafficking of IL-6 
in dendritic cells. IL-6 is a 27 kDa glycoprotein that is secreted upon exposure 
to stress hormones, cytokines or pathogens by almost all stromal cells and 
cells of the immune system 15,16. This cytokine is not only important in immune 
cell communication, but can promote the activation, growth, proliferation and 
survival of many different cell types in  both inflammatory and anti-inflammatory 
conditions 17. Furthermore, a role in tumor progression and auto-immune 
diseases is described 18–20. IL-6 signals via the IL-6 receptor complex that consists 
of IL-6 receptor alpha and gp130, which is the signal transducing subunit 21. Via 
Janus tyrosine kinases (JAK), gp130 is phosphorylated and recruits and activates 
signal transducer and activator of transcription (STAT) and mitogen-activated 
protein kinase (MAPK)22,23. As most cells only express gp130, signaling occurs via 
trans-signaling were IL-6 binds to soluble IL-6RA in the extracellular space and 
then engages with gp130. This is thought to be a pro-inflammatory signal. Only 
immune cells and hepatocytes  express both IL-6RA and gp130 that induces 
classical signaling, which is thought to be anti-inflammatory 22,24–26. In dendritic 
cells, IL-6 inhibits maturation via STAT3 signalling 19,27,28.
Cytokine trafficking and secretion 
The mechanism of cytokine release is often overlooked in the already complex 
immune response and is dependent on membrane trafficking. Membrane 
trafficking ensures correct localization of all molecules within the cell and is 
required for steady-state cellular functioning as well as for dynamic adaptation 
to changes in the cellular environment. Membrane trafficking is a continuous 
process of vesicle budding and fusion in which molecules that need to be 
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1translocated within the cell are first sorted within a donor compartment, for example the Golgi apparatus, into transport vesicles. Once these transport 
vesicles bud off, they traffic to the acceptor compartment where they will fuse 
29,30.  Membrane trafficking can be classified in two main routes: the exocytic 
and the endocytic pathway. The first is responsible for the transport of newly 
synthesized proteins, such as cytokines, from the endoplasmic reticulum to the 
Golgi complex. Subsequently, proteins are transported to endosomal vesicles, 
secretory granules, or directly to the plasma membrane 29,30. The second pathway 
is responsible for the internalization of molecules from the extracellular space 
or plasma membrane. This endocytic pathway is important for re-use of plasma 
membrane receptors, nutrient uptake, pathogen engulfment, cell movement, 
receptor signaling, and the removal of cytokines and chemokines from the 
circulation29. Depending on the fate of the ingested molecule, it can be returned 
to the cell surface or sorted to late endosomal and lysosomal compartments 
for degradation by acid hydrolases 31. An extra step of complexity is present in 
immune cells, where not only standard cell metabolic processes occur but cells 
also respond to extracellular triggers that induce secretion of cytokines and 
chemokines. In addition, antigen presenting cells are capable of antigen uptake 
by endocytosis (for small antigens, < 1 µm) or phagocytosis (for larger antigens), 
both tightly regulated processes that require increased membrane turnover 32. 
Membrane trafficking and fusion is regulated by a wide variety of proteins, 
phospholipids and protein kinases and phosphatases that coordinate the 
spatiotemporal dynamics of membrane trafficking and fusion 33–36. A special 
type of phospholipids, phosphoinositides are thought to determine organelle 
identity and can be reversibly phosphorylated or de-phosphorylated 37. They 
work together with Rab GTPases, regulatory proteins that bring effector 
proteins together for vesicle budding, transport and fusion. As other GTPases, 
they exist in an active membrane-anchored and GTP-bound conformation, 
in which they interact with downstream effector proteins, and in a soluble, 
inactive, GDP-bound conformation 38. When phosphoinositides, Rab GTPases 
and their effector proteins bring together two lipid membranes for fusion, this 
requires another group of proteins called SNAREs. 
SNAREs (soluble-N-ethylmaleimide-sensitive-factor accessory-protein (SNAP) 
receptors) mediate all eukaryotic membrane fusion steps, except fusion of 
mitochondria 30,39. The 36 members of the human SNARE family all have one or 
two SNARE motifs - stretches of 60-70 amino acids arranged in heptad repeats, 
a specific pattern of hydrophobic and charged amino acid residues 40. Most 
SNAREs have a hydrophobic transmembrane domain, but some are anchored 
to the cell membrane by lipid modifications, like palmitoylation or prenylation 
of their C-terminal cysteines. A variety of regulatory domains can be present at 
the N-terminal of the SNARE domain, like Habc domains that interact with Sec1/
Munc18-like (SM) regulatory proteins 41,42. Habc-domains can keep SNAREs in a 
‘closed’ conformation, preventing complex formation. In other instances they 
are necessary for membrane fusion and are a platform for recruitment of adaptor 
proteins that are essential for targeting of the SNARE to the correct organelle 
and for the spatiotemporal regulation of membrane fusion by complexins and 
synaptotagmins 42–46. 
Classically, SNAREs are classified based on their location on the vesicle 
(v-SNARE) or target (t-SNARE) membrane prior to membrane fusion. However, 
this classification is not always consistent, as sometimes SNAREs are involved in 
both anterograde and retrograde trafficking of molecules or in homotypic vesicle 
fusion where there are no clear donor and target compartments. Therefore, 
a more useful classification is based on the appearance of an arginine (R) or 
glutamine (Q) in the central functional residue of the trans-SNARE complex 39. To 
execute their function SNAREs first have to form a trans-SNARE complex after 
the vesicle is docked to the target membrane. The SNARE protein on the vesicle, 
often an R-SNARE, assembles with 2 or 3 Q-SNAREs (based on their localization 
in the helix, Q-SNAREs are subdivided in Qa, Qb, Qc or Qbc SNAREs). This 
interaction pulls the vesicle and target membranes closer together, releasing 
enough force to eventually fuse the lipid bilayers. Upon fusion the SNARE 
complex changes to a cis-conformation on the target membrane. Subsequently, 
the ATPase NSF (N-ethylmaleimide-sensitive-factor) and α-SNAP disassemble 
the SNARE-complex allowing recycling of the individual SNAREs for future 
fusion events 39 (Figure 2). 
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Figure 2. Vesicle fusion is mediated by SNARE proteins. The Qa-SNARE (red) and Qbc-SNAREs 
(green) on the receiving membrane come together and form a trans-SNARE complex with the 
R-SNARE on the vesicle membrane (blue). This complex is pulled together and upon fusion becomes 
a cis-SNARE complex. After fusion, the SNARE complex is disassembled and recycled for new fusion 
events. 
SNARE proteins in the immune system 
SNARE-mediated cytokine secretion is mostly studied in granulocytes, like mast 
cells and neutrophils, and platelets, as these cells contain pre-formed granules 
in which cytokines are stored and are only released upon a distinct stimulus 
(reviewed in 47). Cytokine secretion in dendritic cells and macrophages is different 
from granulocytes, as they do not contain secretory vesicles with a ready-to-
release pool of cytokines and therefore use distinct secretory pathways 48. In 
these cells, the secretion pathway and SNARE proteins involved therein is only 
well understood for the secretion of TNFα by mouse macrophages. 
Upon TLR4 stimulation by LPS, the transcription and translation of TNFα 
increases, which results in its accumulation in the Golgi apparatus. The SNARE 
proteins VAMP3 (R), syntaxin 7 (STX7; Qa), Vti1b (Qb), and STX6 (Qc) then 
mediate fusion with small vesicles that transport TNFα from the Golgi apparatus 
to the recycling endosome 49,50. VAMP3 positive vesicles derived from the 
recycling endosomes in turn fuse with the plasma membrane by a SNARE complex 
containing VAMP3, STX4 (Qa) and SNAP23 (contains both a Qb and Qc domain), 
a process regulated by the SM protein Munc18c 51. All these SNAREs involved in 
exocytosis are upregulated during LPS stimulation 51. The delivery of TNFα can 
either be polarized at the phagocytic cup during phagocytosis or non-polarized 
as for IL-6 50,52. TNFα is membrane-bound upon synthesis and is cleaved by 
metalloproteases at the plasma membrane before release 53. Plasma membrane 
delivery of TNFα is regulated by lipid rafts, as STX4 translocates within the 
plasma membrane to cholesterol dependent lipid-rafts upon LPS stimulation 54. 
A role for STX4 has also been described for secretion by other immune cells, for 
instance in the plasma membrane fusion of IgE containing vesicles of plasma B 
cells 55. 
In dendritic cells, not only STX4 can mediate cytokine release, but also STX3 is 
described to play a role 56,57. In mouse dendritic cells, TLR4 stimulation by LPS 
results in increased mRNA expression of STX3 and this correlates with an increase 
in IL-6 secretion. On the other hand, siRNA gene silencing of STX3 leads to 
a decrease in IL-6 secretion, while this is not observed for TNFα. In addition, 
STX3 translocates from the cytoplasm to the plasma membrane upon LPS 
stimulation 56. IL-10 secretion in macrophages occurs via two pathways, one 
comparable to IL-6 and TNFα secretion via the Golgi apparatus and VAMP3 
positive recycling endosomes, while for unclear reasons the other pathway 
transports IL-10 from the Golgi apparatus directly to the plasma membrane 58. 
IL-12 on the other hand is secreted in a polarized manner to T cells via VAMP7 
positive late endocytic vesicles 59.
Although the processes of exocytosis may not directly seem to be related to 
phagocytosis, there is a tight interplay between these processes. SNAREs involved 
in exocytosis can be involved in phagocytosis by the same cells. This may serve to 
maintain the surface area of the plasma membrane, as early studies suggest that 
VAMP3-positive recycling endosomes are necessary for increasing the surface 
area of the plasma membrane of murine J774 macrophages during phagocytosis 60. 
However, this was not observed in later studies in macrophages from VAMP3 
knock-out mice, probably because VAMP2 and VAMP8 that also localized in 
recycling endosomes were able to compensate 61. In addition, STX4 and SNAP23 
are not only found at the plasma membrane, but also at phagosomes where they 
mediate delivery of phagosomal proteins 62–64. Finally, exocytic SNAREs can have 
an inhibitory role in phagocytosis, such as described for VAMP8, a general exocytic 
SNARE of exocrine cells, which co-localizes with the lysosomal marker LAMP2 in 
dendritic cells where it inhibits phagocytosis 65. 
At the T cell side of the immunological synapse, the T cell is dependent on 
SNARE proteins for secretion of cytokines, but also for receptor delivery at 
the cell surface. When T cells form an immunological synapse and engage in 
TCR signaling with MHC molecules, STX4 and SNAP23 cluster at the plasma 
membrane of the T cell at the contact plane between cells. In addition, VAMP2 
and VAMP3 are necessary for trafficking of the TCR to the plasma membrane, as 
this decreases when VAMP2 and VAMP3 are inactivated 66. VAMP2 and VAMP3 
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1co-localize with CD3, the co-receptor of the TCR 
67, further supporting the role of 
these R-SNAREs in T cell signaling. Cytokine secretion from T cells is mediated 
by multiple pathways, depending on a polarized or non-polarized secretion 
pattern. While secretion of IL-2 and IFNy at the immunological synapse only 
requires STX6, TNFα secretion away from the synapse requires both STX6 and 
Vti1b 68. Another study revealed that IFNy is not secreted via recycling endosomes 
or secretory lysosomes, but via Rab19 positive structures 69. T helper cells are, 
similar to phagocytic cells, able to secrete IL-10. However, in phagocytes IL-10 is 
secreted in a non-polarized fashion, while in T cells it is specifically delivered at the 
immunological synapse 68. 
An immunological synapse can also be formed between a cytotoxic T lymphocyte 
(CTL) and the target it wants to kill by secretion of lytic granules. A wide range 
of SNARE proteins influences this secretion in CTLs, including STX7 70, STX11 71,72 
Vti1b 73, VAMP2 74, VAMP7 69, and VAMP8 73,75. VAMP8, for example, is recruited to the 
immunological synapse from recycling endosomes 75,76. At the plasma membrane, 
VAMP8 mediates fusion of Rab11a compartments carrying STX11 and Munc18c, a 
SNARE and adaptor protein necessary for lytic granule release 75,77. Other regulatory 
proteins necessary for this are synaptotagmin VII 45, Rab27a 78 and the SM protein 
Munc13-4 79. Genetic mutations in the gene coding for the Munc13-4 protein are 
the cause of a disease called familial hemophagocytic lymphohistiocytosis (FHL) 
type 3 (FHL3), which is characterized by a substantially decreased killing capacity 
of CTLs and increased infection risk 79. Four more types of FHL exist, all showing a 
defect in cytolytic killing, of which FHL4 and FHL5 have mutations in a membrane 
fusion related protein (STX11 and Munc18b, respectively) 29,47. Related to FHL3 
is Griscelli syndrome. These patients lack functional Rab27a, the effector of 
Munc13-4, which next to neurological defects also leads to uncontrolled T cell 
activation 80,81. However, the influence of these rare, genetic diseases on dendritic 
cell and macrophage functions is less well described than for T cells, and mainly 
comprises hyperactivation of macrophages 82. 
Immune disorders in patients carrying mutations in trafficking proteins illustrate 
the importance of the membrane trafficking and -fusion machinery in the 
functioning of the adaptive immune system. This part of the immune system, 
however, can only function when there is proper communication with the 
innate immune system. The dendritic cell has a leading role in providing the 
communication link between innate and adaptive immune systems by antigen 
presentation and expression of many immune receptors and soluble factors, like 
cytokines. The molecular mechanisms underlying the transport and secretion of 
these communication tools by dendritic cells are also dependent on membrane 
trafficking but are often overlooked.
Outline of this thesis
The first aim of this thesis is to decipher the role of membrane trafficking 
and SNARE proteins in IL-6 secretion in dendritic cells. The second aim of this 
thesis is to determine the influence of LPS, a TLR4 stimulus derived from gram-
negative bacteria, on IL-6 trafficking and signaling within dendritic cells. 
Chapter 2 provides an overview on the interactions between dendritic cells and T 
cells at the immunological synapse for T cell activation. In contrast to the widely 
studied T cell side of this cellular interface, in this chapter signaling and trafficking 
at the dendritic cell side of the immunological synapse are discussed. In chapter 
3 a new developed technique using fluorescence lifetime imaging microscopy 
(FLIM) to  study membrane trafficking processes and membrane fusion events 
mediated by SNARE proteins in living cells is described in a step by step protocol. 
This complex imaging technique is subsequently used in chapter 4 to determine 
which SNARE proteins are involved in endosome – plasma membrane fusion 
necessary for IL-6 secretion upon LPS stimulation in dendritic cells. 
The second part of this thesis further focuses on the signaling and localization of 
the model cytokine IL-6 in dendritic cells. Chapter 5 describes how IL-6 mediated 
STAT3 signaling occurs in endosomal compartments and how autocrine signaling 
of newly synthesized IL-6 in transit to the plasma membrane influences LPS 
induced IL-6 production. Finally, in chapter 6 different microscopy techniques 
are combined to estimate how many IL-6 molecules are present within secretory 
compartments of dendritic cells stimulated with LPS.
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Abstract
Immune responses are initiated by the interactions between antigen-presenting 
cells (APCs), such as dendritic cells (DCs), with responder cells, such as T cells, 
via a tight cellular contact interface called the immunological synapse. The 
immunological synapse is a highly organized subcellular structure that provides 
a platform for the presentation of antigen in major histocompatibility class I and 
II complexes (MHC class I and II) on the surface of the APC to receptors on the 
surface of the responder cells. In T cells, these contacts lead to highly polarized 
membrane trafficking that results in the local release of lytic granules and in 
the delivery and recycling of T cell receptors at the immunological synapse. 
Localized trafficking also occurs at the APC side of the immunological synapse, 
especially in DCs where antigen loaded in MHC class I and II is presented and 
cytokines are released specifically at the synapse. Whereas the molecular 
mechanisms underlying polarized membrane trafficking at the T cell side of the 
immunological synapse are increasingly well understood, these are still very 
unclear at the APC side. In this review, we discuss the organization of the APC 
side of the immunological synapse. We focus on the directional trafficking and 
release of membrane vesicles carrying MHC molecules and cytokines at the 
immunological synapses of DCs. We hypothesize that the specific delivery of 
MHC and the release of cytokines at the immunological synapse mechanistically 
resemble that of lytic granule release from T cells.
Introduction
The immune system encompasses a complex and diverse composition of 
structures, cells and molecules. To function properly, they interact with each 
other and with other cells in our body. Especially interesting is how immune 
cells respond to disturbances that change these interactions such as infections 
or cancer 1. Whereas these communications can occur over long distances by 
means of cytokines and chemokines, they can also occur via direct cellular 
contact by means of immunological synapses. Immunological synapses, a term 
derived from the morphologically similar neuronal synapse, are tight cellular 
contact interfaces between antigen presenting cells (APCs) and effector cells 
(T cells or natural killer cells (NKs)) 2, 3.
Immunological synapses are sites of polarized membrane transport where 
cytokines are locally released and membrane receptors are locally presented 
and recycled. Whereas this process is now well studied in T cells and NKs (reviewed 
in 4-7), it is still less clear how localized membrane trafficking is regulated in APCs 8. 
In this review we provide an overview on the molecular cascades that lead to 
polarized trafficking of cargo molecules to the immunological synapse, with an 
emphasis on the trafficking events in dendritic cells (DCs). DCs are professional 
antigen presenting cells that prime naïve CD4+ helper and CD8+ killer T cells by 
means of an immunological synapse 1,9. We focus on the mechanisms underlying 
polarized trafficking of antigen-loaded major histocompatibility complex (MHC) as 
well as of immunostimulatory cytokines from intracellular compartments to the 
immunological synapse, as this process is of great importance for the initiation of 
antigen-specific T cell responses. 
Structure of the immunological synapse 
Not only DCs and T cells, but also other APCs, such as B cells or infected cells, and 
other effector cells, such as NKs, form immunological synapses for intercellular 
communication as well as for the killing of (infected) target cells 6, 10-12. There 
are thus many different types of immunological synapses and these can be 
functionally divided into two categories 13. The first category consists of the 
so-called primary synapses, which are the cell-cell contacts that result in initial 
activation of T cells such as the synapses between DCs and T cells 8. In the T cell, 
the signals conferred at such an immunological synapse can ultimately lead to 
their activation and clonal expansion, depending on the type and activation state 
of the APC and on the efficiency of signal transduction 14, 15. The second category 
consists of the so-called secondary synapses that result from interactions 
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established after initial priming such as activated T cells delivering stimulatory 
signals via for example CD40-CD40L interactions to B cells 1. This category 
also encompasses the synapses formed between NKs or cytotoxic T cells with 
their target APC where lytic granules are released to kill the APC 16. For both 
categories, the formation of immunological synapses can trigger intracellular 
signaling cascades in both the APC and the T cell that lead to reorganization of 
the cytoskeleton and rerouting of membrane trafficking. 
Given the wide functional and structural variety of the different immunological 
synapses, their supramolecular organization is diverse and depends substantially 
on the interacting cell types, cellular activation states, as well as on antigen 
specificity involved 10, 11, 14, 17. Accordingly, an immunological synapse can arrange 
in a well-structured ‘bulls eye’ monocentric structure or can form more complex 
and heterogeneous polycentric arrangements. Furthermore, the time duration 
of cellular engagement varies widely for different synapses and can range from 
seconds up to several hours 13, 18. 
The classical ‘bulls eye’ immunological synapse
Our knowledge of the structure of the immunological synapse was propelled by the 
functional reconstitution of immunological synapses with planar model membranes 
as surrogate APC (reviewed in 6, 19, 20). With this technique the adhesion molecule 
ICAM-1 and MHC are functionally reconstituted in well-defined artificial bilayers 
and this suffices for synapse formation upon contact with T cells or NKs. Because 
the planar bilayer can be positioned directly on the surface of a microscope glass, 
this technique allows visualization of the synapse with total internal reflection 
fluorescence (TIRF) microscopy and other high resolution microscopy techniques. 
Synapses with APCs can also be visualized with high resolution microscopy 
approaches, for instance by reorienting these synapses with a micromanipulator 
parallel to the focal plane of the microscope 21. These and other techniques showed 
well-defined spatially segregated molecule clusters at the immunological synapse, 
and it is now well-established that the immunological synapse can organize in a 
‘bulls eye’ arrangement called the monocentric synapse 19, 22. 
The monocentric synapse contains a distinct central region which is called 
the central supramolecular activation cluster (cSMAC) 22. The cSMAC was 
initially thought to be the location of T cell signaling due to the presence of 
the T cell receptor (TCR) at the cSMAC. However, this is no longer believed and 
the cSMAC is now considered to be a site of signal termination and receptor 
recycling 23, 24. This conjecture is supported by the finding that dissociation of 
signaling molecules, such as Lck, ZAP-70 and the adapter LAT, from the TCR 
microclusters occurs at the cSMAC 25. The peripheral SMAC (pSMAC) surrounds 
the cSMAC and contains adhesion molecules, such as the β2-integrin LFA-1 
and ICAM-1, on the T cell and APC 19, 22, 26. These adhesion molecules provide 
a mechanical scaffold for the immunological synapse and connect the plasma 
membranes and cytoskeletons of the APC and T cell together 27. The pSMAC is in 
turn surrounded by a more distally located SMAC (dSMAC) containing immune-
inhibitory receptors such as CD43 and CD45 28, 29. The dSMAC also contains 
microdomains of T cell receptors which (in contrast to cSMAC) are associated 
with signaling molecules, such as Lck, ZAP-70 and LAT, indicating that receptor 
signaling primarily occurs in dSMAC 25, 30. In the case of cytotoxic T cells and NK 
cells, the cSMAC of the monocentric synapse contains a distinct and separated 
secretory region where release of lytic granules occurs 4, 31.
The molecular cascades that lead to formation of the immunological synapse 
are well established and elaborately reviewed elsewhere 6, 10-12, 32. Importantly, 
synapse formation results in the reorientation of the microtubule organizing 
center (MTOC) towards the immunological synapse. This reorientation facilitates 
polarized membrane trafficking over microtubules to the synapse 33. The actin 
cytoskeleton also plays an important role in synapse formation, and retrograde 
actin transport drives the centripetal motion of many molecules to cSMAC, 
including that of the T cell receptor (reviewed in 7). However, not all molecules 
present at the immunological synapse move in a centripetal fashion as the 
immune-inhibitory protein CD45 moves away from cSMAC within several minutes 
after synapse formation, which is proposed to promote T cell activation 29. The 
cSMAC is largely devoid of actin, although a residual cortical actin network may 
still be present. This actin poor region facilitates the release and recycling of 
trafficking vesicles 34, 35. 
The non-classical multicentric synapse between DCs and T cells
As described above, the structure of immunological synapses strongly depends 
on the cell types involved, the presence and strength of antigen recognition, and 
additional co-stimulatory interactions 10, 11, 17. Especially for the immunological 
synapse between DCs and T cells, there is mounting evidence that the structure 
is aberrant from the classical monocentric synapse that is observed with other 
APCs 8. During the past decade, T cell priming by DCs has been studied by 
multiphoton imaging in explanted lymph nodes and by intravital imaging in live 
mice 17, 18, 36-40 (reviewed in 41, 42). In the absence of cognate antigen, migrating 
T cells only interact briefly with DCs in lymph nodes (<3 min contact) 37. During 
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this phase, DCs scan thousands of T cells per hour by extending agile dendrites 
that transiently contact the motile T cells 43, and this type of synapse is often 
referred to as the ‘immunological kinapse’. Using mouse DCs and a T cell line in 
vitro, it was found that the T cells migrating over the DC surface have different 
zones: an actin-rich leading zone driving migration, a mid-zone mediating TCR-
induced signaling, and a rear uropod mediating MHC-independent signals 44. 
Upon detection of cognate antigen the contact duration between the DCs and 
T cells is prolonged but still in the order of minutes (~11-12 min) 18, 37. Provided 
the antigen dose is sufficiently high, this first phase of T cell priming is followed 
by a second phase, marked by the formation of relatively stable clusters of DCs 
contacting multiple T cells simultaneously 18, 37, 38. This second phase is observed 
within 3 hr after phase 1 18, 37, although the precise onset depends on the antigen 
dose and the number of DCs presenting the congnate antigen 40. The DC/T cell 
clusters during this phase are very stable and can even be isolated from the 
lymph nodes 45. Although experimentally difficult to estimate (e.g. due to spatial 
drift of the microscope, photodamage, or migration of the cells away from the 
field of view), the second phase has an estimated duration of 3-5 hr 46 and is 
followed by a third phase where T cells regain their motility and proliferate 18. 
Thus, it is now firmly established that T cell priming occurs in three distinct 
phases where the immunological synapse between DCs and T cells changes 
consecutively from (i) transient intermittent contacts through (ii) stable clusters 
to (iii) proliferation of the T cells.
Prolonged DC/T cell contacts are not required for T cell activation, and T cells 
can already get activated during the first phase of highly transient DC/T cell 
contacts 18, 40. The second phase of DC/T cell contacts coincides with IL-2 secretion 
from the T cells 37 and may facilitate development of effector cells and long-lived 
memory T cells 39, 40. The third phase is required for the development of T follicular 
helper cells 47. This corresponds with in vitro studies showing that activation of 
helper T cells by DCs does not require formation of a stable synapse, but short 
and sequential cellular interactions are sufficient for T cell activation 10, 13, 48. 
These interactions are too transient for complete formation of a well-defined 
monocentric synapse and the sizes of the cellular interfaces may also be too 
small to accommodate assembly of c- and pSMACs (several µm) 37. In addition, 
DCs can actively prevent formation of a cSMAC by providing mechanical counter 
forces that keep the immunological synapse in a state where TCRs are not or only 
partially clustered and their distribution across the synapse is more scattered 10. 
Here, a multifocal or multicentric immunological synapse can be established where 
the T cell receptors interact with MHC molecules in multiple dispersed clusters at 
the interaction zone 49. In this case, the actin cytoskeleton of the DCs is polarized 
towards the immunological synapse in an antigen-specific manner, and this 
polarization is required for complete T cell activation 50, 51. Actin can also polarize 
in DCs upon synapse formation with NKs 52, 53. 
A monocentric immunological synapse is not only unnecessary for activation of 
T cells, but its absence can even promote survival of the DC as cytolytic granules 
are not released from cytotoxic T cells and NKs 8, 11, 53. The actin cytoskeleton in 
DCs regulates the lateral mobility of ICAM-1 (but not of MHC class II) and this in 
turn opposes forces of LFA-1 on the T cell surface which could inhibit cytolytic 
granule release 54. Indeed, it was shown that when cSMAC formation was 
delayed by a reduced lateral mobility of antibodies against CD3 incorporated in 
bilayers (as surrogate APC), this resulted in less signaling within the T cell 55. DCs 
not only counteract the centripetal forces conferred by the T cell cytoskeleton, 
but also receive signals themselves from T cells at the immunological synapse. 
Engagement of CD40L on the T cell with CD40 on the DC provides a pro-
survival signal that protects the DC from undergoing apoptosis via the Akt1 
pathway 8, 56. Moreover, the accumulation of tyrosine-phosphorylated proteins 
and of the lipid phosphatidylinositol 4,5-bisphosphate (PI(4,5)P2) at the DC side 
of the immunological synapse indicates that active signaling occurs within the 
DC 56, 57. PI(4,5)P2 has many functions in cellular signaling, cytoskeletal attach- 
ment and membrane trafficking 58, and its accumulation correlates with 
increased DC survival 57. In mouse, formation and stabilization of the 
immunological synapse as well as functional T cell priming depends on the small 
GTPases Rac1 and Rac2 36, the Wiskott-Aldrich syndrome protein WASp 59, 60, 
and the mammalian diaphanous-related formins mDia 61. All these proteins 
have well established roles in actin polymerization, which further supports the 
role of the actin cytoskeleton in synapse formation. Similar to T cells 19, 22, 26, the 
activation of LFA-1 on the dendritic cells stabilizes the immunological synapse 
and promotes T cell priming 62.
Nevertheless, it is still controversial whether DCs prevent the formation of a 
monocentric synapse, and some reports show that DCs and T cells form a monocentric 
synapse containing MHC molecules and Notch-ligands in the cSMAC at the DC 
side 63. This controversy likely relates to the precise type of immunological synapse 
formed. Antigen recognition from fully activated DCs by a primary naïve T cell likely 
results in a different type of synapse than observed with commonly used model 
systems that rely on immortalized cell lines, exogenously added antigenic peptides, 
allogenic interactions (T cells and DCs from 2 different donors) or superantigens 
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(Fig. 1). The activation state of the DC is also very important for both the structure 
and duration of the immunological synapse 14. The type of T cell matters as well, 
as we observed differences in synapse formation between DCs with a Jurkat T cell 
line compared to primary CD8+ T lymphocytes. Both these T cells formed antigen 
specific synapses with DCs, as both were transfected with a recombinant TCR 
recognizing tumor antigen gp100 residues 280-288 64. The Jurkat cells first spread on 
the surface of the DC followed by cellular contraction and remained stably attached 
(> 1 hr; Fig. 1A), which is reminiscent of the formation of a monocentric synapse 19. 
Similar morphological steps of spreading followed by contraction of the T cells are 
frequently observed and well understood at the molecular level (reviewed in 32). In 
contrast, the behavior was completely different with primary T lymphocytes. There 
the DCs actively moved around the T cell indicating large structural rearrangements 
within the DCs (Fig. 1B). This is in line with the finding that DCs can rearrange their 
actin cytoskeleton toward T cells in case of antigen recognition 51, but also shows 
that the type of T cell is a critical factor for eliciting such a rearrangement. 
Interestingly, immunological synapses can also have a three-dimensional 
structure. T cells can form pseudopodia that penetrate but do not disrupt the 
APC, a mechanism that was suggested to extend the contact area to facilitate 
screening for antigen in MHC molecules 12, 65. In this respect, it was noted that 
the T cell side of the immunological synapse morphologically and functionally 
resembles cilia formation (reviewed in 4, 66). Similarly, DCs can form extensions 
called microvilli at the immunological synapse which contain a high density of 
co-stimulatory molecules and peptide loaded MHC complexes and this may also 
facilitate T cell activation 67. 
Local membrane trafficking at the immunological synapse
Polarized trafficking at the T cell side of the immunological synapse
Membrane trafficking plays an important role in T cell effector functions, because 
it leads to surface display of TCRs and other membrane proteins, recycling of 
exhausted receptors, as well as to release of cytokines and chemokines at the 
immunological synapse. Most studies that deal with the immunological synapse 
looked at signaling and trafficking of molecules within the T cell. The best understood 
form of exocytosis at the immunological synapse is the release of cytolytic granules 
from CD8+ T-cells and NKs. However, other types of cargo also undergo polarized 
membrane trafficking at the T cell side of the immunological synapse. For example, 
cytokines (e.g. IFNγ) and membrane receptors (TCR, ICAM-1) are delivered and/or 
recycled at the synapse 4, 6, 12, 26, 66, 68, 69. The polarized delivery of these molecules to 
the immunological synapse allows a more sensitive antigen presentation and/or 
promotes T cell effector functions, while preventing unwanted activation of other 
(immune) cells nearby. Membrane trafficking is well studied for the classical ‘bulls 
eye’ immunological synapse, where the TCR reaches the plasma membrane at the 
dSMAC and gets internalized for degradation and recycling at the cSMAC 23-25, 30. At 
the secretory synapse of CD8+ T-cells and NKs, cytolytic granules are released at 
the cSMAC (reviewed in 4, 10, 32, 70). Thus, endocytosis and exocytosis in T cells can be 
spatially restrained to discrete areas of the immunological synapse. 
Figure 1. Structural differences in DC immunological synapses with Jurkat or primary T cells.
(A) An antigen specific synapse between a Jurkat T cell (red) and a DC differentiated from peripheral 
blood mononuclear cells (green). Jurkat T cells were heterologously expressing a TCR recognizing a 
tumor antigenic peptide (gp100 residues 280-288) 64. DCs were expressing the actin binding protein 
LifeAct fused to GFP (green), as described 108, and were loaded with an excess of antigenic gp100 peptide. 
The Jurkat T cells were labeled with a far-red fluorescent membrane marker (red). The bright F-actin rich 
structures in the DC are podosomes (marked with a yellow arrowhead for t = 5 min) 108. The upper row 
shows z-projections of confocal stacks recorded at the indicated time points after T cell addition. The 
lower row shows the schematic outline of the cells. Note that the Jurkat T cell first spreads out covering a 
large area of the DC surface and this is followed by cellular contraction. (B) Same as panel A, but now with 
primary CD8+ T cells transfected with the same TCR recognizing tumor antigen from gp100 64. Primary 
T cells are much smaller (~5 – 10 µm diameter) than Jurkat T cells (20 – 50 µm diameter). Note that with 
primary T cells, the DCs (but not the T cells) show large structural deformations and cover large areas of 
the surface of the T cells. Scale bar, 20 µm.
A
B
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The mechanism of release of cytotoxic granules at the immunological synapse from 
CD8+ killer T cells and NKs towards the target cell is now well understood. Secretory 
vesicles are transported via the microtubular network by motor proteins towards 
the cSMAC of the cell membrane 33. This is followed by fusion of the vesicles with the 
plasma membrane, a process which is remarkably similar to neurotransmitter release 
from neurons and neuroendocrine cells (reviewed in 5). Indeed, several studies have 
identified proteins participating in lytic granule release with functional and structural 
homology to those involved in neurotransmitter release. Examples include the 
C2-type calcium sensor synaptotagmin-7 71, which is a close homolog of the main 
calcium-trigger for neurotransmitter release synaptotagmin-1 72, and the docking/
tethering proteins Munc18-2, Munc13-1 and Munc13-4 73-76, which are homologous 
or identical to the tethering/docking factors of synaptic vesicles Munc18-1 and 
Munc13-1 72. The similarity of lytic granule release with neurotransmitter release is 
even more apparent from the recent finding that the final membrane fusion step of 
lytic granule release is catalyzed by the SNARE protein VAMP2 77. This is remarkable, 
because VAMP2, also called synaptobrevin-2, is very well known as the R-SNARE 
for neurotransmitter release 72. The role of VAMP2 in lytic granule release was 
previously missed because of the embryonically lethal phenotype of the VAMP2 
knockout mouse (due to neurological defects) and because of the very low and 
transient expression of VAMP2 in cytotoxic T cells. This finding answers the long-
standing question of which R-SNARE catalyzes lytic granule release 5, 77, 78. 
It is also known how the TCR reaches the dSMAC of the immunological synapse. 
The TCR traffics via recycling endosomal compartments that polarize towards 
the immunological synapse 66, 68. Membrane fusion is catalyzed by the SNARE 
proteins SNAP-23 and syntaxin-4 which cluster in the plasma membrane and likely 
interact with the SNARE protein VAMP3 in the TCR-containing trafficking vesicle 
68, 79. Similar to VAMP2 described above, these SNAREs also have well-known 
roles outside the immune system. Syntaxin-4 and SNAP-23 catalyze constitutive 
exocytosis in many different cell types, but also catalyze forms of evoked release 
such as insulin secretion by β-cells and surface display of GLUT4 by adipocytes 80. 
Moreover, release of vesicular compartments containing the TCR subunit ζ and the 
adapter protein LAT at the immunological synapse depends on synaptotagmin-7 
69, which also plays a role in the delivery of lytic granules at the synapse 71. Thus, 
immunological synapses not only resemble neurological synapses morphologically 
3, but also contain a similar or even identical protein machinery. Additionally, the 
formation of immunological synapses (and of neurological synapses) structurally 
and morphologically resembles ciliogenesis 4, 66, with the small GTPase Rab8 being 
involved in both processes 79.
Polarized trafficking at the DC side of the immunological synapse
Although much less studied than the T cell side of the immunological synapse, 
polarized membrane trafficking occurs at the APC side as well. In DCs, MHC class 
I and II 81-84 and the costimulatory molecule CD40 85 can be locally trafficked to and 
presented at the immunological synapse. The local release of these molecules 
improves the efficiency of T cell activation and helps to explain how T-cells can 
detect as few as a handful (or even a single 86) of MHC ligands among an abundance 
of endogenous peptide-bound MHC (reviewed in 12). In addition, IL-12 is also locally 
released by the DC at the immunological synapse with T cells 87. IL-12 promotes 
a T helper 1 response, enhances the cytolytic activity of CD8+ T cells and induces 
production of IFN-γ by T-cells. The polarized release of IL-12 was also observed at 
the immunological synapse between DCs and NKs 52, 53.
The intracellular sorting and trafficking of MHC class II in DCs is well understood 
(reviewed in 88-90). After assembly in the ER and Golgi, MHC class II bound to 
the inactivating Li fragment traffics to the plasma membrane. It then reaches the 
antigen processing compartment by endocytosis. In this compartment, which 
is of endosomal/lysosomal nature and is called MIIC (MHC class II-containing 
compartment), MHC class II is activated by proteolytic degradation of the Li 
fragment and exchange with an antigenic peptide. In immature (i.e. inactivated) 
DCs from mice, a large fraction of MHC class II remains in MIIC. Upon DC 
maturation by cytokines and/or recognition of pathogens, tubular vesicles extend 
from MIIC towards the plasma membrane 83, 91-93. Vesicles bud off from these 
tubules for membrane fusion with the plasma membrane 91. Pathogen recognition 
by Toll-like receptors, such as TLR4, promotes tubulation and this process may 83 
or may not 94 depend on the adapter protein MyD88. TLR-stimulated tubulation 
further requires the small GTPases Rab7 and Arl8b, as well as the effector proteins 
RILP, FYCO1 and SKIP, at least in macrophages 95. TLR induced tubulation of late 
endosomal compartments can also be observed in human DCs derived from blood 
monocytes (i.e. a commonly used DC model system) 84, but here a large fraction 
of peptide loaded MHC class II resides on the plasma membrane already in the 
immature state (Fig. 2). Upon formation of an antigen-specific immunological 
synapse, the MIIC tubules can orientate selectively towards the immunological 
synapse in mouse DCs 81-83. This polarized MIIC tubulation is dependent on the 
clustering of signaling proteins, such as TCR and CD4, on the T cell surface and 
MHC class II on the DC surface, but also on the engagement of adhesion molecules 
such as LFA-1 with ICAMs 82.
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Figure 2. Surface display of peptide loaded MHC class II by 
both immature and mature human monocyte derived DCs.
Histogram with FACS data of MHC class II surface staining of 
DCs differentiated from peripheral blood mononuclear cells 
(with PE labeled antibody L243). Blue curve: inactivated DCs 
(immature). Orange curve: DCs stimulated overnight with 1 µg 
ml-1 of the TLR4 ligand LPS (mature DCs). Grey curve: isotype 
control (PE labeled mouse IgG2a). L243 does not bind to MHC 
class II with the invariant Li chain associated 109.
Similar to the T cell side of the immunological synapse, the cytoskeleton plays a 
major role in the polarized trafficking of molecules to the DC side. Upon formation 
of an immunological synapse, the MTOC in DCs can reorient towards the T cell 
and this remodeling is mediated by the GTPase Cdc42 87. MIIC tubules and other 
compartments of endosomal nature move over microtubules 84, 93, 94, 96, although 
MHC class II recruitment via actin has also been reported 97. The transport of 
IL-12, CD86 and ICAM-1 also depends on the microtubular cytoskeleton 26, 87, 98. 
As described above, the actin cytoskeleton of DCs rearranges upon antigen 
recognition in MHC class II and this is required for formation of a T cell activating 
synapse 50, 51. This actin reorganization is induced by LFA-1 interactions with ICAMs, 
which also induces MHC class II redistribution to the immunological synapse 27.
Recycling endosomes carrying MHC class I in human DCs were also shown 
to tubulate and to extend towards CD8+ T cells upon formation of an antigen 
specific synapse and this was dependent on ICAM-1 engagement with LFA-1 84. 
As mentioned above, co-stimulatory molecules, such as CD40 85 and IL-12 87, can 
also be recruited to the immunological synapse between DCs and T cells. Some 
co-stimulatory molecules may share their intracellular trafficking pathway with 
MHC, such as ICAM-1 and CD70, that may traffic via tubular MIIC to the plasma 
membrane 26, 96, 99. Other molecules do not traffic via MIIC to the plasma membrane 
such as the co-stimulatory receptor CD86 98. It remains an interesting possibility 
that IL-12 shares the same transport route with MHC class II and traffics to the 
immunological synapse in MIIC. How MHC class I and II, IL-12, CD40 and other 
stimulatory factors and adhesion molecules are finally released in a polarized 
fashion at the immunological synapse is still unknown. At the plasma membrane, 
peptide loaded MHC class II complexes are clustered in cholesterol dependent 
membrane domains, often referred to as lipid rafts 100-102. Clustering of MHC 
class II promotes screening for antigen peptides by TCR and thereby facilitates 
antigen presentation 100, 103, 104-105. These membrane domains are already formed 
prior to the arrival of MHC class II at the immunological synapse 103, 105. MHC class 
II containing membrane domains are enriched in tetraspanins (CD63, CD82) that 
also traffic via tubular membrane structures 94, 104. 
Expert opinion and outlook
In this review we discussed polarized trafficking of cargo molecules to both the 
T cell (e.g. TCR, lytic granules) and DC (MHC class I and II, IL-12, CD40) sides of 
the immunological synapse (Fig. 3). The T cell side of the immunological synapse 
is extensively studied and the mechanisms that underlie polarized trafficking 
are increasingly well understood. In contrast, how polarized trafficking to the 
DC side of the immunological synapse is achieved is still almost completely 
unknown. Studying polarized trafficking to the immunological synapse in DCs 
is technically challenging, because of the clear dependency on the precise 
types and activation states of the DC as well as of the T cell. Priming of naïve 
T cells by DCs requires a multitude of factors and, as we discussed, different 
cells or activation states can lead to a completely different structure of the 
synapse. This makes it imperative to work with primary cells, which are however 
very heterogeneous and difficult to study with conventional low-throughput 
microscopy-based techniques. New high-throughput-based techniques are 
clearly required to cope with this challenge such as the recently developed 
flow cytometry-based technique that allows fast imaging of large numbers of 
immunological synapses 106.  
As we discussed above, polarized release at the T cell side of the immunological 
synapse mechanistically resembles other forms of evoked release such as 
neurotransmitter release. Indeed, it is increasingly clear that all forms of evoked 
release in mammalian cells have a common evolutionary origin and consequently 
share many mechanistic similarities. It therefore seems reasonable to 
hypothesize that polarized release at the DC side of the immunological synapse 
will also share many structural and mechanistic similarities to polarized release 
at the T cell side. In this respect, it would be interesting to more systematically 
study the role in DCs of signaling molecules and metabolites with well-known 
roles at the T cell side of the immunological synapse, such as the small GTPases 
RhoA, Rac and Rap1, kinases such as PKC, and metabolites such as cAMP and 
calcium which can all be measured with FRET probes 107. As we discussed above, 
our understanding of release at the T cell side was propelled by the development 
of supported bilayers as surrogate APC. This system, with artificial bilayer 
carrying MHC (or antibodies against TCR) and the adhesion molecule ICAM-1, 
allowed not only to study synapse formation in well-defined conditions, but 
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also to address the structure of the synapse with high resolution microscopy 
and without interference from the APC. For these same reasons, reversing 
this model, thus reconstituting TCR and LFA-1 in planar model membranes for 
synapse formation with DCs, would be a very powerful tool for elucidating the 
mechanisms of polarized trafficking to the immunological synapse in DCs.
Figure 3. Scheme of membrane trafficking to the DC and T cell sides of the immunological synapse. 
At the T cell side, lytic granules containing granzyme and perforin, but also vesicles containing cargo, 
such as TCR and IFNγ, traffic to the synapse in a highly polarized fashion. Similarly, vesicles and/
or tubulovesicular structures carrying molecular cargo, such as MHC class I and II, CD40 and IL-12, 
specifically traffic to the DC side of the immunological synapse as well. We hypothesize IL-12 traffics in 
MIIC, but this is still unknown; see text for details.
It bears no question that a better understanding of the mechanism of polarized 
trafficking to the immunological synapse in DCs is not only of fundamental 
importance for the field of immunology, but also has large therapeutic potential. 
A functional immunological synapse between DCs and naïve T cells is essential 
to mount functional T cell responses and is thereby vital for the induction of an 
adaptive immune response and for homeostasis of self-tolerance. Any mechanistic 
insight in this process will therefore uncover important potential targets for the 
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development of new immunostimulatory or immunosuppressive drugs to combat 
a wide variety of diseases such as infection, cancer and auto-immune diseases. 
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Abstract
Soluble NSF attachment protein receptor (SNARE) proteins are key for 
membrane trafficking, as they catalyze membrane fusion within eukaryotic 
cells. The SNARE protein family consists of about 36 different members. Specific 
intracellular transport routes are catalyzed by specific sets of 3 or 4 SNARE 
proteins that thereby contribute to the specificity and fidelity of membrane 
trafficking. However, studying the precise function of SNARE proteins is 
technically challenging, because SNAREs are highly abundant and functionally 
redundant, with most SNAREs having multiple and overlapping functions. In 
this protocol, a new method for the visualization of SNARE complex formation 
in live cells is described. This method is based on expressing SNARE proteins 
C-terminally fused to fluorescent proteins and measuring their interaction by 
Förster resonance energy transfer (FRET) employing fluorescence lifetime 
imaging microscopy (FLIM). By fitting the fluorescence lifetime histograms 
with a multicomponent decay model, FRET-FLIM allows (semi-)quantitative 
estimation of the fraction of SNARE complex formation at different vesicles. This 
protocol has been successfully applied to visualize SNARE complex formation 
at the plasma membrane and at endosomal compartments in mammalian cell 
lines and primary immune cells and can be readily extended to study SNARE 
functions at other organelles in animal, plant and fungal cells.
Introduction
Membrane trafficking is a central feature of eukaryotic cells, where membrane 
vesicles bud off from a donor organelle and then move to and fuse with a target 
organelle1,2. Except for mitochondria, all these membrane fusion steps are 
catalyzed by members of the so-called soluble NSF attachment protein receptor 
(SNARE) protein family1,2. The SNARE protein family consists of about 36 members 
in mammalian cells and about 20 members in yeast2. SNARE proteins contain one or 
two ~52 residues long natively unstructured regions, called SNARE-motifs. SNARE 
proteins are often tethered to membranes by a C-terminal transmembrane helix1,2. 
SNAREs can be categorized based on the central residues they contribute to the 
SNARE complex into arginine (R) and glutamine (Q) SNAREs1,2. Membrane fusion 
is driven by the interaction of 3 or 4 cognate SNAREs that together contribute 4 
SNARE-motifs and are distributed over both the donor and acceptor membrane1,2. A 
SNARE complex consists of one R-SNARE motif and three Q-SNARE motifs (termed 
Qa, Qb and Qc). Complex formation starts at the N-termini of the SNARE-motifs, 
forming a so-called trans-SNARE-complex, and proceeds towards the C-termini, 
forming a tight α-helical coiled-coil bundle called a cis-SNARE-complex. The 
complex formation of even a single SNARE complex drags the donor and acceptor 
membranes together and overcomes the energy barrier for membrane fusion3. 
Assigning distinct SNARE complexes to specific transport routes within cells 
is often technically challenging. Although SNAREs clearly contribute to the 
specificity of membrane trafficking, they are promiscuous, functionally redundant 
and their functions overlap1,2. Because of this, perturbation experiments targeting 
SNAREs, such as by gene knockout, RNA interference, the introduction of blocking 
antibodies, or with soluble SNARE fragments acting as dominant negatives, 
frequently does not result in clear phenotypes as other SNAREs compensate2,4. 
Moreover, it is difficult to differentiate specific membrane fusion steps from 
upstream trafficking events, because SNAREs can be involved in multiple 
transport routes2. Localization studies of SNAREs by microscopy approaches, 
using immunolabeling or genetic fusion to fluorescent reporter proteins, suffers 
from the problems that (i) SNAREs locate to multiple organelles as they often 
mediate multiple trafficking steps, and (ii) their localization does not automatically 
mean they are functionally engaged in SNARE complex formation. Finally, SNARE 
complexes can be identified using immunoprecipitation experiments using one of 
the SNAREs as bait and the other SNAREs as targets, but this does not allow to 
assign these complexes to specific organelles or trafficking routes. Thus, currently, 
there is no alternative technique to visualize SNARE complexes with organellar 
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resolution. Immunofluorescence is not able to prove SNARE interactions but can 
show only the presence or absence of co-localization, while immunoprecipitation 
only can show SNARE interactions in the whole cell population but not assign the 
organelles where these interactions occur.
To overcome these limitations, a novel method allowing for the quantitative 
visualization of SNARE complexes within live cells with organellar resolution was 
recently developed by Verboogen and colleagues5. This method is based on the 
expression of pairs of SNAREs with spectrally shifted fluorescent proteins fused 
C-terminally to their transmembrane helices. After completion of membrane 
fusion and formation of a cis-SNARE complex, these fluorophores at the C-termini 
of the transmembrane helices are immediately juxtaposed to each other. The 
fluorophores are then well within the Förster distance (typically < 5 nm), resulting 
in Förster resonance energy transfer (FRET) from the green-shifted donor 
fluorophore to the red-shifted acceptor fluorophore5,6. FRET results in quenching 
of the donor fluorophore and an increased emission of the acceptor fluorophore 
that can be measured from the ratios of the donor and acceptor emission 
(ratiometric FRET). However, ratiometric FRET between two different molecules 
is challenging, because of fluorescence cross-talk and different levels of donor 
and acceptor SNAREs at different organelles and among cells7,8. FRET can also be 
measured from the fluorescence lifetime, which is the time between the excitation 
and the emission of a photon. If the donor fluorophore can release its energy by 
FRET, this competing process results in an apparent shortening of the fluorescence 
lifetime. This can be measured by fluorescence lifetime imaging microscopy 
(FLIM)7,8.  Lifetime FRET is much more robust than ratiometric FRET for measuring 
interactions between two different molecules, as the fluorescence lifetime is an 
intrinsic property of a fluorophore and is insensitive to its concentration. Moreover, 
FRET is by approximation quantitative, because the efficiency of FRET is inversely 
proportional to the sixth power of the distance between the donor and acceptor 
fluorophores (essentially a step function). Therefore, by fitting the fluorescence 
lifetime histograms recorded by FLIM with a double-component decay model, 
FRET-FLIM allows for the (semi-)quantitative estimation of the fraction of SNARE 
molecules engaged in SNARE complex formation5. 
Recently, this FRET-FLIM method was used by Verboogen and colleagues to 
visualize SNARE complex formation in primary dendritic cells of the immune 
system5. It was shown that upon encountering a pathogenic stimulus, dendritic 
cells reroute their membrane trafficking accompanied by an increased complexing 
of the R-SNARE vesicle-associated membrane protein (VAMP) 3 with the Qa-
SNARE syntaxin 4 specifically at the plasma membrane. This increased SNARE 
complex formation is likely required to meet the increased secretory capacity 
for the secretion of inflammatory cytokines such as interleukin 65. This protocol 
describes the experimental steps needed for the acquisition of FRET-FLIM data for 
the visualization and semi-quantitative measurement of SNARE complexes. It is 
explained how to fit the whole-cell fluorescence lifetime histograms with mono- 
and bi-exponential decay functions, resulting in the apparent fluorescence lifetime 
as a quantitative estimate to SNARE interactions. In this protocol, the widely used 
HeLa cell line is used as an example, but the method can be readily extended to 
study SNARE complexes in other eukaryotic cells. 
 
Protocol
1. Preparation of the microscope samples.
1.1.  Expression of Qa-SNARE syntaxin 4 fused to mCitrine (syntaxin 
4-mCitrine; donor fluorophore) and the R-SNARE VAMP3 fused to 
mCherry (VAMP3-mCherry). Note: other SNAREs with fluorescent 
proteins fused to their C-terminal transmembrane helices can also be 
used. Note: instead of mCitrine-mCherry, other donor-acceptor pairs of 
spectrally separated fluorophores can also be used (e.g., CFP-YFP).
 1.1.1.  Divide 900,000 HeLa cells over 3 35 mm-diameter glass bottom dishes 
suitable for microscopy). Note: in principle this protocol can be adapted 
for other eukaryotic cell types and microscopy dishes.
  1.1.1.1.  Maintain HeLa cell cultures in T75 flasks with 10 mL high glucose 
Dulbecco’s Modified Eagle’s medium (DMEM), supplemented 
with 10% fetal calf serum (FCS) and 1% antibiotic-antimycotic 
(containing amphotericin B, penicillin, streptomycin) at 37°C 
and 5% CO2 in a cell culture incubator. Note:  Replenish 
medium twice a week and split cells 1:10 once a week or when 
85-90% confluent to new T75 flasks (500,000 cells on average 
per flask).
  1.1.1.2.  Remove DMEM and wash HeLa monolayers twice with 8 mL 
sterile PBS for 3 minutes.
  1.1.1.3.  Remove PBS and add 2 mL PBS with 2 mM EDTA. 
  1.1.1.4.  Incubate 5 minutes at 37°C and 5% CO2 in cell culture incubator 
and subsequently lightly agitate the flask to separate HeLa 
cells from the bottom of the flask.
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  1.1.1.5.  Flush cells out with 10 mL medium and transfer to 15 mL tube 
and take 10 µL aliquot for counting. 
  1.1.1.6.  Dilute the aliquot 1:1 with 0.4% trypan blue stain and count cells 
with a Bürker haemocytometer9. Note: Count 2 4x4 squares and 
multiple cell number with 10,000 for number of cells per mL. 
  1.1.1.7.  After cell counting, take 900,000 cells from 15 mL tube, divide 
over the 3 glass bottom dishes (see step 1.1.1) and prepare for 
transfection. 
 1.1.2.  Transfect the cells by electroporation10 (see table of materials) with: 
  Sample #1: syntaxin 4-mCitrine construct (donor only); 
  Sample #2: syntaxin 4-mCitrine together with VAMP3-mCherry; 
  Sample #3: syntaxin 3 fused to both mCitrine and mCherry . 
   Note: Other cell transfection methods can also be used11. The tandem 
construct in sample #3 is a positive control for estimating the shortest 
lifetime expectable (i.e., maximal expectable FRET). 
1.2.  Culture the cells overnight in high glucose DMEM supplied with 10% 
FCS and 1% antibiotic-antimycotic at 37 oC with 5% CO2 in a cell culture 
incubator.
1.3.  Aspirate DMEM and wash the cells once with live cell imaging medium 
(140 mM NaCl, 2.5 mM KCl, 1.8 mM CaCl2, 1 mM MgCl2, 20 mM HEPES, 
pH = 7.4, mOsm = 300; see table of materials) for 2 minutes and 
subsequently place the cells in fresh imaging medium.
2.  Recording of the FLIM data.
2.1.  Place sample #2 under a time-domain FLIM confocal microscope with 
a pulsed excitation source for the donor fluorophore (i.e., mCitrine) and 
time-resolved data acquisition. Keep the cells at 37 oC with a heated 
stage.Note: The confocal microscope used in this protocol is equipped 
with a 63x 1.20 NA water immersion objective, a pulsed white light laser 
(80 MHz pulsing, <100 ps pulse duration), a photon multiplier tube (PMT), 
and a Time-Correlated Single Photon Counting (TCSPC) system (see table 
of materials for specific setup used). Other FLIM microscopes can also 
be used (e.g. single-photon avalanche diodes (SPAD) instead of PMTs, 
single-wavelength pulsed lasers instead of a white-light pulsed laser). 
2.2.  Select a cell with visible expression of the mCitrine and mCherry-
labeled SNARE proteins and record a confocal image of 256×256 pixels 
with simultaneous excitation of both fluorophores prior to each FLIM 
measurement. A pixel step of about 2-fold smaller than the diffraction 
limited spatial resolution of the microscope (~200 nm) should be used. 
For mCitrine, excite at 516 nm and collect emission from 521 to 565 nm; 
for mCherry, excite at 610 nm and collect emission from 613 to 668 nm. 
Note: do not position the imaging plane too close to the bottom of the 
dish (within ~2 µm distance), as this will result in a reflection peak in the 
fluorescence lifetime histogram. Simultaneous excitation of the donor and 
acceptor fluorophores is preferred, as this allows to overcome the potential 
problem of sample movement. However, sequential excitation can be used 
as well. 
2.3.  Record a FLIM image by clicking the button “Run FLIM”. This FLIM image will 
be recorded with the same dimensions and spatial resolution as the confocal 
image recorded at step 2.2. Record at least 50,000 photons for whole-cell 
FLIM analysis, or at least 400 photons per pixel for the generating FLIM 
images. Only excite the mCitrine donor fluorophore and not the mCherry 
acceptor fluorophore, thus excite at 516 nm and collect emission from 521 
to 565 nm.
2.4.   Repeat steps 2.1 to 2.3 for multiple cells and for the other samples #1 (donor 
only) and #3 (the mCitrine-mCherry tandem construct).
2.5.  Record an instrument response function (IRF). Tune the monochromator of 
the emission detector to the excitation wavelength (e.g., record emission 
from 510 to 550 nm) and then record a FLIM image with the back scattering 
from a clean glass cover slip (by clicking the button “Run FLIM”). The 
excitation wavelength (516 nm) and laser power should be identical as used 
for recording the cell data at steps 2.1-2.4. Note: If multiple peaks are visible 
in the IRF or if the emission monochromators cannot be tuned, the IRF can 
also be measured with a solution of fluorescent dye with ultrafast lifetime, 
for instance by fluorescence quenching of an organic dye in a saturated 
aqueous solution of potassium iodide. Moreover, it is not strictly required to 
record an IRF, because the decay slope of the fluorescence histograms can 
also be fitted without deconvolution of the IRF. However, an IRF enables 
to correct for the timing characteristics of the photon detector used and 
thereby makes the fits of the lifetime histograms more accurate. 
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3.  Conversion of the photon recordings to FLIM images. 
3.1.  Download and install the PT32ICS conversion software5.
   Note: the lifetime data can also be analysed by other software, including 
software from several microscope vendors.
3.2.  Configure the PT32ICS software:
 3.2.1.  Set the ‘Size‘ to 256×256 pixels image size via ‘Settings’ > ‘Size’.
 3.2.2.  Set the ‘Channel‘ to ‘2’ via ‘Settings’ > ‘Size’.
   Note: the channel of the mCitrine emission is exclusively dependent 
on the configuration of the microscope. A wrong channel will result 
in a FLIM image with no photons (i.e., black image) and as a result an 
empty ‘ LifetimeTable.txt’-file (See point 4.1). The correct channel can 
be identified by trial-and-error. 
 3.2.3  Set ‘Output’ to ‘ImageJ (xyz)’ (or ‘TRI2 (xyt)’ for generating FLIM images 
(see step 3.4)). 
3.3   Press ‘Convert’ and load one or more photon traces (the .pt3 
files; for selecting multiple photon traces keep the ‘Ctrl’ key 
pressed).
   Note: the newer 64 bit .ptu format can also be converted. 
3.4  The PT32ICS software generates the following files in the same folder 
as where the pt3 files are saved:
  -  One photon stack per .pt3 photon trace in image cytometry standard 
format (.ics).
   Note: this file can be used for single pixel fitting in order to generate 
FLIM images, for instance with TRI2 software (Gray institute, Oxford, 
UK)12,13 or the SLIM curve fitting library in FIJI ImageJ14,15. This file can 
also be used for Phasor analysis16, for instance with the Time Gated 
Phasor plugin for FIJI from Spechron (developed by F. Fereidoni, UC 
Davis Medical Center).
  -  One bitmap file per .pt3 photon trace (.bmp). 
  Note: this contains no lifetime information.
  -  A text file per conversion (_Report.txt) containing information on the 
photon statistics (i.e., the total number of photons in each .pt3 photon 
trace, the time resolution of detector).
  -  A second text file per conversion (_LifetimeTable.txt) containing the 
total fluorescence lifetime histograms in tab-delimited format for 
each .pt3 photon trace. Note: this file is used for the whole-cell FLIM 
analysis in step 4.
4.  Fitting of fluorescence lifetime histograms for whole-cell FLIM 
analysis.
 
   Note: this step (deconvoluted fitting of the IRF) requires software 
capable of deconvoluted fitting. Fitting the slopes of the fluorescence 
histograms without deconvolution of the IRF can be done with other 
software as well.
4.1.   Open the data analysis software program capable of fitting with 
deconvolution (see table of materials) and import the text file containing 
the histogram for each photon trace (_LifetimeTable.txt) via ‘File’ > 
‘Import’ > ‘Single ASCII’. 
4.2.  Reorganize the table such that the IRF is in the second column of the table 
(using ‘Copy’ and ‘Paste’). The IRF should thus be placed in the second 
column ‘B’ immediately next to the time values in the first column ‘A’.
4.3  Determine the quality of the recorded photon traces by selecting all 
columns (Press ‘Ctrl’+ ‘A’ to select all) and select ‘Plot’ > ‘Multi-panel’ > 
‘9 panel’. Photon traces with a high reflection peak (see Fig. 4F) should 
not be analyzed.
4.3.  Select all columns containing the quality-controlled lifetime histograms 
that will be fitted as well as the IRF in column ‘B’ (use ‘Ctrl’ key while 
selecting) and load the non-linear fitting (‘Analysis’ > ‘Fitting’ > ‘Nonlinear 
Curve Fit’ > ‘Open Dialog’).
4.4.   Load the deconvoluted fit function (available in the Supplementary 
Information) by adding this function to the analysis software (via ‘Category’ 
> ‘User Defined’, then ‘Function’ > ‘<Add>’). Select the fit function file 
‘FLIM_convoluted_IRF.fdf’. This function fits the fluorescence lifetime 
histograms with a mono-exponential decay function deconvoluted with 
the IRF (i.e., the second column ‘B’ in the table) (Eqn. 1):
𝑦𝑦(𝑡𝑡) = 𝑦𝑦& +	)𝐴𝐴 exp .−
𝑡𝑡
𝜏𝜏
1 ∗ IRF(𝑡𝑡)	d𝑡𝑡 
 
 
𝑦𝑦(𝑡𝑡) = 𝑦𝑦& +	)(𝐴𝐴7 exp .−
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   (Eqn. 1)
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   with t the time, τ the apparent fluorescence lifetime, A the amplitude, and 
y0 the offset. Note: Another option is to fit the lifetime histograms with a 
bi-exponential fit function (Eqn. 2): 
𝑦𝑦(𝑡𝑡) = 𝑦𝑦& +	)𝐴𝐴 exp .−
𝑡𝑡
𝜏𝜏
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 (Eqn. 2)
   By fixing the lifetime of the slow component (τ1) to the donor 
only condition (step 1.1.2: sample #1) and that of the fast 
component (τ2) to the tandem construct (sample #3), this 
allows estimation of the fraction of SNARE proteins in complex 
(F) from the amplitudes of the slow (A1) and fast components 
(A2; see discussion; Eqn. 3):
𝑦𝑦(𝑡𝑡) = 𝑦𝑦& +	)𝐴𝐴 exp .−
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𝐹𝐹 =
𝐴𝐴8
𝐴𝐴7 + 𝐴𝐴8
      (Eqn. 3)
   The fit function file for deconvoluted bi-exponential fitting ‘FLIM_
convoluted_IRF_biexp.fdf’ is available in the Supplementary 
Information.
4.5.  Select ‘Fitted Curves’ tab > ‘X Data Type’ as ‘Same as Input Data’. 
 Note: this will result in the appropriate x-axis scaling of the fitted 
curves.
4.6.  Fit the curves (press ‘Fit’). Note: This will convert the fit and generate 
a ‘report sheet’ in the array with a table containing the fluorescence 
lifetimes, offsets and amplitudes. It will also generate a data sheet with 
the fitted curves and the residuals of the fit. 
Results 
The rationale of the assay for measuring SNARE interactions by FRET-FLIM 
is shown in Figure 1. The C-termini of the transmembrane helices of cognate 
SNARE proteins are fused to a pair of spectrally shifted fluorescent proteins (e.g., 
mCitrine and mCherry). The formation of a cis-SNARE complex upon membrane 
fusion results in these fluorescent proteins becoming immediately juxtaposed 
to each other and FRET. Figure 2 shows representative confocal images of 
HeLa cells expressing fluorescently-labeled SNARE proteins. Shown are a cell 
expressing syntaxin 4-mCitrine (donor fluorophore) with VAMP3-mCherry 
(acceptor fluorophore), as well as control conditions of cells expressing only the 
syntaxin 4-mCitrine construct (donor only; no FRET) and syntaxin 3 fused to both 
mCitrine and mCherry in tandem (maximal expectable FRET). Figure 3 shows the 
accompanying fluorescence lifetime and FLIM images generating by fitting the 
lifetime histograms of each pixel with mono-exponential decay functions (3A-B) 
and bi-exponential decay functions (3C-D). Figure 4A shows the IRF of our setup 
measured by back scattering of a microscope cover glass. Figure 4B-E show 
representative fluorescence lifetime histograms of the whole cell FLIM analysis 
together with accompanying fit curves for mono-exponential decay functions. 
Figure 4F shows a fluorescent lifetime histogram of an experiment imaged too 
close to the surface of the microscope cover glass, resulting in a prominent 
reflection peak. Figure 4G shows a lifetime histogram with representative fit 
with a bi-exponential decay function.
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Figure 1. Scheme of the rationale for visualizing SNARE complexes by FRET.
(A) Structural model of the neuronal SNAREs (protein database 3HD717) vesicle-associated membrane 
protein (VAMP) 2, (blue; R), syntaxin 1 (red; Qa-SNARE) and SNAP25 (green; contains both a Qb- and 
Qc-SNARE motif). The C-terminus of the transmembrane helix of syntaxin-1 is conjugated to mCitrine 
(donor fluorophore; protein database 3DQ118). The C-terminus of the transmembrane helix of VAMP2 
is conjugated to mCherry (acceptor fluorophore; protein database 2H5Q19). (B) Scheme of SNARE 
mediated membrane fusion resulting in FRET. After membrane fusion by formation of a cis-SNARE 
complex, the SNAREs are immediately juxtaposed to each other resulting in FRET.
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Figure 2. Expression of SNARE proteins fused to fluorescent proteins.
First column: donor fluorophore, was excited at 516 nm. Second column: acceptor fluorophore was 
excited at 610 nm. (A) Donor only condition. Representative confocal image of a HeLa cell expressing 
syntaxin 4-mCitrine (donor fluorophore; green in merge). The acceptor channel (second column) shows 
the fluorescence cross-talk. (B) Negative control (no FRET). Representative confocal image of a HeLa cell 
expressing both syntaxin 4-mCitrine with VAMP3-mCherry (acceptor fluorophore; magenta in merge). 
(C) Positive control (maximal expectable FRET). Representative confocal image of a HeLa cell expressing 
the syntaxin 3-mCitrine-mCherry tandem construct. Note that the fluorescence signal of the mCitrine 
and mCherry signals does not completely overlap, likely because of a lower resistance of mCitrine to 
lysosomal degradation compared to mCherry (see Discussion section). BF: bright field. Scale bars, 20 µm.
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< Figure 3. FLIM images of SNARE complex formation.
(A) Representative fluorescence lifetime images of the cells shown in figure 2. The images were 
generated by first converting the photon traces recorded by a TCSPC system (.pt3) to the image 
cytometry standard (.ics) using the PT32ICS software. Single pixel fitted fluorescence lifetime images 
were then generated using the TRI2 software (version 2.8.6.2; Gray institute, Oxford, UK)12,13 with 
thresholding from 15 to 100% intensity, 7 pixel circular binning and monoexponential fitting algorithm 
(Marquardt). The color indicates the average apparent fluorescent lifetime. (B) FLIM images where the 
fluorescence lifetime images (shown in panel A) were convoluted with the fluorescence intensities of 
the mCitrine donor fluorophore (shown in figure 2). The convolution was performed with FIJI ImageJ 
using a custom-made macro (see table of materials). (C) Fluorescence lifetime and FLIM images of the 
HeLa cell expressing both syntaxin 4-mCitrine and VAMP3-mCherry from panels A-B, but now with 
fitting with bi-exponential decay curves (with lifetimes fixed to the control conditions; see step 4.4 
in protocol). The pixel colors indicate the estimated fractions F of syntaxin 4 in complex with VAMP3 
(Eqn. 3). (D) Same as panel B, but now for the bi-exponential fit. The convolution was performed with 
FIJI ImageJ using a custom-made macro (see table of materials).
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< Figure 4. Whole cell FLIM analysis.
(A) The instrument response function (IRF) of our setup. The IRF was measured using the back 
scattering on the glass-water interface (using a clean glass microscopy dish containing water). B-E) 
Whole cell lifetime histograms for the cells shown in figures 2 and 3. All photons present in the images 
were pooled. The curves were deconvoluted with the IRF and fitted with mono-exponential decay 
functions (Eqn. 1). For these cells, fluorescence lifetimes were obtained of 2.82 ns (cells expressing 
only syntaxin 4-mCitrine; donor only; panel (B), 2.09 ns (cells co-expressing syntaxin 4-mCitrine with 
VAMP3-mCherry; panel (C) and 2.08 ns (cells expressing the syntaxin 3-mCitrine-mCherry tandem 
construct; maximal expectable FRET control; panel (D). The inlays show the same graphs, but now 
with logarithmic scaling of the y-axis. Panel (E) shows an overlay of the decay curves of panels B-D. (F) 
Example of a fluorescent lifetime histogram recorded too close to the surface of the microscope cover 
slip. This results in a large reflection peak (depicted by the yellow shaded area). (G) Same as panel C, 
but now with fitting with a bi-exponential decay curve with lifetimes fixed to the control conditions 
(see step 4.4 in protocol). The amplitudes of the fast (A1) and slow (A2) components were 14.42 and 
0.01, respectively, resulting in an estimated fraction of SNAREs in complex F of 0.99 (Eqn. 3).Stx3-mCitrine-mCherry
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Discussion
This protocol demonstrates the use of FRET-FLIM for visualization of SNARE 
interactions between syntaxin 4 and VAMP3 in live HeLa cells. Syntaxin 4 is a 
Qa-SNARE protein predominantly locating at the plasma membrane where it 
mediates exocytosis1,2,20,21. VAMP3 is an R-SNARE which is mainly described to 
locate at recycling endosomal compartments and mediates trafficking to other 
endosomes as well as to the plasma membrane1,2,20. However, the FRET-FLIM 
assay can be readily adapted for studying other SNARE proteins. The only 
condition is that these SNAREs contain a C-terminal transmembrane helix, 
which is the case for most SNARE proteins by far1,2. In addition, the protocol 
described here can be adapted for visualization of SNARE complexes in any 
eukaryotic cell type, including plants and yeast. In this protocol, we used the 
shortening of the fluorescence lifetime of the donor fluorophore as a measure 
of FRET. As a complementary approach, the lifetime of the acceptor fluorophore 
could be examined, because the sensitized emission causes a distinct rise phase 
which provides unambiguous proof that resonance energy transfer occurs.
Currently, the FRET-FLIM technique may be not able to visualize SNARE complexes 
in lysosomal compartments. For the syntaxin 3-mCitrine-mCherry tandem 
construct, the mCherry fluorescence can often be found more accumulated 
in a juxtanuclear area, which likely corresponds to lysosomal compartments, 
whereas the mCitrine signal is more abundant in the cellular periphery5. A 
similar juxtanuclear accumulation of mCherry compared to mCitrine was 
observed, when the same SNARE proteins fused to these fluorescent proteins 
were co-expressed5. Lysosomes are characterized by an extremely low pH (<4) 
and a high activity of proteolytic enzymes. The juxtanuclear accumulation of 
mCherry is likely caused by a higher resistance of the mCherry fluorophore to 
lysosomal degradation compared to the mCitrine fluorophore. It is not due to 
pH-quenching of mCitrine, as juxtanuclear accumulation of mCherry also occurs 
upon fixation of the cells5. Thus, the FRET-FLIM technique underestimates the 
amount of FRET in the juxtanuclear (lysosomal) regions and this would require 
other fluorescent reporter proteins that survive the harsh conditions within the 
lumens of lysosomes.
FRET-FLIM in principle allows to obtain a semi-quantitative estimate of the 
fraction of SNAREs in complex5. As we explained in this protocol, this requires the 
fitting of the fluorescence lifetime histograms with double-exponential decay 
functions (Eqn. 2), where the amplitude of the fast component is proportional 
to the fraction of SNAREs in complex (Eqn. 3). However, such fitting with a 
two-component model is technically challenging. Fitting with multiple free fit 
parameters (two fluorescence lifetimes and two amplitudes) requires a very large 
number of photons, especially since the parameters will influence each other and 
small errors in the lifetime will affect the amplitudes and vice versa. To overcome 
these fitting problems, the fluorescence lifetimes of the slow component can 
be fixed to the lifetime of the donor only condition (i.e., no FRET; only mCitrine 
present) and that of the fast component to the lifetime of the tandem construct 
(maximal expectable FRET). However, this should also be interpreted with care, 
because the fluorescence lifetimes may not be the same as in these control states, 
and could deviate because of multiple reasons (self-quenching, dipole orientation, 
variations in the microenvironment). Multiple SNARE complexes within close 
proximity (<10 nm) can result in distance dependent FRET, the same principle 
that allows FRET to be used as a “molecular ruler”, but in this case obscures the 
quantification of SNARE complexes. Moreover, a quantitative estimate is not 
always meaningful, because the labeled SNAREs compete with endogenous 
(unlabeled) SNAREs. As a consequence, the expression level of mCherry-labeled 
SNARE is a main determinant for the percentage FRET5. Because of all these 
caveats, it is recommended to fit the fluorescent lifetime histograms with a 
mono-exponential decay function (Eqn. 1). This has the advantage that it does not 
require any a-priori knowledge of the lifetimes and the resulting apparent average 
fluorescent lifetime provides a solid measure for SNARE complexing5.
Nevertheless, it is expected that quantitative FRET-FLIM imaging by two-
component fitting models will have potent future applications. SNARE-
encoding genes within the chromosome can be fused with fluorescent 
reporter proteins, for example by CRISPR/CAS9. This results in the fluorescent 
labeling of endogenous SNARE proteins, with endogenous protein levels and 
no background of unlabeled SNAREs, and thereby allows for a meaningful 
quantitative estimation of the fraction of SNARE complexes by FRET-FLIM. 
While the expression levels of endogenous SNAREs might be quite low and 
give relatively low fluorescent signals, it is expected that a sufficient number 
of photons can be obtained, especially for the whole cell FLIM (which requires 
only a few 1000 of photons). Moreover, these FRET-FLIM measurements can be 
performed with more sensitive avalanche photodiode detectors which will also 
result in higher fluorescence signals and better photon statistics. 
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Abstract 
SNARE proteins play a crucial role in intracellular trafficking by catalyzing 
membrane fusion. However, assigning SNAREs to specific intracellular transport 
routes is challenging with current techniques. We developed a novel Förster 
resonance energy transfer-fluorescence lifetime imaging microscopy (FRET-
FLIM)-based technique allowing visualization of real-time local interactions 
of fluorescently tagged SNARE proteins in live cells. We used FRET-FLIM to 
delineate the trafficking steps underlying the release of the inflammatory 
cytokine interleukin 6 (IL-6) from human blood-derived dendritic cells. We 
found that activation of dendritic cells by bacterial lipopolysaccharide leads to 
increased FRET of fluorescently labeled syntaxin 4 with VAMP3 specifically at the 
plasma membrane, indicating increased SNARE complex formation, whereas 
FRET with other tested SNAREs was unaltered. Our results revealed that SNARE 
complexing is a key regulatory step for cytokine production by immune cells and 
prove the applicability of FRET-FLIM for visualizing SNARE complexes in live 
cells with subcellular spatial resolution. 
Introduction
One of the central paradigms in cell biology is that all intracellular membrane 
fusion, except for mitochondrial fusion, is catalyzed by soluble NSF 
(N-ethylmaleimide-sensitive fusion protein) attachment protein receptor 
(SNARE) proteins 1,2. There are about 36 SNARE proteins identified in mammals 
which can be classified in R-SNAREs or Q-SNAREs depending on the central 
residue of their SNARE motif being either arginine (R) or glutamine (Q). The 
interaction of one R motif and three Q motifs (termed Qa, Qb and Qc) of 
cognate SNARE proteins located in opposing membranes leads to the formation 
of a 4-helix coiled-coil bundle. This trans-SNARE complex formation brings 
the membranes in close proximity and catalyzes their fusion. After membrane 
fusion is complete, the SNAREs are in a so-called cis-conformation and need to 
be disassembled by the AAA-ATPase NSF in conjunction with α-SNAP 1–3. 
From studies in yeast and many mammalian cell types, including neurons, 
neuroendocrine cells, adipocytes and epithelial cells, it is clear that different 
intracellular trafficking steps are catalyzed by specific sets of SNARE 
proteins 1,2,4. Also in immune cells, such as granulocytes, platelets, mast cells, 
macrophages and T cells, specific combinations of SNARE proteins mediate 
release of cytokines, chemokines and delivery of surface receptors via specific 
secretory pathways 5–9. In order to identify the combinations of SNARE proteins 
responsible for a particular intracellular trafficking step, most studies rely on 
localization microscopy experiments either with endogenous or overexpressed 
SNAREs. However, these approaches suffer from the problems that many 
SNAREs locate to multiple organelles, as SNAREs are promiscuous and can be 
involved in different trafficking steps, and that mere co-localization of SNAREs 
does not prove their actual interaction 1,4. Interactions can be shown with co-
immunoprecipitation experiments, but these cannot resolve in which organelle 
the interactions take place. Perturbation experiments, such as genetic ablation 
of SNAREs, overexpression of soluble ‘dominant negative’ SNARE fragments, 
or microinjection of antibodies directed against SNAREs, are also difficult to 
interpret because SNAREs are functionally redundant and defects in a specific 
trafficking route cannot be discerned from upstream trafficking steps. Because 
of this, knockdown or knockout of many SNARE proteins often does not show 
a clear phenotype 1,10,11. Thus, a method that allows quantitative visualization of 
SNARE complexes with subcellular resolution is highly desirable.
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In this study, we aimed to fill this gap in methodology by developing an assay 
to locally detect SNARE interactions with Förster resonance energy transfer 
(FRET) based fluorescence lifetime imaging microscopy (FLIM) 12,13. FRET is 
based on the energy transfer from a donor to an acceptor fluorophore within 
the Förster distance range. FRET leads to quenching of the donor fluorophore 
and sensitization of the acceptor fluorophore and can either be measured from 
fluorescence intensities (ratiometric FRET) or from a decrease in fluorescence 
lifetime of the donor fluorophore (FRET-FLIM). Ratiometric FRET and FRET-
FLIM have been previously used to characterize cytosolic interactions of fungal 
SNAREs 14 and of the neuronal Qa-SNARE syntaxin 1 (STX1) and the Qb/c-
SNARE SNAP25 15–19. We hypothesized that FRET-FLIM could also be used to 
measure full ternary cis-SNARE complex formation, as the crystal structure of 
the neuronal SNARE complex revealed that the luminal/extracellular C-termini 
of the R-SNARE vesicle-associated membrane protein 2 (VAMP2) and of STX1 
are in immediate proximity (< 1 nm) after membrane fusion (i.e., in the cis-
SNARE complex) 20. In vitro, FRET between these SNAREs can be measured 
by labeling their C-termini by means of site-specific labeling with organic 
fluorophores 21. In vivo, Degtyar, et al. (2013) showed interactions between 
VAMP2 and STX1 C-terminally fused to fluorescent proteins by total internal 
reflection fluorescence (TIRF) microscopy combined with ratiometric FRET 22. 
However, ratiometric FRET is technically challenging as extensive controls are 
required to correct for local concentration differences of the donor and acceptor 
fluorophores 12,13. FLIM does not suffer from this limitation, as the lifetime (τ) is 
an intrinsic characteristic of a fluorophore which is not influenced by the probe 
concentration nor by the excitation intensity 12,13. Occurrence of FRET leads to 
quenching of the donor signal, which in turn shortens its fluorescence lifetime. 
Therefore, reductions in the donor’s lifetime reflect interactions between the 
proteins conjugated to the donor and acceptor fluorophores. In this study, we 
demonstrate the applicability of our FRET-FLIM assay to visualize the complexes 
of several SNAREs in dendritic cells of the immune system.
Dendritic cells are leukocytes essential for the activation of T cells 23. Activation of 
dendritic cells by inflammatory or pathogenic stimuli triggers the production and 
release of cytokines and chemokines that orchestrate the immune response 5,7. 
Despite many studies characterizing the cytokines that are released by dendritic 
cells and their mechanisms of action, not much is known about the trafficking 
pathways involved. Using FRET-FLIM, we measured how activation of dendritic 
cells affects the interactions between the R-SNAREs vesicle-associated 
membrane protein 3 (VAMP3) and VAMP8 with the Qa-SNAREs syntaxin 3 
(STX3) and syntaxin 4 (STX4). While both VAMP3 and VAMP8 are associated 
with cytokine release from immune cells 5–9, VAMP3 is mostly associated with 
early and recycling endosomes and VAMP8 with late endosomes 1,24–27. VAMP8 
has also been reported to inhibit phagocytosis by dendritic cells 28. STX3 and 
STX4 are mainly plasma membrane localized SNAREs mediating exocytosis, but 
also have intracellular roles in immune cells 6–9,29–32. Our FRET-FLIM experiments 
revealed FRET of fluorescently labeled STX3 with VAMP3 in live dendritic cells 
and this was predominantly present at the plasma membrane, indicative of 
increased STX3-VAMP3 complexing at this site. In contrast, FRET of fluorescently 
labeled STX3 with VAMP8 was higher at intracellular compartments. Our results 
also showed an increase in FRET of fluorescently labeled STX4, but not of STX3, 
with VAMP3 upon cellular activation with the Toll-like receptor 4 (TLR4) agonist 
lipopolysaccharide (LPS), indicating that LPS promotes the complex formation 
of STX4 with VAMP3. LPS activation of dendritic cells induces an inflammatory 
response, which is characterized by the secretion of inflammatory cytokines 
such as interleukin 6 (IL-6) 6. VAMP3 plays a key role in this cytokine secretion, as 
siRNA knockdown of VAMP3 resulted in impaired release of IL-6 from dendritic 
cells. Our study demonstrates that the secretion of IL-6 is regulated at the level 
of SNARE complex formation and proves the use of FRET-FLIM for quantitative 
visualization of SNARE interactions in live cells.
 
Results
SNAREs interactions in live cells visualized by FLIM
We generated variants of VAMP3 and STX3 with their C-termini conjugated to 
mCitrine 33 and mCherry 34, respectively. The emission spectrum of mCitrine 
overlaps with the excitation spectrum of mCherry which makes them a suitable 
donor-acceptor pair for FRET (Fig. S1A). Both mCitrine and mCherry are pH-
insensitive and therefore their fluorescence lifetimes are not affected by low 
pH within the lumen of intracellular compartments 33,34. In addition, they are 
monomeric which is important to prevent oligomerization artifacts. Modeling 
the crystal structure of the neuronal cis-SNARE complex 20 with mCitrine 35 
and mCherry 36 fused to C-termini of VAMP2 and STX1 showed that these 
fluorophores are immediately juxtaposed to each other (Fig. 1A). Based on the 
high structural homology of SNARE proteins, we expected that mCitrine and 
mCherry attached to the C-termini of VAMP3 or VAMP8 and STX3 or STX4 would 
also be in close proximity in a cis-SNARE complex and that this would result in 
FRET and a decrease of the donor (mCitrine) fluorescence lifetime (Fig. 1B). 
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Human blood-isolated monocyte-derived dendritic cells were transfected 
with either STX3-mCitrine alone or in combination with VAMP3-mCherry 
(Fig. 1C). STX3-mCitrine localized to the plasma membrane and to intracellular 
compartments. VAMP3-mCherry was predominantly present in intracellular 
compartments with only a small fraction located at the plasma membrane similar 
to the localization of endogenous VAMP3 (Fig. S1B). We recorded fluorescent 
lifetime images of live (unfixed) cells at an image plane locating at the height of 
the nucleus and accumulated on average ~750,000 photons per cell (Fig. S1C). 
The fluorescence life time histograms of single pixels were fitted with a mono-
exponential decay function to generate FLIM images showing the apparent 
lifetime of each pixel (Fig. 1C; Fig. S1D–E). Compared to cells expressing only 
STX3-mCitrine, the FLIM images of cells co-transfected with STX3-mCitrine 
and VAMP3-mCherry showed a reduction of the donor’s apparent lifetime. The 
lowest apparent lifetime was present at the plasma membrane (quantification 
below), indicating that the complexing of VAMP3 with STX3 mainly took place 
at the cell membrane and less at intracellular compartments. FRET was also 
clear from Phasor analysis 37, as co-expression of STX3-mCitrine with VAMP3-
mCherry resulted in a shift of the phasor location compared to the condition 
with the donor fluorophore only (STX3-mCitrine) (Fig. S1F). Thus, FRET-FLIM 
allows visualization of SNARE complexes in living cells.
In order to obtain an estimate of the lowest lifetime observable, we recorded 
FLIM images of STX3 conjugated to both mCitrine and mCherry in tandem 
(STX3-mCitrine-mCherry) (Fig. 1C; Fig. S1E–F). Although the colocalization of 
the mCitrine and mCherry signals was apparent, the overlap was not complete 
and the mCherry signal was more present in a cellular area juxtaposed to the 
nucleus (Fig. 1C; Fig. S1G-H). To investigate this phenomenon further, we co-
expressed VAMP3-mCitrine with VAMP3-mCherry or VAMP8-mCitrine with 
VAMP8-mCherry and compared the localization of these constructs (Fig. S1I). 
In this case, the mCherry signals were also more prevalent than mCitrine in a 
juxtanuclear area. This juxtanuclear accumulation of mCherry was also observed 
upon dissipating the proton gradients by paraformaldehyde fixation (Fig. S1G, 
S1J), indicating that the differential localization of mCherry and mCitrine was 
not caused by pH-quenching of mCitrine, but possibly due to differences in 
maturation speed or stability of the used fluorophores 33,34. Consequently, our 
FRET-FLIM approach likely underestimates the amount of FRET in juxtanuclear 
regions and more stable or rapidly maturating YFP analogs need to be developed 
for this. However, we observed clear overlap of mCherry and mCitrine in more 
peripheral cellular regions (Pearson correlation coefficients between 0.6–0.8 for 
the whole cell; Fig. S1H, S1K), supporting the conclusion that our FRET-FLIM 
method can report on SNARE interactions in those regions.
Stx3-mCitrine Merge FLIM
Stx3-mCitrine Merge FLIM
Stx3-mCitrine-mCherry Merge FLIM
VAMP3-mCherry
1.6 3.0 ns
Low High
Intensity
Lifetime
VAMP3
Stx3
mCherry
mCitrine
NO FRET NO FRET FRET FRET NO FRET
Figure 1. SNARE complex formation by FRET-FLIM.
(A) Model of the neuronal SNAREs (crystal structure; protein database 3HD7 (Stein et al, 2009)) with 
the C-termini of syntaxin 1 (red) conjugated to mCitrine (3DQ1 (Barstow et al, 2008); yellow) and 
VAMP2 (blue) conjugated to mCherry (2H5Q (Shu et al, 2006); magenta). mCitrine (donor fluorophore) 
and mCherry (acceptor) are within 3 nm proximity resulting in FRET. Green: SNAP25. (B) Scheme of 
membrane fusion resulting in FRET. (C) Representative confocal microscopy (left) and FLIM (right) 
images of dendritic cells expressing STX3-mCitrine (green in merge; upper panels), STX3-mCitrine 
with VAMP3-mCherry (magenta; middle panels), or STX3 conjugated to both mCitrine and mCherry 
(STX3-mCitrine-mCherry; lower panels). Apparent fluorescence lifetimes of STX3-mCitrine with 
VAMP3-mCherry were lowest at the cell membrane (yellow arrowheads). Scale bars, 10 µm. Full 
lifetime/intensity lookup table and lifetime images are in Fig. S1D–E.
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C
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We performed whole-cell fluorescence lifetime analysis to directly compare 
between cells and conditions. We fitted all pooled photons collected from 
each individual cell with single exponential decay functions convoluted with 
the instrument response function (IRF) (Fig. 2A–B; Fig. S2A–B). We obtained 
reasonable fitting accuracy (within ~2% deviation), although these deviations 
were larger at very short time intervals (<2.5 ns; Fig. S2A). These deviations 
at short time intervals are likely caused by imperfect fitting of the IRF due to 
drift of the laser pulsing or timing of the detectors, reflections and/or (auto)
fluorescence with fast kinetics, but do not cause major deviations of the resulting 
apparent lifetimes as our experiments with the reference dye rhodamine B show 
(Fig. S2C). In STX3-mCitrine expressing cells, co-transfection with VAMP3-
mCherry significantly reduced the apparent lifetime of mCitrine from 2.79 ± 
0.02 ns to 2.49 ± 0.03 ns (mean ± SEM) (Fig. 2C). Cells from at least 4 different 
donors (>8 cells/donor) were measured for each condition (Fig. S2D). The 
spread of apparent lifetimes for cells co-expressing STX3-mCitrine with VAMP3-
mCherry was quite large, ranging from 2–3 ns (Fig. 2C). This large spread was at 
least partly caused by the availability of VAMP3-mCherry and competition with 
endogenous SNAREs, because the fluorescence lifetimes inversely correlated 
with the expression levels of VAMP3-mCherry (Fig. 2D; Fig. S2E). To account for 
the whole cell population with varying levels of acceptor fluorophore-labeled 
SNAREs, we randomly selected cells with visible expression of both donor and 
acceptor fluorophores for our FRET-FLIM experiments. In order to quantify the 
difference in apparent lifetimes between the plasma membrane and intracellular 
compartments, we manually selected peripheral and intracellular regions of the 
image cell areas and fitted the fluorescence lifetime histograms of these two 
areas with mono-exponential decay functions (Fig. S2F–G). Most cells showed 
a lower apparent lifetime at the cellular periphery compared to the intracellular 
region (Fig. 2E). This reduction was on average 55 ps (paired two-sided Student’s 
t-test; P = 0.0078) but was larger for cells with higher FRET (linear regression: 
β = 1.18, R2 = 0.82). 
The co-expression of STX3-mCitrine and VAMP3-mCherry will result in a mixed 
population, with part of STX3-mCitrine interacting with VAMP3-mCherry and the 
remainder free or engaged with endogenous VAMP3 or other R SNAREs. In order 
to estimate the fraction of FRET, we fitted the whole-cell lifetime histograms of 
cells co-expressing STX3-mCitrine and VAMP3-mCherry with double exponential 
decay functions (Fig. 2F; Fig. S3A). In our biexponential fitting, we had to fix the 
lifetime components, as we did not have sufficient photon counts for extra free 
fit parameters since small errors in the lifetimes will influence the amplitudes 
of the two components and vice versa. The time constants of the slow and fast 
components of the double exponential decay function were fixed to the values of 
the donor only (i.e., no FRET; 2.79 ns) and of the tandem STX3-mCitrine-mCherry 
construct (100% FRET; 2.0 ns). This allowed estimating the percentage of FRET 
from the amplitudes of the fast and slow components, which provides a measure 
for the fraction of STX3-mCitrine in complex with VAMP3-mCherry (Fig. 2G). 
Using this analysis, the percentage of complexed STX3-mCitrine again correlated 
with the expression level of VAMP3-mCherry and reached up to almost 100% at 
high expression levels (Fig. 2H; Fig. S3B). These data support our conclusion that 
complex formation of the donor fluorophore-labeled SNARE depends on the 
availability of acceptor fluorophore-labeled SNAREs. The observed fluorescence 
lifetimes of mCitrine not only depend on FRET, but will also be sensitive to other 
factors including the microenvironment, dipole orientation, and self-quenching of 
mCitrine within SNARE domains 38. As a consequence, the observed fluorescence 
lifetimes in our samples may not be the same as in our control samples (i.e., donor 
only and tandem STX3-mCitrine-mCherry). Fitting with mono-exponential decay 
functions does not require any a-priori knowledge of the fluorescence lifetimes. 
Moreover, correlation of the apparent lifetimes from mono-exponential fits with 
the amplitudes from the bi-exponential fits resulted in a clear linear correlation 
(Fig. S3C; linear regression: R2 = 0.812), demonstrating that these apparent 
lifetimes provide a reliable measure of the percentage FRET. We therefore 
analyzed the remainder of our FLIM data with mono-exponential decay functions.
Validation of the FLIM assay for SNARE complex formation
We performed two sets of control experiments to confirm that FRET-FLIM is a 
reliable method to measure interactions between SNARE proteins in live cells. 
First, we generated fusion constructs of SNARE proteins with either the FK506 
binding protein 12 (FKBP) or FKBP rapamycin binding (FRB) domain of mTOR 
fused to their N-termini. Dendritic cells were transfected with FRB-VAMP3-
mCherry in combination with FKBP-STX3-mCitrine or FKBP-STX4-mCitrine 
(Fig. 3A; Fig. S4A). FKBP and FRB are rapamycin binding domains and the 
presence of this compound induces their dimerization 39. Thus, we reasoned 
that the rapamycin-induced heteromerization of FKBP and FRB would 
force or stabilize SNARE association. Indeed, addition of rapamycin or the 
rapamycin analogue A/C Heterodimerizer resulted in a decrease of the apparent 
fluorescence lifetimes (Fig. 3A). 
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As a second approach to validate our FLIM method, we generated a mutant form of 
VAMP3-mCherry lacking leucine 71 (VAMP3(Δ71)) (Fig. 3B–C; Fig. S4B). This residue 
is located at the C-terminal end of the SNARE region which is identical to VAMP2 
(Fig. 3B). For VAMP2, deletion of leucine 84, homologous to leucine 71 of VAMP3, 
allows formation of a trans-SNARE complex but impairs fusion of membranes as 
progression to the cis-conformation cannot take place 40. For VAMP3, deletion of 
leucine 71 also impairs membrane fusion, as cells co-expressing STX3-mCitrine 
with VAMP3(Δ71)-mCherry showed a significantly higher apparent fluorescence 
lifetime compared to cells expressing non-mutant VAMP3-mCherry (Fig. 3C). These 
data confirm that FRET-FLIM allows detection of SNARE complexes.
Comparison of different SNAREs involved in exocytosis
Next, we used our FRET-FLIM assay to compare complex formation between 
different SNARE proteins. Dendritic cells were transfected with STX3-mCitrine 
or STX4-mCitrine alone or in combination with VAMP3-mCherry or VAMP8-
mCherry (Fig. 4A; Fig. S5A). STX4-mCitrine mainly localized to the plasma 
membrane and only somewhat to intracellular compartments. Similar to 
VAMP3-mCherry, the majority of VAMP8-mCherry was present in intracellular 
compartments (Fig. 4A) and this corresponded to the localization of endogenous 
VAMP8 (Fig. S1B). Whole-cell fluorescence lifetime analysis revealed 
interactions between all SNARE pairs tested, as reflected by reductions of the 
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< Figure 2. SNARE complex formation by whole-cell fluorescence lifetime measurements.
(A) Representative whole-cell fluorescence lifetime histograms of dendritic cells expressing STX3-mCitrine (red 
curves; left graph), STX3-mCitrine with VAMP3-mCherry (green; middle graph), or STX3 conjugated to both 
mCitrine and mCherry (STX3-mCitrine-mCherry; cyan; right graph). Dashed lines: fits with mono-exponential 
decay functions convoluted with the instrument response function (IRF; gray). Graphs are normalized to the 
maximum photon counts (depicted in each graph). Apparent fluorescence lifetimes for STX3-mCitrine: 2.90 ns; 
for STX3-mCitrine with VAMP3-mCherry: 2.29 ns; for STX3-mCitrine-mCherry: 2.05 ns. Shown with logarithmic 
scaling in Fig. S2A. (B) Overlap of the fluorescence lifetime decay curves from panel A (logarithmic scaling in 
Fig. S2B). (C) Whole-cell apparent fluorescence lifetimes for the conditions from panel A. Shown are individual 
cells pooled from at least 4 donors (mean ± SEM shown; one-way ANOVA with Bonferroni correction; n: number 
of cells; individual donors in Fig. S2D). (D) Whole-cell apparent fluorescence lifetimes of STX3-mCitrine as a 
function of the expression level of VAMP3-mCherry (by fluorescence intensities) of a representative donor (more 
donors in Fig. S2E). Dashed line: linear regression (β = -0.008; R2 = 0.800). (E) Apparent fluorescence lifetimes 
of dendritic cells expressing STX3-mCitrine with VAMP3-mCherry at the peripheral region (P) vs. the internal 
region (I) of the imaged cell areas (Fig. S2F–G). Individual cells from 5 donors are shown (grey curve: line of 
equality; black dashed curve: linear regression (β = 1.174; R2 = 0.821)). Note that for most cells, the lifetime at the 
periphery is lower than at intracellular regions (Paired two-sided Student’s t-test; p = 0.0078). (F) Fluorescence 
lifetime histogram from panel A for a dendritic cell co-expressing STX3-mCitrine with VAMP3-mCherry, but 
now fitted with a double-exponential decay function with the lifetimes of the slow (2.8 ns) and fast (2.0 ns) 
components fixed and convoluted with the IRF (gray curve). The percentage FRET (% FRET) was calculated as 
the amplitude of the fast component over the total amplitude and was 81% (logarithmic scaling in Fig. S3A). 
(G) Same as panel C, but now fitted with double-exponential decay functions and % FRET shown. (H) Same as 
panel D, but now fitted with double-exponential decay functions and % FRET shown (more donors in Fig. S3B). 
Dashed line: linear regression (β = 0.927; R2 = 0.771).
A
C
F
D
G
B
E
H
7978
FLIM reveals rerouting of SNARE trafficking driving dendritic cell activationChapter 4
4
apparent fluorescence lifetime of mCitrine in the presence of mCherry-fused 
VAMP3 or VAMP8, although for STX4 these reductions were relatively small 
(<100 ps) and not significant when analyzing donor-averaged lifetimes (Fig. 4B; 
Fig. S5B). FLIM imaging showed that whereas interactions of STX3-mCitrine with 
VAMP3-mCherry mainly occurred at the plasma membrane, the interactions 
with VAMP8-mCherry predominantly occurred at intracellular compartments 
(Fig. 1C, Fig. 4A; Fig. S5A). As a positive control, we treated our cells with 
N-ethylmaleimide (NEM), which impairs the AAA-ATPase NSF responsible for 
dissociation of SNARE complexes. Addition of this compound traps all SNARE 
complexes in their cis-conformation 3 and resulted in a trend showing further 
reductions of the apparent fluorescence lifetimes for all combinations of donor 
and acceptor SNAREs tested (Fig. 4B; Fig. S5B). Thus, our FLIM data resulted 
in 2 new observations of SNARE complex formation in unstimulated dendritic 
cells: (i) FRET at the plasma membrane of fluorescently-labeled VAMP3 with 
STX3 was higher than with STX4, suggesting more interactions of VAMP3 with 
STX3 even though most STX4 is present at the plasma membrane. (ii) FRET of 
fluorescently-labeled STX3, but not STX4, with VAMP3 was observed mainly at 
the plasma membrane while FRET with VAMP8 was found mainly at intracellular 
compartments, indicating that complex formation of these SNAREs occurred in 
different subcellular compartments.
LPS stimulation promotes VAMP3 interaction with STX4 at the 
plasma membrane
Activation of dendritic cells by inflammatory stimuli triggers the production 
and secretion of immunomodulatory cytokines and alters the surface receptors 
displayed on the cell membrane and this is accompanied by marked changes 
of the membrane trafficking machinery 5–9,26,41. We therefore wondered 
whether the SNARE interactions that we observed in unstimulated dendritic 
cells by FRET-FLIM would be altered by activation of the cells. We transfected 
dendritic cells with combinations of SNAREs and stimulated the cells overnight 
with the bacterial antigen LPS, a component from the outer cell membrane 
of gram-negative bacteria and a strong agonist of TLR4 (Fig. 5A; Fig. S6A). 
TLR4 stimulation triggers danger signaling in dendritic cells leading to cell 
maturation characterized by a strong increase in cytokine production. Although 
LPS stimulation can upregulate the expression of several SNAREs in immune 
cells 26,30,41–43, the protein levels of both endogenous and overexpressed STX3, 
STX4, VAMP3 and VAMP8 in monocyte-derived dendritic cells were not altered 
by LPS (Fig. S6B–C). Whole-cell FLIM analysis revealed that LPS activation of 
dendritic cells expressing STX4-mCitrine in combination with VAMP3-mCherry 
led to a significant reduction of the apparent lifetime compared to the condition 
without LPS (Fig. 5B; Fig. S6D). In contrast, no significant changes were observed 
for STX3-mCitrine or for VAMP8-mCherry. FLIM imaging demonstrated that 
the interactions of VAMP3-mCherry with STX4-mCitrine mainly occurred at 
the plasma membrane (Fig. 5A; Fig. S6A). Because of the photobleaching we 
were unable to measure FLIM of the same cell pre- and post-LPS treatment. 
VAMP3 is known to mediate release of inflammatory cytokines by the murine 
macrophage cell line RAW264.7 25 and the human synovial sarcoma cell line 
SW982 44. VAMP3 is also required for the secretion of cytokines by LPS activated 
monocyte-derived dendritic cells, as siRNA knockdown of this SNARE impaired 
release of the cytokine IL-6, as shown by ELISA (Fig. 5C–D; Fig. S6E). These FLIM 
data support the conclusion that LPS activation of dendritic cells results in an 
increased complex formation of STX4 with VAMP3 at the plasma membrane and 
that this promotes IL-6 secretion. 
Figure 3. Forced interactions between SNAREs increases FRET while FRET is reduced with a fusion 
incompetent VAMP3 mutant.
(A) Whole-cell apparent fluorescence lifetimes for dendritic cells expressing FKBP-STX3-mCitrine or 
FKBP-STX4-mCitrine together with FRB-VAMP3-mCherry and incubated in absence or presence of 
rapamycin or a rapamycin analogue. (B) Alignment of VAMP2 and VAMP3 (mouse sequences) showing 
100% identity of the region containing leucines 84 (VAMP2) and 71 (VAMP3). (C) Whole-cell apparent 
fluorescence lifetimes for dendritic cells expressing STX3-mCitrine with wild-type VAMP3-mCherry 
or a mutant lacking leucine 71 (VAMP3(Δ71)-mCherry). Shown in panels A and C are individual cells 
pooled from at least 4 donors (mean ± SEM shown; one-way ANOVA with Bonferroni correction; 
n: number of cells). Representative confocal and FLIM images are in Fig. S4. 
VAMP2
FETSAAKLKRKYWWKN
FETSAAKLKRKYWWKN77-
VAMP3 64-
-92
-79
VAMP2
SELDDRADALQAGASQ
SELDDRADALQAGASQ61-
VAMP3 48-
-76
-63
V3 mCherry
Stx3 mCitrine
Stx4 mCitrine
FKBP1a
FKBP1a
FRB
TMDSNARE
2.0
2.5
3.0
ns
ns
ns
ns
***
***
***
***
A
pp
ar
en
t l
ife
tim
e 
(n
s)
FKBP-Stx3-mCit
FKBP-Stx4-mCit
FRB-VAMP3-mCh
Rapamycin
+ +
+ +
- - - -
+ + + +- - - -
- - - -
+ +
+ +
+- +- +- +-
n 29 29 34 40 23 21 40 43
2.0
2.5
3.0
***
*** ***
A
pp
ar
en
t l
ife
tim
e 
(n
s)
Stx3-mCit
VAMP3-mCh
VAMP3 -mCh( 71)∆
+ + +
+
+-
--
-
n 97 163 33
VAMP2
FETSAAKLKRKYWWKN
FETSAAKLKRKYWWKN77-
VAMP3 64-
-92
-79
VAMP2
SELDDRADALQAGASQ
SELDDRADALQAGASQ61-
VAMP3 48-
-76
-63
V3 mCherry
Stx3 mCitrine
Stx4 mCitrine
FKBP1a
FKBP1a
FRB
TMDSNARE
2.0
2.5
3.0
ns
ns
ns
ns
***
***
***
***
A
pp
ar
en
t l
ife
tim
e 
(n
s)
FKBP-Stx3-mCit
FKBP-Stx4-mCit
FRB-VAMP3-mCh
Rapamycin
+ +
+ +
- - - -
+ + + +- - - -
- - - -
+ +
+ +
+- +- +- +-
n 29 29 34 40 23 21 40 43
2.0
2.5
3.0
***
*** ***
A
pp
ar
en
t l
ife
tim
e 
(n
s)
Stx3-mCit
VAMP3-mCh
VAMP3 -mCh( 71)∆
+ + +
+
+-
--
-
n 97 163 33
A B
C
8180
FLIM reveals rerouting of SNARE trafficking driving dendritic cell activationChapter 4
4Discussion
SNARE proteins are pivotal for membrane fusion and coordinate intracellular 
organellar trafficking, exocytosis and endocytosis 1,2. Although it is generally 
accepted that different intracellular trafficking routes are catalyzed by specific 
sets of SNARE proteins 5–9, current microscopy techniques often cannot resolve 
distinct SNARE pairs for specific trafficking routes. In this study, we demonstrate 
that FRET-FLIM enables the assignment of SNARE partners to specific trafficking 
routes, as it allows visualization of SNARE pairing at subcellular resolution. Our 
data show that FLIM-FRET is a quantitative method that in principle allows to 
determine the fraction of SNAREs engaged in complex formation by fitting 
the photon counts with bi-exponential decay functions with fixed lifetimes 
(i.e., for no FRET (donor only) and 100% FRET (all SNAREs interacting)). 
While the transient overexpression system used for our primary cells does not 
allow meaningful quantification of SNARE complexing, we expect that fusing 
chromosomal SNARE-encoding genes with fluorescent proteins using CRISPR/
CAS9 in cell lines will enable to quantify endogenous SNARE interactions by 
FRET-FLIM.
We used FRET-FLIM to measure SNARE complex formation in human blood-
derived dendritic cells. In unstimulated dendritic cells, the apparent lifetime of 
fluorescently labeled STX3 with VAMP3 was lower at the periphery of the imaged 
cell areas, whereas the apparent lifetime with VAMP8 was lower at intracellular 
areas. This indicates that complex formation of STX3 with VAMP3 mainly 
occurs at the plasma membrane, while interactions with VAMP8 predominantly 
occur at intracellular compartments. VAMP3 is primarily localized in early and 
recycling endosomes and VAMP8 locates predominately at late endosomal 
compartments 1,24,25,27. Our data are therefore perfectly in line with the widely 
accepted notion that fusion of compartments of early/recycling endosomal 
nature with the plasma membrane is more abundant than of late endosomal 
< Figure 4. FRET-FLIM of STX3 and STX4 with VAMP3 and VAMP8.
(A) Representative confocal microscopy (left) and convoluted FLIM (right) images of dendritic cells 
expressing STX3-mCitrine or STX4-mCitrine (green in merge) with VAMP3-mCherry or VAMP8-
mCherry (magenta). The apparent fluorescence lifetimes of STX3-mCitrine with VAMP3-mCherry were 
lowest at the cell membrane, whereas the lifetimes with VAMP8-mCherry were lowest at intracellular 
compartments (yellow arrowheads). Scale bars, 10 µm. Lifetime images are in Fig. S5A. (B) Whole-cell 
apparent fluorescence lifetimes for the conditions from panel A, both in presence or absence of NEM. 
Shown are individual cells pooled from at least 3 donors (mean ± SEM shown; one-way ANOVA with 
Bonferroni correction; n: number of cells; individual donors in Fig. S5B). 
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compartments. Based on differences in apparent fluorescence lifetimes, we 
also conclude that the interactions of VAMP3 at the plasma membrane with 
STX4 are lower than with STX3 in unstimulated dendritic cells, even though the 
vast majority of STX4 is present at the plasma membrane. This changes upon 
activation of the dendritic cells by the pathogenic stimulus LPS, which results in 
a decreased apparent lifetime of fluorescently labeled STX4 with VAMP3 at the 
plasma membrane, whereas the apparent lifetimes of STX3 remain unaltered. 
This result indicates that LPS triggers increased exocytosis by VAMP3 and STX4. 
VAMP3 is a recycling endosomal SNARE 1,24–26 and many cytokines traffic via 
recycling endosomes to the plasma membrane, including IL-6 and tumor 
necrosis factor alpha (TNFα) 25,26. Indeed, our data show that siRNA knockdown of 
VAMP3 impairs IL-6 secretion by monocyte-derived dendritic cells as previously 
observed for RAW264.7 murine macrophages 25 and SW982 human synovial 
sarcoma cells 44. As supported by our FRET-FLIM data the increased complexing 
of VAMP3 with STX4 is thus likely responsible for the increased secretion of 
IL-6 and other cytokines by activated dendritic cells. Interestingly, we observed 
that LPS increased FRET only of VAMP3 with STX4 and not with STX3. STX3 
and STX4 have been well described in epithelial cells, where they catalyze apical 
and basolateral exocytosis respectively 45–47, but why non-polarized cells such as 
dendritic cells express both syntaxins is not well understood. Our study provides 
a possible clue why this could be the case, as our data indicate that activation 
of the dendritic cells leads to a rerouting of intracellular trafficking with more 
VAMP3-containing compartments fusing with the plasma membrane by 
interacting with STX4. Perhaps STX3 catalyzes the constitutive cycling of early/
recycling endosomes in resting cells and STX4 offers the spare capacity to fulfil 
the additional secretory requirements upon dendritic cell activation needed for 
the secretion of massive amounts of cytokines. 
What could cause the increased STX4 complex formation with VAMP3 upon 
dendritic cell activation? Our data show that such increased SNARE complexing 
is not caused by increased levels of STX4 or VAMP3. Possibly, the increased 
complexing might be regulated by direct phosphorylation of STX4, VAMP3 and/or 
the Qb/c-SNARE SNAP23 48. SNAP23 was recently shown to be phosphorylated in 
an IκB-kinase 2 dependent fashion upon stimulation of mouse dendritic cells with 
LPS and this mediates the delivery of major histocompatibility complex (MHC) 
class I from recycling endosomes to phagosomes, presumably via STX4 and VAMP3 
or VAMP8 11. Alternatively, or additionally, the increased complex formation could 
be regulated by the Sec1/Munc18-protein Munc18c (STXBP3). Munc18c and STX4 
are well known to regulate GLUT4 trafficking in adipocytes and skeletal muscle 
cells 1,49, and are also implied in insulin secretion from pancreatic beta cells 50, 
secretion of dense-core granules, α-granules and lysosomes from human platelets 51 
and TNFα secretion from macrophages 41. In any case, the mechanism must be 
specific for STX4 and VAMP3, as our data show that FRET of STX3 with VAMP3 
and of STX4 with VAMP8 are not altered by LPS-activation of dendritic cells. 
Overall, our study demonstrates the use of FRET-FLIM for the identification 
of the SNARE partners orchestrating specific organellar membrane trafficking 
steps. We expect this technique will allow deciphering the precise intracellular 
trafficking pathways of molecules important in health and disease, such as 
cytokines, receptors, hormones, metabolic enzymes and metabolites.
Materials & methods
Cells
Dendritic cells were derived from monocytes by culturing in the presence of IL-4 
and GM-CSF for 6 days as described 52. Monocytes were isolated from blood 
of healthy individuals (informed consent and consent to publish obtained, 
approved by Sanquin ethical committee and according to Radboudumc 
institutional guidelines). Dendritic cells were transfected with plasmid DNA 
(overnight) or siRNA (for 48h; VAMP3 Stealth; HSS113848, HSS113849, 
HSS113850; Thermo Scientific) using a Neon Transfection system (Invitrogen) as 
described 52. To induce SNARE complex formation, NEM (400 µM; 10 minutes 
before imaging), rapamycin (Selleck chemicals) or the rapamycin analog A/C 
Heterodimerizer (Clontech #635057; 0.5 µM; 90 minutes before imaging) were 
added to the samples. LPS was used at 1 µg ml-1 and incubated for 16 h for FLIM 
measurements and for 4, 8 or 24h after which the supernatant was collected for 
IL-6 determination. IL-6 concentration was measured by ELISA (88-7066-88; E 
Bioscience).
SNARE constructs
DNA coding for mCitrine was ordered as a synthetic gene and inserted in 
the BamHI/NotI sites of pEGFP-N1 (Clontech) yielding pmCitrine-N1. STX3 
and STX4 46 were inserted in the EcoRI/BamHI sites of pmCitrine-N1. VAMP3 
and VAMP8 were inserted in the EcoRI/BamHI site of pmCherry-N1. The 
VAMP3(Δ71)-mCitrine mutant was generated by site directed mutagenesis. For 
FKBP-STX4-mCitrine, synthetic DNA coding for human FKBP1A residues 1–108 
with a serine-glycine linker (SGGGGSGGGGSGGGG) (Genscript) was subcloned 
in the restriction sites XhoI/EcoRI of STX4-mCitrine. STX4 was then replaced 
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with STX3 for FKBP-STX3-mCitrine. For FRB-VAMP3-mCherry, residues 2,015–
2,114 of human mTOR with T2098L and a serine-glycine linker (Genscript) was 
subcloned in the XhoI/EcoRI restriction sites of the VAMP3-mCherry construct. 
For STX3-mCitrine-mCherry, mCitrine with BamHI restriction sites on both sides 
was subcloned in the STX3-mCherry construct. 
FLIM
FLIM was recorded with live (unfixed) dendritic cells on a Leica SP8 confocal 
microscope equipped with a 63x 1.20 NA water immersion objective. Confocal 
images of the cells were recorded prior to each FLIM measurement. The image 
plane was selected at the height of the nucleus and was between 2–5 µm above 
the surface of the cover slips. Excitation was done with a pulsed white light 
laser (Leica; 80,000 MHz pulsing) operating at 516 nm. Emission from 521 to 
565 nm was collected with a photomultiplier tube and processed by a PicoHarp 
300 Time-Correlated Single Photon Counting (TCSPC) system (PicoQuant). At 
least 50,000 photons with on average ~750,000 photons were recorded for each 
individual cell (Fig. S1C). Samples were imaged in Live Cell Imaging Solution 
(Thermo Scientific) at 37°C. Photon traces in Picoquant PT3 format were used 
to construct FLIM images in Image Cytometry Standard (ICS) format using in-
house developed PT32ICS conversion software (Membrane Trafficking Group, 
Radboudumc, Nijmegen, The Netherlands). For single cell FLIM, all photons 
were pooled for each individual cell and fitted with exponential decay functions 
convoluted with the IRF using OriginPro2016 (Originlab). Single pixel fitted FLIM 
images were generated for individual cells (with at least 1,000,000 photons per 
cell) using the TRI2 software (version 2.8.6.2; Gray institute, Oxford, UK) 53,54 
with monoexponential (Marquardt) fitting algorithm, 7x7 pixel circular binning 
and thresholding from 15 to 100% intensity. Phasor plots were generated using 
FIJI ImageJ 55,56 with the Time Gated Phasor plugin from Spechron (developed by 
F. Fereidoni, UC Davis Medical Center). 
Immunofluorescence
Cells were plated and stained as described previously 57. For immunofluorescence 
labeling, primary antibodies rabbit anti-VAMP3 (Abcam #5789; 1:200 dilution 
(v/v)) or rabbit anti-VAMP8 (Synaptic Systems #104-303; 1:200 dilution (v/v)) 
were used in combination with secondary antibody goat anti-rabbit conjugated 
with Alexa fluor 647 (Thermo Scientific; 1;400 dilution (v/v)). The cells were 
imaged on a Leica SP8 confocal microscope equipped with a 63x 1.20 NA water 
immersion objective.
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Figure 5. LPS activation of dendritic cells increases complex formation of STX4 with VAMP3 at 
the plasma membrane.
(A) Representative confocal microscopy (left) and convoluted FLIM (right) images of unstimulated or 
LPS-activated dendritic cells expressing STX3-mCitrine or STX4-mCitrine (green in merge) with VAMP3-
mCherry or VAMP8-mCherry (magenta). Apparent fluorescence lifetimes of STX3-mCitrine and STX4-
mCitrine with VAMP3-mCherry were lowest at the cell membrane (yellow arrowheads), whereas the 
lifetimes of STX3-mCitrine with VAMP8-mCherry were lowest at intracellular compartments (yellow 
arrowheads). Scale bars, 10 µm. Lifetime images are in Fig. S6A. (B) Whole-cell apparent fluorescence 
lifetimes for the conditions from panel A in presence or absence of LPS. Shown are individual cells 
pooled from at least 4 donors (mean ± SEM shown; one-way ANOVA with Bonferroni correction; n: 
number of cells; individual donors in Fig. S6D). (C) Representative Western blot and quantification 
of siRNA knockdown of VAMP3 (siV3; p = 0.0001, paired two-sided Student’s t-test). siCntrl: non-
targeting siRNA control. GAPDH: loading control. (D) IL-6 production after 24 hours LPS exposure by 
dendritic cells with VAMP3 knockdown (siV3) or siCntrl (individual donors shown; p = 0.0199, paired 
two-sided Student’s t-test; time traces shown in Fig. S6E).
A
B C D
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Western blot
Dendritic cells were incubated for 16 h in complete medium in the absence or 
presence of LPS (1 µg ml-1). Cells were harvested and analyzed by Western blot. 
Primary antibodies used were a rabbit monoclonal against GAPDH (clone 14C10; 
Cell signaling #2118; 1:1,000 dilution (v/v)), a rabbit polyclonal against STX3 46 
(1:500 dilution (v/v)), a mouse monoclonal against STX3 (clone 1-146; Millipore 
MAB2258; 1:500 dilution (v/v)), a rabbit polyclonal against VAMP3 (Abcam 
#5789; 1:1,000 dilution (v/v)), a mouse monoclonal against VAMP8 (Santa Cruz 
sc-166820; 1:500 dilution (v/v)), a mouse IgG1 against STX4 (Abcam #77037; 
1:1,000 dilution (v/v)) and a rabbit polyclonal against mCherry (Abcam #167453; 
1:500 dilution (v/v)). Secondary antibodies were goat anti-rabbit or goat anti-
mouse conjugated with IRDye 800 (LI-COR; 1:5,000 dilution (v/v)) or goat anti-
rabbit conjugated with Alexa fluor 647 (Thermo Scientific; 1:500 dilution (v/v)).
Statistics
For all the FLIM experiments, significant difference between two samples 
was assessed using one-way ANOVA with post-hoc Bonferroni correction for 
relevant pairs. Error bars indicate the SEM for at least > 30 cells or for at least 
3 donors. Western blots and ELISA results were analyzed by paired two-sided 
Student’s t-test and error bars indicate the SEM for at least 3 donors. The level 
of statistical significance is represented by * p ≤ 0.05, **p ≤ 0.01, ***p ≤0.001.
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Supplementary figures
< Figure S1. Lifetime images, confocal images and phasor analysis belonging to main figure 1.
(A) The excitation (open curves) and emission (filled curves) spectra of mCitrine (yellow) and mCherry 
(pink) (data from Chroma Technology). (B) Representative confocal microscopy images of antibody 
staining of endogenous VAMP3 (top; magenta in merge) and VAMP8 (bottom) in dendritic cells. Blue: 
DAPI. BF: bright-field. (C) Distribution of total photon counts for all fluorescence lifetime recordings. 
(D) Full lookup table belonging to the FLIM images. Plotted is the fluorescence intensity (y-axis) versus 
the fluorescence lifetime (x-axis). (E) Fluorescence lifetime images belonging to main Fig. 1C. FLIM 
images were generated by convolution of these lifetime images with the fluorescence intensities (i.e., 
the mCitrine images shown in the main figure). (F) Phasor plots for the cells shown in main Fig. 1C. 
Cyan circles: center of the phasor location for STX3-mCitrine in absence of acceptor fluorophore (upper 
graph); purple circles: center for STX3-mCitrine with VAMP3-mCherry (middle graph); pink circle: 
center for STX3-mCitrine-mCherry (lower graph). (G) Representative confocal microscopy images of 
live (top) and fixed (bottom) dendritic cells expressing the STX3-mCitrine-mCherry tandem construct 
(mCitrine: green in merge; mCherry: magenta). (H) Pearson correlation coefficients for colocalization 
of the fluorophores of the STX3-mCitrine-mCherry tandem construct for 3 donors (average ± SEM; 
paired two-sided Student’s t-test). (I–J) Same as panel G, but now for live (I) and fixed (J) cells co-
expressing VAMP3-mCitrine with VAMP3-mCherry (left) or VAMP8-mCitrine with VAMP8-mCherry 
(right). (K) Pearson correlation coefficients for panels I–J (average ± SEM; VAMP3: p = 0.046, paired 
two-sided Student’s t-test). Scale bars, 10 µm.
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< Figure S2. Fluorescence lifetime histograms fitted with mono-exponential decay functions and 
calibration of FLIM setup.
(A) Same as main Fig. 2A, but now with logarithmic scaling. Shown are representative whole-
cell fluorescence lifetime decay curves of dendritic cells expressing STX3-mCitrine (red curves; left 
graphs), STX3-mCitrine with VAMP3-mCherry (green; middle graphs), or STX3 conjugated to both 
mCitrine and mCherry (STX3-mCitrine-mCherry; cyan; right graphs). Dashed lines: fits with mono-
exponential decay functions convoluted with the instrument response function (IRF; gray; residuals 
from the fits shown). Graphs are normalized to the maximum photon counts (depicted in each graph). 
(B) Same as main Fig. 2B, but now with logarithmic scaling. Shown is the overlap of the fluorescence 
lifetime decay curves from panel A. (C) Representative fluorescence lifetime decay curve of rhodamine 
B in methanol (about 1 µM concentration; magenta curves). Dashed line: fit with a mono-exponential 
decay function. The fit is shown with a linear (left) and a logarithmic (right) scaling. A fluorescence 
lifetime was obtained of 2.19 ± 0.04 ns (mean ± SEM from 4 independent measurements), close to the 
reported lifetime of 2.32 ns (Kristoffersen et al, 2014). (D) Same as main Fig. 2C, but now the average 
whole-cell apparent fluorescence lifetimes of individual donors are shown (n: number of donors; mean 
± SEM shown; one-way ANOVA with Bonferroni correction). (E) Same as main figure 2D for 3 more 
donors. Shown are whole-cell apparent fluorescence lifetimes of STX3-mCitrine from fits with mono-
exponential decay functions for individual cells co-expressing STX3-mCitrine with VAMP3-mCherry. 
Dashed lines: linear regression (top: β = -0.001, R2 = 0.756; middle: β = -0.001, R2 = 0.702; bottom: 
β = -0.001, R2 = 0.869). (F) Representative confocal microscopy and FLIM images of a dendritic cell 
co-expressing STX3-mCitrine (green in merge) and VAMP3-mCherry (magenta). The intracellular 
(I; light blue in lower right panel) and peripheral (P; white) regions of the imaged cell area were manually 
selected. BF: bright-field. Scale bar, 10 µm. (G) Whole-cell fluorescence lifetime decay curves of the 
intracellular (I) and peripheral (P) cell regions for the cell from panel F. The apparent fluorescence 
lifetimes obtained from mono-exponential fits were 2.41 ns (I) and 2.24 ns (P). 
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Figure S3. Fluorescence lifetime histograms fitted with double-exponential decay functions. 
(A) Same as main Fig. 2F, but now with logarithmic scaling. Shown is a representative whole-cell 
fluorescence lifetime histogram of a dendritic cell co-expressing STX3-mCitrine with VAMP3-
mCherry. Dashed line: fit with double-exponential decay function convoluted with the instrument 
response function (IRF; gray; residuals from the fit shown). Graphs are normalized to the maximum 
photon counts (depicted in graph). (B) Same as main Fig. 2H for 3 more donors. Shown are % FRET 
from fits with double-exponential decay functions for individual cells co-expressing STX3-mCitrine 
with VAMP3-mCherry. Dashed lines: linear regression (top: β = 0.055, R2 = 0.704; middle: β = 0.065, 
R2 = 0.674; bottom: β = 0.147, R2 = 0.867). (C) The apparent fluorescence lifetime from mono-exponential 
fits as a function of the % FRET from double exponential fits for individual cells co-expressing STX3-
mCitrine with VAMP3-mCherry. Dashed line: linear regression (β = -0.007, R2 = 0.812).
Figure S4. FLIM images belonging to main figure 3.
(A) Representative confocal microscopy, convoluted FLIM and fluorescence lifetime images of 
dendritic cells expressing FKBP-STX3-mCitrine (upper panel) or FKBP-STX4-mCitrine (lower panel; 
green in merge) together with FRB-VAMP3-mCherry (magenta) and incubated in absence or presence 
of a rapamycin analogue. (B) Representative confocal microscopy, convoluted FLIM and lifetime 
images of dendritic cells expressing STX3-mCitrine (green) with mutant VAMP3-mCherry lacking 
leucine 71 (VAMP3(Δ71)-mCherry; magenta). Scale bars, 10 µm.
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Figure S5. Fluorescence lifetime images belonging to main figure 4.
(A) Fluorescence lifetime images belonging to main Fig. 4A. FLIM images were generated by 
convolution of these lifetime images with the fluorescence intensities (i.e., the mCitrine images 
shown in the main figure). Scale bars, 10 µm. (B) Same as main Fig 4B, but now with the averages for 
individual donors. Shown are donor-averaged whole-cell apparent fluorescence lifetimes of dendritic 
cells expressing STX3-mCitrine or STX4-mCitrine with or without VAMP3-mCherry or VAMP8-mCherry 
and in absence or presence of NEM treatment (mean ± SEM shown; one-way ANOVA with Bonferroni 
correction; n: number of donors).
> Figure S6. Fluorescence lifetime images belonging to main figure 5, expression levels of 
endogenous and overexpressed SNAREs upon LPS treatment and time traces of IL-6 secretion.
(A) Fluorescence lifetime images belonging to main Fig. 5A. FLIM images were generated by 
convolution of these lifetime images with the fluorescence intensities (i.e., the mCitrine images shown 
in the main figure). Scale bars, 10 µm. (B) Expression levels of overexpressed STX3, STX4, VAMP3, 
and VAMP8 by dendritic cells with and without overnight LPS-activation. Shown are representative 
Western blots and quantification (mean ± SEM from 3 donors). GAPDH: loading control. VAMP8-
mCherry appears as a double band because of incomplete stripping of the GAPDH antibody (lower 
band). LPS treatment did not result in significant changes in SNARE expression (paired two-sided 
Student’s t-tests). (C) Same as panel B, but now for endogenous STX3, STX4, VAMP3, and VAMP8. (D) 
Same as main Fig. 5B, but now with the averages for individual donors. Shown donor-averaged whole-
cell apparent fluorescence lifetimes of dendritic cells expressing STX3-mCitrine or STX4-mCitrine 
with or without VAMP3-mCherry or VAMP8-mCherry and in absence or presence of LPS treatment 
(mean ± SEM shown; one-way ANOVA with Bonferroni correction; n: number of donors). (E) Time 
course of IL-6 secretion with siCntrl or siV3 knock-down for 4 individual donors.
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Abstract 
Cells producing cytokines often express the receptor for the same cytokine 
which makes them prone to autocrine signaling. How cytokine production 
and signaling are regulated in the same cell is not understood. In this study, 
we demonstrate that signaling of exogenous and self-synthesized interleukin 6 
(IL-6) within endosomal compartments acts as a cellular brake limiting synthesis 
of IL-6. Our data show that IL-6 is internalized by dendritic cells and signals from 
endosomal compartments containing the IL-6 receptor. Newly synthesized 
IL-6 also traffics via these endosomal compartments and signals in transit to 
the plasma membrane. This allows activation of STAT3 which in turn limits the 
Toll-like receptor 4 stimulant lipopolysaccharide (LPS) triggered transcription of 
IL-6. Long-term exposure to LPS removes this brake via inhibition of STAT3 by 
increased expression of suppressor of cytokine signaling 3 (SOCS3) and results 
in fully-fledged IL-6 production. This transient regulation could well dampen 
excessive IL-6 production during early infections.
Introduction
Interleukin 6 (IL-6) is the most pleiotropic cytokine known in mammals 1. It has 
both pro- and anti-inflammatory properties and is involved in the pathogenesis 
of all inflammatory diseases 2–4. IL-6 can promote the activation, growth, 
proliferation and survival of many different cell types 5. IL-6 production by 
immune phagocytes is triggered by a wide range of stimuli, such as stress 
hormones, cytokines and pathogen recognition by Toll-like receptors (TLR) 6. 
In healthy individuals, blood levels of free IL-6 (i.e., not in complex with soluble 
IL-6 receptor) are in the low pg ml-1 range, depending on the assays used, but 
these can increase to ng ml-1 levels in autoimmune diseases and to µg ml-1 range 
during septic shock 7–13. IL-6 levels correlate with tumor progression in many 
cancer types 14–16. IL-6 induces the development of Th17 cells while inhibiting 
differentiation of regulatory T cells. These T cell subsets have key functions 
in immune regulation: IL-17-producing Th17 cells protect against microbial 
infections but also contribute to the pathogenesis of many autoimmune diseases, 
including multiple sclerosis and rheumatoid arthritis, whereas regulatory T cells 
limit excessive effector T cell responses 17. Differentiation of pathogenic Th17 
cells mainly occurs by presentation of IL-6 loaded onto the IL-6 receptor on the 
surface of dendritic cells, in a process called trans-presentation 18.
The IL-6 receptor consists of IL-6 receptor alpha (IL-6RA, CD126, gp80) and the 
signal transducing subunit glycoprotein 130 (gp130, CD130) 2. IL-6 first binds to 
IL-6RA with a low affinity dissociation constant of about 10 nM 6,19. This complex 
of IL-6 with IL-6RA in turn binds to two molecules of gp130 with a two orders 
of magnitude higher affinity resulting in a net dissociation constant in the pM 
to nM range 6,20,21. Following oligomerization, Janus tyrosine kinases (JAK) 
phosphorylates the intracellular tails of gp130 which in turn recruit and activate 
signal transducer and activator of transcription (STAT) and mitogen-activated 
protein kinase (MAPK) signaling systems 1,22. In addition to the activation of 
STAT3 by phosphorylation of tyrosine 705, its activity is further promoted 
by phosphorylation at serine 727 23–25 by the mammalian target of rapamycin 
(mTOR) 26 or protein kinase C δ (PKC)  27. In contrast to IL-6RA, which is specific 
for IL-6, gp130 is shared by all cytokines of the IL-6 family: IL-11, leukemia 
inhibitory factor (LIF), oncostatin M (OsM), cardiotrophin-1 (CT-1), ciliary 
neurotrophic factor (CNTF) and cardiotrophin-like cytokine (CLC) 1. Whereas 
gp130 is ubiquitously expressed in hematopoietic and non-hematopoietic cells, 
IL-6RA is expressed only by a limited number of cell types, such as hepatocytes 
and immune cells 2,3,22,28,29.
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Interestingly, many leukocytes (monocytes, dendritic cells, macrophages, B 
cells) that produce IL-6 also express IL-6RA 30, enabling autocrine signaling. 
Although IL-6 was originally believed to promote activation and maturation 
of dendritic cells 31, it is increasingly clear that IL-6 inhibits these processes 
via STAT3 activation 16,32,33. In line with this, IL-6 knockout mice have increased 
numbers of mature dendritic cells 32 and bone marrow-derived dendritic cells 
from STAT3 knockout mice show enhanced activation compared to wild-type 
33,34. IL-6 also influences activation of other immune cells as it for instance 
blocks the proliferation of proinflammatory M1 macrophages in mice 35. STAT3 
activation interferes with TLR signaling, as pre-treatment of dendritic cells with 
IL-6 reduces maturation triggered by lipopolysaccharide (LPS), a bacterial TLR4 
stimulus, and leads to decreased expression of the maturation markers CD86 
and MHC class II 32. LPS in turn is well-known to inhibit tyrosine phosphorylation 
of STAT3 (pSTAT3) 36 and promote IL-6 synthesis by dendritic cells 37,38, raising 
the question of how this cross-talk between STAT3 and TLR4 signaling would 
affect cellular responses to IL-6 and LPS. 
In this study, we investigated how signaling of self-synthesized IL-6 affects 
the production of IL-6 by dendritic cells. By microscopy, we show that newly 
synthesized IL-6 traffics from the Golgi network to the plasma membrane 
via recycling endosomes, a network of tubulovesicular compartments that 
interconnects endocytic and exocytic trafficking pathways, as previously 
shown for macrophages 39 and dendritic cells 40. We hypothesized that newly 
synthesized IL-6 in transit to the plasma membrane could signal from these 
recycling endosomal compartments, since IL-6 has been described to signal from 
endosomes in hepatocytes 41–43. Indeed, we found that in dendritic cells pSTAT3 
signaling is initiated by binding of both internalized IL-6 and newly synthesized 
IL-6 to IL-6RA within intracellular compartments. This signaling results in a 
negative feedback loop and acts as a brake limiting IL-6 synthesis. However, 
long-term exposure to LPS releases this brake as pSTAT3 is inhibited by a LPS-
induced increase of expression of suppressor of cytokine signaling 3 (SOCS3), a 
previously described suppressor of STAT3 signaling 44–46, and this allows full IL-6 
production. Thus, our data show that self-signaling of newly synthesized IL-6 
limits the production of IL-6 during short-term exposure to the inflammatory 
stimulus LPS. This mechanism might serve to restrain IL-6 responses during 
early infection and sepsis.
Results
Cross-inhibition of IL-6 and LPS signaling in dendritic cells
We first confirmed that the IL-6 receptor is expressed by dendritic cells. Reverse 
transcription (RT-) PCR, Western blot and flow cytometry showed that IL-6RA is 
expressed by human CD1c+ myeloid and BDCA4+ plasmacytoid dendritic cells 
(mDC and pDC) isolated from the blood of healthy donors (Fig 1A; Suppl Fig 1A-E). 
IL-6RA is also expressed by dendritic cells differentiated from human blood-isolated 
monocytes (moDCs) by granulocyte macrophage colony-stimulating factor (GM-
CSF) and IL-4, as reported previously 36, in GM-CSF and Fms-related tyrosine 
kinase 3 ligand (FLT3L) differentiated mouse bone-marrow derived dendritic cells 
(BMDCs), as also reported previously 30, and in the murine macrophage cell line 
RAW264.7. IL-6RA can be expressed as a long transmembrane isoform and as 
a short soluble isoform lacking its transmembrane helix and cytoplasmic 
domain 2,3. Soluble IL-6RA can also be produced by shedding of the long isoform 
of IL-6RA from the cell membrane 47,48 by metalloproteases ADAM10 and 
ADAM17 49–51. For Western blot, we used an antibody recognizing the cytoplasmic 
C-terminal tail of IL-6RA, meaning that only the full-length membrane bound 
form of IL-6RA was detected. However, transcription of the short isoform was also 
detected by RT-PCR with isoform specific primers 52 (Suppl Fig 1C), as also recently 
shown by ELISA 36. 
Although the expression levels of IL-6RA varied widely among donors/mice, 
repeats and conditions, Western blot experiments showed that IL-6RA expression 
did not change significantly after stimulation with LPS up to 24 hours in GM-CSF 
and FLT3L-differentiated BMDCs and RAW264.7 macrophages (Fig 1A; Suppl 
Fig 1A). Similarly, Western blot and flow cytometry experiments revealed that IL-
6RA expression did not change significantly in primary CD1c+ myeloid dendritic 
cells after overnight stimulation with LPS or with a combination of the TLR3 
agonist polyinosinic:polycytidylic acid (poly(I:C)) and the TLR7/8 agonist R848, 
nor in plasmacytoid dendritic cells stimulated with the TLR9 agonist CpG-C 
(Fig 1A; Suppl Fig 1A, D).
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For the rest of the experiments, we focused on moDCs, a widely used model 
system for immune cell function capable of producing large amounts of IL-6 37,40. 
MoDCs do not only express IL-6RA, but also the signaling co-receptor gp130 
(Fig 1A; Suppl Fig 1A, E, F). For some donors LPS resulted in lower levels of 
IL-6RA and gp130, but this was not consistent as no changes were observed 
for other donors, and, although there was a trend towards overall lower IL-
6RA and gp130 levels, the donor-averaged cellular levels of gp130 and IL-6RA 
did not significantly change upon LPS stimulation (Fig 1A; Suppl Fig 1A, E, F). 
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Figure 1. Cross-inhibition of IL-6 and LPS signaling in dendritic cells.
(A) IL-6RA expression by Western blot for myeloid dendritic cells (mDC) with or without overnight 
stimulation with LPS or a combination of Poly(I:C) and R848, for plasmacytoid dendritic cells (pDC), and 
for moDCs, RAW264.7, and murine GM-CSF and FLT3L-differentiated bone marrow derived dendritic 
cells (BMDCs) stimulated with LPS for the times indicated. GAPDH: loading control. Quantification 
for multiple donors in Suppl Fig 1A. (B) STAT3 tyrosine 705 phosphorylation (pSTAT3) by Western blot. 
MoDCs were incubated for 20 min with the IL-6 concentrations indicated and with or without 4 hours 
LPS pre-incubation. α-Tubulin: loading control. 3 more donors in Suppl Fig 2A. (C) Quantification of 
pSTAT3/STAT3 from panel B (error bars: SEM for 4 donors; see Suppl Fig 2A).  Highest pSTAT3/STAT3 
ratio per donor was used to calculate % of max pSTAT3/STAT3. (D) pSTAT3 (Tyr705) by Western blot. 
moDCs were incubated with LPS for 4, 8 or 24 hours (individual donors shown). (E) Same as panel D, 
but now for 4 hours incubation with the LPS concentrations indicated. (F) The IL-6 concentration in 
the medium from panel E by ELISA.
These results seem to contrast the observation by Meley, et al. that short-term 
(up to 8 hours) LPS treatment resulted in a slight decrease of IL-6RA levels 
whereas longer incubations resulted in higher levels of IL-6RA, and gp130 levels 
decreased strongly upon LPS treatment 36, possibly because of donor variation 
or the source of LPS used. IL-6RA and gp130 are capable of forming a signaling 
competent complex, as culturing in the presence of IL-6 concentrations above 
0.15 ng ml-1 resulted in tyrosine phosphorylation of STAT3 (pSTAT3; Tyr705) 
in a dose-dependent manner (Fig 1B-C; Suppl Fig 2A-B). In contrast, serine 
phosphorylation of STAT3 (pS-STAT3; Ser727) was already observed in absence 
of IL-6 and only increased at the highest concentration of IL-6 tested (15 ng ml-1; 
Suppl Fig 2B). 
Next, we tested whether LPS-stimulation of the moDCs would block this STAT3 
activation, as has been described 36, 53, 54. Indeed, LPS partially blocked STAT3 
activation, as tyrosine phosphorylation of STAT3 by IL-6 was reduced when 
we pre-cultured the cells for 4 h with LPS prior to the addition of IL-6 (~90% 
reduction for 15 ng ml-1 IL-6 compared to without LPS) (Fig 1B-C; Suppl Fig 2A-
B). In contrast, LPS did not affect serine phosphorylation for all concentrations 
of IL-6 tested, except for the highest concentration of 15 ng ml-1 IL-6, where we 
observed a slight reduction of serine phosphorylation (Suppl Fig 2B). Tyrosine 
phosphorylation of STAT3 in presence of LPS was no longer dependent on the 
concentration of IL-6, but already 10 ng ml-1 LPS (i.e., the lowest dose of LPS 
tested) without IL-6 resulted in tyrosine phosphorylation of STAT3 in a time-
dependent fashion, albeit with slower kinetics than IL-6-mediated pSTAT3 
phosphorylation (Fig 1B-C), and as previously shown 36. 
This increase was likely caused by autocrine signaling, as the dendritic cells 
transcribed and produced IL-6 during the LPS incubation to a final concentration 
of approximately 3 ng ml-1 (Fig 1F and Suppl Fig 2C). These results demonstrate 
that already low concentrations of LPS partially, but not completely, block 
activation of STAT3 by IL-6. We did find evidence that this blockage of STAT3 
signaling by LPS was due to increased levels of SOCS3, a well-known negative 
regulator of STAT3 44–46, since LPS stimulation resulted in higher cellular levels 
of SOCS3 (Fig 2A-C). In line with the previously described inhibition of STAT3 
activation by SOCS3. Moreover, pSTAT3 levels were clearly reduced by culturing 
in the presence of MG132, a proteasome inhibitor that prevents degradation of 
SOCS3 (Fig 2D-E). 
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We then investigated cross-talk in the reverse direction, thus whether STAT3 
activation would inhibit TLR responses, because IL-6 is known to inhibit dendritic 
cell maturation via STAT3 16,32,55. Since TLR-signaling promotes IL-6 synthesis 
(Suppl Fig 2C), autocrine activation of STAT3 by IL-6 might lead to a negative 
feedback loop limiting cellular IL-6 production. To address this possibility, we 
performed siRNA gene silencing of IL-6RA (siIL-6RA) in moDCs and used non-
targeting siRNA as a negative control (siCntrl). The levels of IL-6RA knockdown 
were sufficient (>95% by Western blot, flow cytometry and immunofluorescence 
microscopy (Fig 2F; Suppl Fig 3A-B)) to attain about 80% blockage of IL-6 induced 
pSTAT3 signaling (Fig 2G-H). Culturing IL-6RA-silenced moDCs in the presence 
of LPS for 4 hours (i.e., the time after which we observed pSTAT3 signaling; 
Fig. 1D) increased both IL-6 transcription (by qPCR) and protein production (by 
ELISA) by about 2 to 3-fold compared to siCntrl (Fig 2I-J). These differences in 
IL-6 transcription and secretion disappeared after prolonged culturing with LPS 
(Fig 2J; Suppl Fig 3C), likely because of the refractory phase in which pSTAT3 
signaling is disabled by increased cellular levels of SOCS 3 (Fig 2). Thus, LPS 
inhibits IL-6-induced tyrosine phosphorylation of STAT3, whereas IL-6 reduces 
LPS-induced IL-6 production, suggesting that there is a mutual cross-inhibition 
between the IL-6 and the LPS signaling pathways in dendritic cells. 
< Figure 2. Cross-inhibition of IL-6 and LPS signaling in dendritic cells.
(A) Quantification of SOCS3 mRNA levels in moDCs upon 4 h incubation in presence or absence of 
LPS and/or IL-6. (B) SOCS3 protein levels upon 0, 4 or 24 hours LPS stimulation by Western blot. 0 
hours exposure to LPS was a quick wash in LPS-containing culture medium (<10 s). For each donor, 
SOCS3 levels were normalized to 0 hours exposure to LPS. Representative blot is shown below the 
graph and individual donors are shown in the graph. (C) Quantification of tyrosine phosphorylated 
(Tyr705) pSTAT3 over total STAT3 levels for panel B. Representative blot (same donor as panel B) is 
shown below the graph. For each donor, pSTAT3/STAT3 levels were normalized to 0 hours exposure to 
LPS stimulation.  Individual donors are shown in the same color as in panel B. (D) Same as panel B, but 
now in presence of the proteasome inhibitor MG132. For each donor, SOCS3 levels were normalized 
to 0 hours LPS stimulation from panel B. Representative blot (same donor as panel B) is shown below 
the graph. (E) Same as panel C, but now in the presence of MG132. For each donor, pSTAT3/STAT3 
levels were normalized to 0 hours LPS stimulation from panel C. Representative blot (same donor 
as panel B) is shown below the graph. (F) Western blot showing IL-6RA levels in moDCs upon siRNA 
silencing of IL-6RA (siIL-6RA) and non-targeting siRNA (siCntrl). Bar-graph: quantification (error bars: 
SEM for 6 donors). (G) pSTAT3 and IL6-RA levels for siIL-6RA and siCntrl and in absence or presence 
of exogenous IL-6 for the times indicated. (H) Quantification of pSTAT3 from panel G (individual 
donors shown). (I) IL-6 secretion by 4 hours LPS-stimulated moDCs with or without siIL-6RA by ELISA 
(individual donors shown). (J) IL-6 mRNA transcription by qPCR for moDCs with or without siIL-6RA 
and 4 or 8 hours LPS incubation.
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IL-6 signals from intracellular compartments 
In hepatocytes, IL-6 predominantly signals from intracellular compartments of 
endosomal nature 41–43,56. We determined the subcellular localization of IL-6RA 
signaling in dendritic cells. First, we measured the fraction of IL-6RA present at 
the cell membrane and at intracellular organelles. MoDCs were immunostained 
with a monoclonal antibody recognizing the extracellular domain of IL-6RA 
both under permeabilizing and non-permeabilizing conditions and analyzed by 
flow cytometry. About ~35% of IL-6RA was present at the plasma membrane, 
similar to the transferrin receptor (TfR) which also cycles via recycling 
endosomes to the plasma membrane (Fig 3A; Suppl Fig 4A). Transmission 
electron microscopy experiments with immuno-gold antibody-conjugate 
uptake confirmed the presence of IL-6RA at intracellular compartments (Fig 2B; 
Suppl Fig 4B). We performed immunofluorescence microscopy experiments to 
characterize the type of intracellular compartments where IL-6RA was residing. 
Because the signal of our IL-6RA antibody was too weak to resolve intracellular 
compartments (Suppl Fig 3B), we visualized IL-6RA by overexpression of a 
construct coding for IL-6RA C-terminally fused to the fluorescent reporter 
protein mCherry. Fusion constructs of IL-6RA C-terminally conjugated to 
fluorescent proteins have been used previously to study IL-6RA trafficking and 
shedding 57. By immunofluorescence labeling, we observed localization of IL-
6RA mCherry at the plasma membrane and an intracellular pool that overlapped 
with compartments positive for the early/recycling endosomal SNARE protein 
VAMP3 58, the early/late endosomal SNARE protein VAMP8 59, the trans-Golgi 
marker TGN3858, the recycling endosomal marker transferrin receptor TfR, and 
less with the late endosomal/lysosomal marker LAMP1 and the early endosomal 
marker EEA1 (Fig 3C-D). These results indicate that IL-6RA traffics to the plasma 
membrane, the Golgi apparatus, recycling endosomes, and late endosomes/
lysosomes. 
Since our data show that the majority of IL-6RA locates at intracellular 
compartments in dendritic cells, and since IL-6RA signaling in hepatocytes 
is known to occur from intracellular compartments 41–43, we then tested for 
intracellular signaling of IL-6RA. Quantitative immunofluorescence experiments 
showed that exogenous IL-6 was taken up by the cells in a concentration-
dependent manner (Fig 4A), with a similar concentration dependency as pSTAT3 
activation (Fig 1C). Although IL-6 exposure resulted in lower cellular levels of IL-
6RA (Fig 2G; Fig 4B), as reported previously 36, we could not detect significant 
breakdown of exogenous IL-6 by the dendritic cells by quantitative ELISA (Suppl 
Fig 5A-C). IL-6 uptake by dendritic cells is important for signaling, because IL-
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Figure 3. IL-6RA localizes at the plasma membrane, Golgi and endosomes in dendritic cells. 
(A) Flow cytometry of moDCs immunostained for IL-6RA with (total) or without permeabilization 
(surface). Geometric mean fluorescence intensities (gMFI) for individual donors are shown (isotype 
subtracted). (B) Transmission electron microscopy image of endocytosed antibody against 
IL-6RA followed by immunogold staining. Pink arrowheads indicate immunogold particles. Scale bar, 
200 nm. (C-D) Confocal images (C) and quantification by Pearson correlation coefficients (D) of moDCs 
expressing IL-6RA fused to mCherry (magenta in merge; IL-6RA-mCherry) and immunolabeled 
for VAMP8, VAMP3, EEA1, LAMP1, transferrin receptor (TfR) or TGN38 (green). DAPI is in blue in 
merge. Graphs: fluorescence cross-sections as indicated. Yellow regions: overlap of IL-6RA-mCherry 
with organellar markers. Representative cells from multiple donors are shown (>7 cells/donor). 
Scale bars, 20 µm. 
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6-dependent activation of STAT3 could be almost completely blocked with the 
dynamin inhibitor hydroxy-dynasore (Fig 4C; Suppl Fig 5D). Hydroxy-dynasore 
treatment increased IL-6RA localization at the plasma membrane by ~50% 
(Fig 4D), indicating that IL-6RA cycles via the plasma membrane to intracellular 
compartments. These findings support signaling of IL-6 from intracellular 
compartments in dendritic cells, in a similar way as in hepatocytes, where IL-6 
and IL-6RA are endocytosed in a dynamin-dependent manner and inhibition of 
dynamin results in impaired STAT3 activation 6, 41, 42, 56, 60. 
The endosomal signaling of IL-6RA was further supported by live cell fluorescence 
microscopy experiments of dendritic cells expressing STAT3 fused to GFP (STAT3-
GFP) which is retained at the nucleus upon activation 41,61. STAT3-GFP was co-
expressed with a mCherry-tagged variant of the endocytic cargo adaptor Epsin 2 
(Epsin2-mCherry) 62. Overexpression of Epsin 2 acts as a dominant negative and 
blocks clathrin-mediated endocytosis by misguiding epidermal growth factor 
receptor substrate 15 (EPS15) and adapter protein 2 (AP-2) to overexpression 
foci 63. Supporting a role for endocytosis in IL-6 signaling, the IL-6-induced 
translocation of STAT3-GFP to the nucleus was about two-fold reduced in 
dendritic cells expressing Epsin 2-mCherry compared to the control of mCherry 
alone (Fig. 4E-G; Suppl Movie 1 and 2). In some cells, we observed punctuated 
signals of STAT3-GFP in the cytosolic region (i.e., control condition of mCherry 
alone in Fig 4E), which might be signaling at endosomes as described for Hep3B 
cells 42. These results show that IL-6RA signals from intracellular compartments, 
and we next addressed whether de novo synthesized IL-6 in transit to the plasma 
membrane could also signal from these sites. 
Intracellular signaling of newly synthesized IL-6 prior to secretion 
In macrophages and dendritic cells, newly synthesized IL-6 does not traffic 
directly from the Golgi apparatus to the plasma membrane, but is instead 
routed via recycling endosomes that partially overlap with TfR and VAMP3 
39,40. We performed fluorescence microscopy experiments to characterize the 
organelles of IL-6 trafficking. However, we only observed a very low signal of 
IL-6 in LPS-stimulated moDCs by immunofluorescence microscopy and flow 
cytometry, and this signal was only observable at 4h after LPS stimulation 
(Suppl Fig 6A-C). As a positive control, inhibition of ER-Golgi trafficking with 
Brefeldin A 39,64 resulted in accumulation of IL-6 within the cells (Suppl Fig 6A-C). 
SiRNA silencing of IL-6RA in moDCs, which blocks pSTAT3 activation and results 
in higher IL-6 production (Fig 2G-J; Suppl Fig 6E), also increased the intracellular 
accumulation of endogenous IL-6 compared to siCntrl by immunofluorescence 
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Figure 4. Endocytosis of IL-6 is required for paracrine STAT3 signaling.
(A) MoDCs incubated with increasing concentrations of IL-6 for 20 minutes and immunostained for intracellular 
IL-6 (green) were imaged by confocal microscopy. DAPI is in blue. Yellow arrowheads: IL-6 positive cells. Graph: 
quantification of IL-6 signals (mean ± SEM from 3 donors). Scale bars, 10 µm. (B) Quantification of IL-6RA upon 
incubation with IL-6 for the times indicated by Western blot (see also Fig 2G). Data is normalized to the highest 
IL-6RA band intensity per donor. α-Tubulin: loading control.(C) STAT3 tyrosine 705 phosphorylation (pSTAT3) of 
moDCs incubated with or without hydroxy-dynasore and/or 15 ng ml-1 IL-6. Graph: quantification for 3 different 
donors (mean ± SEM). Data is normalized to the highest pSTAT3/STAT3 ratio per donor. (D) Flow cytometry of 
moDCs incubated with or without hydroxy-dynasore and immunostained for surface IL-6RA. Geometric mean 
fluorescence intensities (gMFI) of different donors are shown (isotype subtracted). (E) Fluorescence microscopy 
images of moDCs transfected with STAT3-GFP (green in merge) and empty-mCherry or Epsin2-mCherry (magenta 
in merge) upon IL-6 stimulation for 20 minutes. Scale bars, 20 µm (see also Suppl Movies 1 and 2). (F) Quantification 
of STAT3-GFP retainment at the nucleus following IL-6 stimulation from panel E (mean ± SEM for 80 cells from 
4 donors). (G) Quantification of STAT3-GFP retainmentat the nucleus at 20 min after IL-6 stimulation for only 
mCherry or Epsin2-mCherry (Epsin2) (from panel F; individual donor averages shown for 20-23 cells/donor). 
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microscopy and flow cytometry (Fig 5A-B). These results indicate that newly 
synthesized IL-6 does not accumulate within the majority of moDCs but is 
mostly secreted from these cells, as we reported previously 40 and has also 
been described for peripheral blood mononuclear cells 55. In order to resolve the 
organelles involved in IL-6 trafficking, we increased the intracellular presence 
of IL-6 by overexpression of a construct coding for human IL-6 fused to GFP 
(IL-6-GFP). This strategy of overexpression of GFP-tagged IL-6 has been used 
previously to visualize intracellular trafficking of IL-6 39,40. We stimulated IL-6-
GFP-transfected moDCs for 4 hours with LPS and subsequently determined 
the subcellular localization of IL-6-GFP by immunofluorescence labeling with the 
same panel of organellar markers as we used previously for IL-6-RA (Fig. 3C). Partial 
overlap of the IL-6-GFP signal was observed with the Golgi marker TGN38, the early/
recycling endosomal markers EEA1 and VAMP3, the late endosomal/lysosomal 
markers VAMP8 and LAMP1, and the transferrin receptor (Fig 5C-D). These 
results indicate that IL-6-GFP is secreted via the Golgi network and early/recycling 
endosomes, as previously reported for macrophages and dendritic cells 39,40. 
We then determined whether IL-6 would traffic via the same intracellular 
compartments as IL-6-RA. Clear overlap of the IL-6-GFP and IL-6RA-mCherry 
signals was observed in moDCs co-transfected with both proteins, both in absence 
and presence of LPS (Fig 6A), and as reported previously for BMDCs 18. Live-cell 
time-lapse total-internal reflection fluorescence (TIRF) microscopy experiments 
confirmed that IL-6-GFP and IL-6RA-mCherry co-migrated to the plasma 
membrane (Fig 6B; Suppl Movie 3). These experiments suggest that newly 
synthesized IL-6 in transit to the plasma membrane could encounter IL-6RA in 
intracellular compartments, which would enable auto-activation of STAT3. We 
performed flow chamber experiments to determine whether newly synthesized 
IL-6, and possibly other STAT3 activating factors such as IL-10 33, in transit to the 
plasma membrane would suffice for activation of STAT3. We kept moDCs under a 
constant flow, thereby continuously refreshing the LPS-supplemented medium 
and flushing away all secreted cytokines (Fig 6C). Under our experimental 
conditions, the concentration of IL-6 in the flow chamber remained well below 
0.05 ng ml-1 which is far too low for STAT3 activation in absence of LPS (Fig 6C; 
Fig 1B-C). Nevertheless, LPS-induced pSTAT3 activation could be detected under 
flow (Fig 6D), supporting the existence of self-signaling of newly synthesized 
IL-6 (and other factors) from intracellular compartments within the cells. To 
confirm this self-signaling of newly synthesized IL-6, we performed siRNA 
knockdown of the SNARE protein VAMP3. VAMP3 mediates secretion of IL-6 
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Figure 5. IL-6 is secreted via the Golgi and endosomes in dendritic cells.
(A) Confocal micrographs of moDCs with knockdown of IL-6RA (siIL6RA) or control siRNA (siCntrl) and 
immunofluorescence staining of IL-6 (green in merge). DAPI is in blue in merge. Yellow arrowheads: 
IL-6 positive cells. Graph: quantification of IL-6 fluorescence for individual donors. Scale bar, 50 µm. 
(B) Same as panel A, but now with flow cytometry. Shown is IL-6 accumulation after siCntrl or siIL-
6RA with LPS incubation for the times indicated (4 individual donors; mean ± SEM; normalized to 
Brefeldin A treated samples, see Suppl Fig 6C-D). (C-D) Confocal images (C) and quantification by 
Pearson correlation coefficients (D) of moDCs expressing IL-6 fused to GFP (green in merge; IL-6-GFP) 
and immunolabeled for VAMP8, VAMP3, EEA1, LAMP1, transferrin receptor (TfR) or TGN38 (magenta). 
DAPI is in blue in merge. Graphs: fluorescence cross-sections as indicated. Yellow regions: overlap 
of IL-6-GFP and organellar markers. Representative cells from multiple donors are shown (>7 cells/
donor). Scale bars, 20 µm.
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and its knockdown results in impaired IL-6 secretion 39,65,66. VAMP3 knockdown 
also results in increased LPS-induced tyrosine phosphorylation of STAT3 
(Fig 6E-F), in line with intracellular self-signaling of newly synthesized IL-6. 
Finally, we performed experiments with an IL-6 neutralizing antibody that blocks 
IL-6 binding to the receptor (Fig 6G). Whereas this antibody could completely 
block STAT3 activation triggered by extracellular IL-6, LPS-induced STAT3 
tyrosine phosphorylation was not affected compared to conditions without 
antibody or isotype control (Fig 6G). Together, these findings support a model 
where newly synthesized IL-6 activates phosphorylation of STAT3 in transit to 
the plasma membrane from intracellular compartments. 
Discussion
Endosomal signaling is emerging as an important principle for many different 
receptors, including receptor tyrosine kinases, insulin G protein-coupled receptors 
and Toll-like receptors 67,68. In this study, we show that, although IL-6RA appears 
at the plasma membrane, IL-6 mediated tyrosine phosphorylation of STAT3 
mainly occurs from intracellular compartments. This is in line with the finding 
that IL-6 and IL-6RA co-localize in intracellular compartments of BMDCs 18. In 
the hepatocyte cell lines HepG2 and HepB3, endosomal signaling of IL-6 41–43,56 is 
proposed to promote STAT3-induced transcription by reducing the distance that 
STAT3 has to travel to the nucleus 43. A second role of endosomal signaling is that 
it might increase control over signaling, as receptors can be readily sorted to the 
lysosome for degradation or back to the plasma membrane for re-sensitization 
for the corresponding stimulus 68. In hepatocytes, IL-6 bound to IL-6RA and 
gp130 is internalized via the constitutive internalization of gp130 6, 60 and the 
IL-6-receptor complex is subsequently degraded leading to a downregulation of 
the IL-6 receptor 20. Also in dendritic cells, our data shows that cellular levels of 
IL-6RA are reduced upon IL-6 stimulation, in line with previous findings 36, although 
we did not find evidence for breakdown of IL-6 itself. Less efficient IL-6 degradation 
in dendritic cells compared to hepatocytes might well be physiological, since 
dendritic cells are major producers of IL-6 18,66,69, whereas the liver is the major 
organ for removing IL-6 from circulation.
A third potential role of intracellular interactions between IL-6 and IL-6RA is 
that it might facilitate organellar trafficking of IL-6. Our data indicate that these 
interactions already might occur within the Golgi and recycling endosomes. 
In macrophages, immuno-gold labeled IL-6 appeared consistently in close 
proximity to the luminal face of the membrane of recycling endosomes 39, 
suggesting membrane association possibly by interactions with IL-6RA. IL-
6RA thereby might act as an adapter molecule ensuring proper sorting of IL-6 
to the correct target organelles. Such a mechanism would be reminiscent of 
the trafficking of newly formed IL-4 by the IL-4 receptor in eosinophils 70. The 
trafficking of IL-6 by IL-6RA could explain how IL-6 can be sequestered within 
sub-compartments of recycling endosomes 71. This compartmentalization of 
recycling endosomes is key to their sorting function, as it allows to direct cargo 
molecules in different directions, e.g., to the plasma membrane, to the Golgi 
apparatus, or to late endosomes/lysosomes 72. The trafficking of IL-6 by IL-6RA 
could also explain how IL-6 can be readily secreted after synthesis, with secretory 
vesicles containing only a limited number of IL-6 molecules and the majority of 
IL-6 producing cells showing no detectable intracellular pool of IL-6 40.
A fourth role of co-trafficking of a complex of IL-6 with IL-6RA to the plasma 
membrane is that it can facilitate trans-signaling. Trans-signaling is the process 
by which a complex of IL-6RA with IL-6 enables signaling of cells that do not 
express IL-6RA (but only gp130) 73 and largely underlies the pro-inflammatory role 
of IL-6 5,74. Trans-presentation of IL-6 with IL-6RA on the surface of dendritic cells 
is responsible for the differentiation of pathogenic Th17 cells 18. IL-6RA in complex 
with IL-6 can also be cleaved from the membrane 48 by the metalloproteases 
ADAM10 and ADAM17 49. As the K
off
 rate of IL-6 for IL-6RA is relatively low 75, 
IL-6 will remain bound to IL-6RA for seconds to minutes after cleavage and this 
signaling complex could effectively potentiate cells in the vicinity. Such a release 
mechanism would be comparable with the signaling demonstrated for tumor 
necrosis factor (TNF)α, interleukin 15 (IL-15) and interleukin 11 (IL-11) 76–79. For 
TNFα, ADAM17 cleaves its precursor at the plasma membrane resulting in release 
of TNFα 71,80. IL-11 receptor (IL-11R) is cleaved by ADAM10, making all gp130-
positive cells sensitive to IL-11 induced STAT signaling, similar to soluble IL-6RA 
together with IL-6 73,79. IL-15 is cleaved at the plasma membrane together with IL-
15 receptor subunit alpha (IL-15RA) 81–83. However, in contrast to IL-6 with IL-6RA, 
IL-15RA is believed to remain associated with IL-15 and free IL-15 without IL-15RA 
does not, or only little, exist in circulation 81,83,84.
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Based on our data, we propose a fifth role of the intracellular signaling of IL-6. 
Our data shows that self-activation of STAT3 by newly synthesized IL-6 (and 
probably by other factors such as IL-10 33) in transit to the plasma membrane 
results in a transient auto-inhibition of further IL-6 transcription (Fig 7). This 
negative feedback inhibition is caused by an antagonistic cross-talk between 
the LPS-TLR4-p38MAPK and IL-6-STAT3 pathways 36,53, and results in a short-
term limit of IL-6 production by the dendritic cells. Our data shows that during 
sustained exposure to LPS, this brake in IL-6 production is effectively shut off 
via the increased transcription and higher protein presence of SOCS3 which 
inhibits pSTAT3 activity 44–46. This transient auto-inhibition of IL-6 synthesis 
by IL-6 signaling supports a new cellular mechanism by which the immune 
system might limit production of excessive IL-6 during sepsis or the invasion 
of microbial pathogens into the bloodstream. Following sepsis, an excessive 
systemic proinflammatory response can lead to tissue damage and organ 
failure and this so-called septic shock is a main cause of death in intensive 
care units 85. IL-6 is a key mediator of septic shock as low serum levels of IL-6 
are associated with a better prognosis and IL-6  levels in patients with septic 
shock are higher than in patients without shock 9,12,86,87. In vivo studies in IL-6-
knockout mice demonstrated that LPS administration leads to higher levels 
of proinflammatory cytokines such as TNFα 88 and they do not develop the 
hypothermia characteristic of early sepsis and show less weight loss compared 
to wild-type mice 89. Moreover, the absence of the IL-6 gene in mouse models of 
<  Figure 6. Signaling of newly synthesized IL-6 in transit to the plasma membrane.
(A) Confocal images and Pearson correlation coefficients of moDCs stimulated with or without LPS 
for 4 hours and co-expressing IL-6 fused to GFP (green in merge; IL-6-GFP) with IL-6RA fused to 
mCherry (magenta; IL-6RA-mCherry). DAPI is in blue in merge. Graphs: fluorescence cross-sections 
as indicated. Yellow regions: overlap of IL-6-GFP and IL-6RA-mCherry. Bar graph: quantification of 
overlap by Pearson correlation coefficient (4 donors; >7 cells/donor). Scale bars, 20 µm. (B) Stills from 
time-lapse TIRF microscopy of moDC overexpressing IL-6-GFP (green in merge) and IL-6RA-mCherry 
(magenta). Details of two exocytosis events indicated by the yellow arrowheads are shown. Graphs: 
quantification of the signals over time. Scale bars, 10 µm. Yellow regions: occurrence of exocytosis 
events (see also Suppl Movie 3). (C) Scheme of the flow setup for STAT3 activation under flow with or 
without LPS for 4 hours. The graph shows the IL-6 concentrations in supernatant from moDCs cultured 
in presence or absence of LPS and with or without flow by ELISA. (D) Quantification by Western blot 
of STAT3 activation from panel C for different donors (mean ± SEM). Data is normalized to the highest 
pSTAT3/STAT3 ratio per donor. (E) Quantification by Western blot of VAMP3 after siRNA gene silencing 
(siV3) or non-targeting siRNA control (siCntrl) with or without 4 hours LPS stimulation (mean ± SEM 
from 3 donors). GAPDH: loading control. (F) Quantification by Western blot of STAT3 activation after 
siV3 with or without LPS for 4 hours (mean ± SEM from 3 donors). (G) Quantification by Western blot 
of STAT3 activation upon incubation for 4 h with 1 µg ml-1 LPS or 20 min with 15 ng ml-1 IL-6, and in 
absence or presence of an IL-6 neutralizing antibody (anti-IL-6) or IgG control (IgG-cntrl) (mean ± SEM 
from 3 donors). Representative Western blots are shown below the graphs. 
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acute infection decreases inflammatory responses and protects from mortality 
and organ failure 90. In humans, IL-6 was identified as a key mediator of 
myocardial depression in septic shock, which leads to impaired tissue perfusion, 
multi-organ failure, and death 91. Thus, excessive IL-6 secretion following acute 
infection can be detrimental 4, and the transient restraining of IL-6 production 
by self-signaling of newly produced IL-6 might be beneficial.
Materials and methods
Cell culture
MoDCs were derived from peripheral blood monocytes isolated from buffy coats 
from healthy volunteers (informed consent obtained and according to institutional 
and national ethics guidelines) by 6 days culturing with 300 U ml-1 IL-4 and 450 U 
ml-1 GM-CSF, as described 92,93. Monocyte-derived macrophages were derived 
from CD14+ monocytes isolated from peripheral blood monocytes with anti-CD14 
conjugated magnetic beads (Miltenyi Biotec) by 6 days culturing with 20 ng ml-1 
M-CSF (ProteinPrep). Plasmacytoid dendritic cells were isolated by positive selection 
with anti-BDCA4 conjugated magnetic beads and CD1c+ dendritic cells were 
isolated with anti-CD1c conjugated magnetic beads after B cell depletion (Miltenyi 
Biotec). All cells were cultured in RPMI-1640 medium (Gibco) supplemented with 2 
mM ultraglutamine (Westburg), 10% fetal bovine serum (FBS) and 1% antibiotic-
antimyotic (AA; PAA), except for HeLa cells which were cultured in high glucose 
DMEM with Glutamax and sodium pyruvate (Gibco), supplemented with 10% FBS 
and 1% AA. HeLa cell dissociation was performed with 2 mM EDTA for 5 mins at 
37°C and 5% CO2 and cells were routinely passaged when 85-90% confluent. Where 
indicated, cells were treated with a log series up to 15 ng ml-1 of IL-6 (Cell Genix) 
for 20 minutes, 1 µg ml-1 LPS (Invivogen, E. coli O111:B4 UltraPure) for 4, 6, 8, 18 
or 24 hours, a combination of 2 µg ml-1 Poly(I:C) (Enzo Life Sciences) and 4 µg ml-1 
R848 for 22 hours (Enzo Life Sciences), 10 µg ml-1 Brefeldin A (Sigma Aldrich), or 
25 µM MG132 (Sigma). For dynamin inhibition, cells were incubated with 20 µM 
hydroxy-dynasore (Sigma-Aldrich) for 40 minutes. IL-6 secretion was measured by 
ELISA (88-7066-88; E Bioscience). Flow experiments were performed with 375,000 
cells in a Sykes-Moore culture chamber (Bellco Glass) at 3 ml hour-1 flow rate. For 
blocking extracellular IL-6, we used 1 µg ml-1 of neutralizing mouse IgG1 (mabg-
hil6-3; InvivoGen) and azide free mouse IgG1 as negative isotype control (MA1-
10407; ThermoFisher).
BMDCs were generated from the femurs and tibias of 6–18 weeks old female 
mice. After isolation, bone marrow cells were cultured in RPMI-1640 medium 
supplemented with 10% FBS, 1% L-glutamine (Lonza), 50 μM β-mercaptoethanol 
(Sigma-Aldrich) and 0.5% AA. For differentiation, medium was supplemented with 
either 200 ng ml-1 of FLT3L (Miltenyi) on the day of culture start (Day 0), or with 20 ng 
ml-1 of GM-CSF (Prepotech) on Day 0, with replenishment of medium on Day 3 and 
Day 6 (at a final concentration of 87.5 ng ml-1 FLT3L or 8.75 ng ml-1 GM-CSF each 
day), as described 94. In both cases, the cells were harvested on Day 8. BMDCs were 
either not activated (0h) or activated with 1 µg ml-1 of LPS for 6h, 24h and 48h. 
PCR 
mRNA was isolated from homogenized moDCs with the Quick-RNA 
MiniPrep kit (Zymo Research). RNA was reverse transcribed into cDNA 
with Moloney murine leukemia virus reverse transcriptase and random 
hexamers (Invitrogen). IL-6RA mRNA was amplified by PCR with the forward 
primer: CCCCTCAGCAATGTTGTTTGT and three reverse primers: GGCGT-
CGTGGATGACACAG, GGCAGTGGTACTGAAGAAGAA and CAGAACAATGGCA-
ATGCAGA. To determine the occurrence of the short isoform of IL-6RA, the 
forward primer 6R5-1 (ACGCCTTGGACAGAATCCAG) and the reverse primer 6R3-
2 (TGGCTCGAGGTATTGTCAGA) were used, as described 52. The following primers 
were used for qPCR of IL-6: forward: AGTGAGGAACAAGCCAGAGC, reverse: 
AGCTGCGCAGAATGAGATGA; GUSB: forward: GACACGCTAGAGCATGAGGG, 
reverse: GGGTGAGTGTGTTGTTGATGG; and SOCS3: forward: CCTGCGCCTCAA-
GACCTTC, reverse: GTCACTGCGCTCCAGTAGAA.
Transfection
MoDCs were transfected with plasmid DNA or siRNA against IL-6RA (hIL-6R 
Stealth; HSS105342; Thermo Scientific) or VAMP3 (HSS113848, HSS113849, 
HSS113850; Thermo Scientific 40) using a Neon Transfection system (Thermo 
Scientific) as described 93,94. Genes coding for human IL-6 and human STAT3 
were ordered as synthetic genes from GenScript (sequences in Supplementary 
Information) and subcloned into the XhoI/BamHI and HindIII/AgeI sites of 
pEGFP-N1 (Clontech), respectively. The IL-6RA gene (HGl0398-M-N; Sino 
Biological) was subcloned into the EcoRI/SalI sites of pmCherry-N1 (Clontech). 
Epsin2-pmCherryC1 was a gift from Christien Merrifield (Addgene plasmid 
#27673) 62. 
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Figure 7. Self-signaling of IL-6RA at intracellular compartments limits IL-6 synthesis by dendritic 
cells.
Model scheme depicting the interplay of the synthesis, trafficking and intracellular signaling of 
IL-6. LPS binding to TLR4 promotes transcription of IL-6 and SOCS3. Newly synthesized IL-6 in transit 
to the plasma membrane self-signals from endosomal compartments prior to secretion. Extracellular 
IL-6 is taken up by the cell and also signals from endosomal compartments. This leads to increased 
STAT3 activation (phosphorylation of Tyr705) which represses transcription of further IL-6. STAT3 
activation in turn is inhibited by increased presence of SOCS3.
Western blot
For Western blot, moDCs were lysed in 1% SDS and 10 mM Tris-HCl, pH 6.8 and 
blotted to PVDF. Antibodies used were a polyclonal rabbit against IL-6RA (sc-661; 
Santa Cruz Biotechnology), a polyclonal rabbit against mouse IL-6RA (23457-1-
AP; Proteintech), a rat IgG2a against α-Tubulin (YOL1/34; Novus biological), a 
rabbit monoclonal IgG against GAPDH (clone 14C10; Cell Signaling Technology), 
a rabbit polyclonal against VAMP3 (ab5789; Abcam), a rabbit monoclonal IgG 
against total STAT3 (clone 79D7; Cell Signaling), a rabbit monoclonal IgG against 
tyrosine phospho-STAT3 (Tyr705; clone D3A7; Cell Signaling), a rabbit monoclonal 
IgG against serine phospho-STAT3 (Ser727; #9134; Cell Signaling 24), and a 
goat polyclonal against SOCS3 (M-20; Santa Cruz Biotechnology). Secondary 
antibodies were conjugated to IRDye680 or IRDye800 (Li-Cor).
Flow cytometry 
MoDCs were stained with mouse IgG1 against human IL-6RA conjugated to PE or 
APC (clone UV-4; Biolegend), a polyclonal rabbit against human IL-6RA (sc-661; 
Santa Cruz Biotechnology), mouse IgG2a against human gp130 conjugated to PE 
(clone 2E1B02; Biolegend), rat IgG1 against human IL-6 conjugated to PE (clone 
MQ2-13A5; Biolegend) and mouse ascites IgG1 against human TfR (clone b3/25; 
Santa Cruz Biotechnology) combined with a secondary antibody labeled with 
Alexa fluor 488 (Life Technologies) under 0.1% saponin (Sigma) permeabilizing 
and non-permeabilizing conditions. A FACS Calibur (BD biosciences) was used 
and data was analyzed using FlowJo software. 
Immunofluorescence
For immunofluorescence staining, 75,000 moDCs were cultured on 12 mm 
diameter glass coverslips. The cells were fixed with 4% paraformaldehyde (PFA), 
permeabilized with 0.1% saponin and blocked in PBS containing 20 mM glycine, 
3% BSA and 0.1% saponin (CLSM-buffer). Cells were stained with the following 
primary antibodies in CLSM-buffer at a 1:100 dilution: polyclonal rabbit IgG against 
IL-6RA (sc-661; Santa Cruz Biotechnology), mouse IgG2a against IL-6 (sc-28343; 
Santa Cruz Biotechnology), mouse IgG1 against GM130 (610822; BD), mouse 
ascites IgG1 against TfR (clone b3/25; Santa Cruz Biotechnology), polyclonal rabbit 
against VAMP3 (ab5789; Abcam), polyclonal rabbit against VAMP8 (104 302; SySy), 
polyclonal goat against TGN38 (Clone C-15; Santa Cruz Biotechnology), mouse IgG1 
against LAMP1 (328601; Biolegend), and mouse IgG1 against EEA1 (610456; BD). 
Secondary antibodies were labeled with Alexa fluor 488 or 647 (Life Technologies) 
and used at a 1:400 dilution. Cells were mounted in 100 mM Na-phosphate buffer at 
pH 7.4 with 68% glycerol and 4’,6-diamidino-2-phenylindole (DAPI).
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Optical microscopy
Fluorescence live cell imaging was performed with a Leica DMI6000 epi-
fluorescence microscope fitted with a 63× 1.4 NA oil immersion objective. Focus 
was kept stable with the adaptive focus control (Leica). Confocal images were 
recorded with a Leica SP8 confocal laser scanning microscope with a 63× 1.20 NA 
water immersion objective. Overlap was quantified with an unbiased macro in 
FIJI that automatically selected imaged cell areas based on fluorescence intensity 
and then calculated Pearson correlation coefficients using the JACoP plugin. 
TIRF was performed on an Olympus IX71 inverted microscope equipped with a 
150× 1.45 NA oil immersion objective and a Cell^TIRF illuminator and appropriate 
lasers for excitation (Olympus). Fluorescence emission was separated from the 
excitation light with a CMR-U-M4TIR-SBX dichroic mirror (Olympus) and FF01-
530/43-25 emission band-pass filter (Semrock). Fluorescence from GFP and 
mCherry was separated with a T565lpxr (Chroma) dichroic mirror and FF01-
530/43-25 (GFP; Semrock) and FF01-612/69-25 (mCherry; Semrock) emission 
filters. Images were recorded with an EM-CCD camera (C9100-13, Hamamatsu). 
The sample was kept at 37oC by a sample heater (Pecon) and an objective heater 
(Tokai-Hit). 
Electron microscopy
Primary rabbit IgG against IL-6RA at 100x dilution (Clone 23457-1-AP; Proteintech) 
or matching isotype control was pre-incubated with 10 nm diameter gold-labeled 
protein A (binds rabbit IgG) for 20 minutes. Subsequently, antibody mixes were 
incubated with the cells for 1 hour at 37oC for their uptake. Cells were washed 
twice with PBS and fixed in 2% glutaraldehyde in 0.1 M phosphate buffer at pH 7.4 
(PB). Post-fixation of cells was done with 1% (w/v) OsO4 and 1% (w/v) potassium 
ferrocyanide in 0.1 M PB for 1 hour. Following dehydration with a graded ethanol 
series (30–100%) the cells were incubated in a 1:1 mixture of Epon resin and ethanol 
for 3.5 hour. After ethanol evaporation, the Epon was replaced and polymerized 
for 24 hour at 60oC. 90 nm thin sections were cut with a microtome and specimens 
were imaged with a JEOL 1010 transmission electron microscope.
Statistical analysis
All data were analyzed using paired 2-sided Student’s t-tests (for datasets with 2 
conditions), and ANOVA with post-hoc Bonferroni multiple comparison test (for 
>2 conditions). A value of p < 0.05 was considered statistically significant (*p < 
0.05, **p < 0.01, ***p < 0.001).
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Suppl Fig 1. Levels of IL-6RA and gp130 in dendritic cells upon LPS stimulation.
(A) Quantification of IL-6RA protein levels by Western blot for CD1c+ myeloid dendritic cells (mDC) 
with or without overnight stimulation with LPS or a combination of Poly(I:C) and R848, plasmacytoid 
dendritic cells (pDC) and for moDCs, RAW264.7, and murine GM-CSF and FLT3L-differentiated bone 
marrow derived dendritic cells (BMDCs) stimulated with LPS for the times indicated (mean ± SEM from 
at least 4 donors or mice). The highest band intensity of IL-6RA per donor was used to calculate % of 
max (see main Fig 1A for representative blots). (B) mRNA expression of IL-6RA determined in moDCs 
by PCR. The position of the forward and reverse primers and the expected band sizes are indicated. 
(C) mRNA expression of IL-6RA isoforms determined by PCR. Plasmid DNA (pDNA) codes only for the 
long isoform 1 of IL-6RA (pink arrow); cDNA is derived from unstimulated moDCs. The forward primer 
6R5-1 and the reverse primer 6R3-2 were used, as described (Horiuchio et al, 1994). (D) Quantification 
of IL-6RA protein levels by flow cytometry in mDCs treated overnight (16 h) with LPS, plasmacytoid 
DCs treated with CpG-C and moDCs with or without LPS for individual donors. Representative 
histograms from 1 donor are shown. Note the large variability among donors. (E) Quantification of 
IL-6RA protein levels by flow cytometry of moDCs upon LPS stimulation for 4, 8, 18 or 24 hours (mean 
± SEM from 6 donors). The highest intensity IL-6RA per donor was used to calculate % of max. (F) 
Quantification of gp130 expression by flow cytometry of moDCs upon LPS stimulation for 4, 8 or 24 
hours (mean ± SEM from 4 donors). The highest intensity gp130 per donor was used to calculate % of 
max. Representative histograms from 1 donor are shown. 
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Suppl Fig 2. STAT3 tyrosine and serine phosphorylation upon IL-6 and LPS stimulation.
(A) Complete gels from main figure 1B. STAT3 phosphorylation of tyrosine 705 (pSTAT3) by Western blot. MoDCs 
were incubated for 20 min with the IL-6 concentrations indicated and with or without 4 hours LPS pre-incubation. 
α-Tubulin: loading control. Three donors are shown (4th donor in main Fig 1B). Arrow heads indicate the location of 
the quantified bands. (B) Same as panel A, but now for phosphorylation at serine 727 (left; pS-STAT3) and tyrosine 705 
(right; pY-STAT3) for 3 donors. Graphs show quantification normalized to the maximum band intensities per donor. (C) 
IL-6 expression by qPCR for 4 h incubation in presence or absence of exogenous IL-6 and/or LPS (average ± SEM from 
3 donors).
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Suppl Fig 3. Control experiments for siIL-6RA.
(A) Validation of IL-6RA antibody for flow cytometry by siRNA knockdown in moDCs of IL6-RA (siIL-
6RA). SiCntrl: non-targeting siRNA control. Representative histograms are shown for IL-6RA (green) 
and isotype control (dashed grey). (B) Same as panel A, but now with confocal microscopy with 
immunostaining for IL-6RA (green in merge) and DAPI (blue). Note that the antibody for IL-6RA shows 
some a-specific nuclear staining. Yellow arrowheads: IL-6RA-positive cells. Scale bar, 50 µm. (C) IL-6 
secretion from LPS-stimulated moDCs over time with or without siIL-6RA (mean ± SEM from 3 donors). 
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Suppl Fig 4. Control experiments for localization of IL-6RA in dendritic cells.
(A) Flow cytometry of moDCs immunostained for the transferring receptor (TfR) with (total) or without 
permeabilization (surface). Left: representative histograms. Right: geometric mean fluorescence 
intensities (gMFI) for individual donors (isotype subtracted). (B) Transmission electron microscopy 
image of moDC that endocytosed antibody against IL-6RA or isotype control followed by immunogold 
staining. Pink arrowheads indicate immunogold particles. Scale bars, 200 nm. 
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Suppl Fig 5. Control experiments for uptake and breakdown of exogenous IL-6.
(A) Titration experiment of exogenous IL-6 in presence or absence of moDCs (mean ± SEM from 3 
donors). IL-6 was measured by ELISA. (B) IL-6 secretion after 4 hours LPS stimulation upon siRNA 
silencing of IL-6 (siIL6; mean ± SEM from 4 donors). siCntrl: non-targeting siRNA control. (C) 
Breakdown of exogenous IL-6 by monocyte-derived macrophages, HeLa cells and moDCs with and 
without siRNA knockdown of IL-6 and after 15, 30, 60 or 120 minutes incubation determined by ELISA 
(mean ± SEM from at least 3 donors). (D) Confocal micrographs of moDCs treated with or without 
hydroxy-dynasore. Hydroxy-dynasore blocked uptake of fluorescently-labeled transferrin (left; green) 
and ovalbumin (right) at 15 and 30 minutes incubation. Blue: DAPI. Yellow arrowheads: transferrin and 
ovalbumin-positive cells. Scale bar, 50 µm. 
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Suppl Fig 6. Control experiments for the secretion of IL-6.
(A) Representative confocal images of LPS-treated moDCs with or without Brefeldin A (BFA). Cells were 
immunostained for IL-6 (green in merge) and GM130 (magenta). DAPI is in blue in merge. (B) Gating 
strategy of flow cytometry experiment for intracellular IL-6 accumulation in moDCs treated with LPS 
and/or BFA. IL-6PE: immunolabeling for IL-6 with a primary antibody labeled with phycoerythrin (PE). 
FSC: forward scatter. (C) Quantification of IL-6-positive cells from panel B for 4 individual donors (mean 
± SEM). (D) Positive controls of main figure 4B. MoDCs with non-targeting siRNA control (siCntrl) or 
siRNA knockdown of IL-6RA (siIL-6RA) were treated with LPS and BFA for 5 hours. The ratios between 
siCntrl and siIL-6RA were used to normalize % IL-6 positive cells in sIL-6RA samples. Individual donors 
are shown. (E) STAT3 phosphorylation (pSTAT3; Tyr705) of moDCs treated with siIL-6RA in absence or 
presence of IL-6 for 20 minutes. Graph: quantification for 3 different donors. The highest pSTAT3/STAT3 
ratio per donor was used to calculate % of max pSTAT3/STAT3. Blot from a representative donor is shown. 
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Abstract
Immune cells communicate by releasing large quantities of cytokines. Although 
the intracellular production and trafficking pathways of cytokine secretion are 
increasingly understood, quantitative knowledge of the number of cytokines 
per vesicle is still lacking. Here, we measured with quantitative microscopy 
the release rate of vesicles potentially carrying interleukin 6 (IL-6) in human 
blood-derived dendritic cells. By comparing this rate to the total amount of 
secreted IL-6, we estimate that secretory vesicles contain on average about 
0.5 – 3 IL-6 molecules, but with a large spread among cells/donors. Moreover, 
IL-6 did not accumulate within most cells, indicating that the synthesis and not 
trafficking is the bottleneck for IL-6 production. Only in about ~10% of the cells 
trafficking was the bottleneck, because IL-6 accumulated in the Golgi apparatus. 
Understanding how immune cells produce cytokines is important for designing 
new immunomodulatory drugs. 
Introduction
A general and important hallmark of the immune system is the remarkable 
plasticity of cytokine secretion by immune cells. Cellular activation, for 
instance during infection or tissue damage, triggers the secretion of pro- or 
anti-inflammatory cytokines to orders of magnitude higher levels compared 
to resting conditions 1,2. One of the most prominent examples is the secretion 
of the soluble cytokine interleukin 6 (IL-6) within hours after stimulation of 
macrophages and dendritic cells by the bacterial cell membrane component 
lipopolysaccharide (LPS) 3–5. Here, LPS binds to the pattern recognition receptor 
Toll-like receptor 4 (TLR4) on the plasma membrane of these immune cells and 
this triggers activation of NF-κB and other transcription factors, which in turn 
result in the transcription and translation of IL-6. As most cytokines, IL-6 traffics 
from the endoplasmic reticulum (ER) to the recycling endosome (RE) through 
the Golgi apparatus 2,6. REs are tubulovesicular organelles that regulate the 
trafficking of secretory vesicles to the plasma membrane 1, eventually resulting 
in the release of IL-6 into the extracellular environment.
Of course, not only the biosynthetic transcription- and translation machinery, 
but also the secretory trafficking machinery must be capable to cope with the 
requirements for increased release of IL-6 upon LPS activation. However, several 
pieces of evidence suggest that secretion (and not synthesis) might be limiting for 
cellular production of IL-6. In the macrophage cell line RAW264.7, endogenous 
IL-6 accumulates in the Golgi area within 1 hr after LPS stimulation, indicating 
that the Golgi may act as a bottleneck limiting the secretion of newly synthesized 
IL-6 6. In addition, several trafficking proteins involved in release of IL-6 (and other 
cytokines) are upregulated together with IL-6 1, such as syntaxin-3 and vesicle-
associated membrane protein 3 (VAMP3), both soluble NSF attachment protein 
receptor (SNARE) proteins mediating IL-6 secretion 6–8. Finally, the interactions 
of VAMP3 with syntaxin-4 at the plasma membrane increase upon LPS activation 
of dendritic cells and this coincides with increased IL-6 secretion 3. However, 
any quantitative data on the secretory pathway for IL-6 or other cytokines is 
surprisingly lacking. In this study, we set out to fill this gap by means of quantitative 
microscopy. We quantified the number of IL-6 molecules per secretory vesicle in 
human dendritic cells derived from blood. Surprisingly, we estimate that even 
under strong inflammatory conditions, potential secretory vesicles contained on 
average only approximately 3 IL-6 molecules in case secretion only occurs at the 
ventral (glass-adhered) membrane and 0.5 in case of completely non-polarized 
secretion. However, this number varied widely among cells and donors. These low 
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numbers suggest that the secretory pathway is not a major bottleneck for IL-6 
production, and this is supported by our finding that IL-6 did not accumulate within 
the majority of dendritic cells. However, for a minor fraction of dendritic cells 
(~10%) we observed IL-6 accumulation at the Golgi, suggesting that trafficking 
can be the bottleneck for some cells. 
 
Materials and Methods
Cells
Dendritic cells were derived from peripheral blood monocytes isolated from a 
buffy coat from healthy volunteers (informed consent obtained and according 
to national and institutional ethics guidelines) 9, as described 10. Cells were 
stimulated overnight with a final concentration of 1 µg ml-1 LPS. Cells were 
transfected using the Neon Transfection system (Invitrogen), as described 10. The 
plasmid coding for IL-6-GFP has been described 6 and was a gift from Jennifer 
Stow (Addgene plasmid # 28088). 
ELISA
IL-6 production was measured by using an ELISA kit (eBioscience; 88-7066-88) 
according to the manufacturer’s instructions. 
Immunofluorescence
Immunofluorescence labeling was performed as described 11. Primary antibodies 
used were mouse IgG1 anti-CD9 clone M-L13 (BD Biosciences; #555370), 
mouse ascites IgG1 against human transferrin receptor (TfR) (clone b3/25; 
Santa Cruz Biotechnology) and mouse IgG1 against GM130 (BD; 610822), all at 
a 1:100 dilution. Secondary antibodies were labeled with Alexa Fluor 647 (Life 
Technologies) and used at a 1:400 dilution. F-actin was stained with phalloidin 
conjugated to Alexa Fluor 647 (Molecular probes; A22287; 1:400 dilution). For 
staining of endogenous IL-6, cells were fixed with ice cold methanol for 20 
minutes at -20oC and blocked with 5% donkey serum in phosphate-buffered 
saline (PBS). Cells were incubated overnight with mouse IgG2b against IL-6 
(Santa Cruz; sc-130326) and rabbit IgG against VAMP3 (Abcam; ab5789). 
After extensive washing, the cells were incubated with secondary antibodies 
conjugated to Alexa Fluor 647 (donkey-anti-mouse) and Alexa Fluor 488 (donkey-
anti-rabbit). Cells were embedded in mounting medium containing 0.01% (v/v) 
Trolox (6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid), 68% (v/v) 
glycerol and 0.3 µg ml-1 DAPI (4’,6-diamidino-2-phenylindole). The cells were 
imaged with a Leica SP8 confocal laser scanning microscope equipped with a 
63× 1.20 NA water immersion objective.
TIRF microscopy
TIRF was performed on an Olympus IX71 inverted microscope equipped with a 
150× 1.45NA oil immersion objective and a Cell^TIRF illuminator (Olympus). 
Excitation light was provided with 100 mW 488 nm solid state laser (Olympus). 
Fluorescence emission was collected using an appropriate dichroic mirror (CMR-
U-M4TIR-SBX, Olympus) and emission band-pass filter (FF01-530/43-25, Semrock) 
with an EM-CCD camera (C9100-13, Hamamatsu). The sample was kept at 37oC 
by a sample heater (Pecon) and an objective heater (Tokai-Hit). Bursts were 
identified from time-lapse movies of dendritic cells expressing IL-6-GFP I(x, y, t) 
by first calculating the time-differences in fluorescence with (Eqn. 1):
   ΔI(x, y, t) = I(x, y, t) - I(x, y, t - 1).   (1)
By conventional blob detection on this time series ΔI(x, y, t), a list containing 
the coordinates and times of each fluorescence burst was then generated. 
We manually validated the efficiency of this semi-automatic burst detection 
algorithm and estimate that >90% of bursts are correctly identified. To generate 
fluorescence intensity histograms of the bursts, we integrated peak intensities 
over the surface area of the detected bursts. Intensity histograms were fitted 
with Poisson distributions using OriginPro 2016 (OriginLab).
STED microscopy
Dendritic cells were labeled with a PEGylated cholesterol analog labeled with 
a far-red fluorophore 12,13. Cells were resuspended in Live Cell Imaging Solution 
(Thermo Fisher). 3D image stacks were recorded with a 3-dimensional super-
resolution STED microscope with an isometric resolution of approximately 100 
nm in all dimensions, as described 14,15. 
Flow cytometry 
Dendritic cells were stained with rat IgG2a against human IL-6 conjugated to 
phycoerythrin (PE) (clone MQ2-6A3; Biolegend) and with a fixable viability dye 
eFluor™ 780 (eBioscience). Cells were measured on a MACSQuant (Miltenyi 
Biotec). Data was analyzed using FlowJo software.
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Statistical analysis
All data were analyzed using a paired 2-sided Student’s t-test (2 conditions) 
or ANOVA with post-hoc Bonferroni multiple comparison test (>2 conditions). 
A value of p < 0.05 was considered statistically significant (*p < 0.05, 
**p < 0.01, ***p < 0.001).
Results
We first measured the secretion of IL-6 from dendritic cells derived from 
monocytes isolated from blood of healthy volunteers. In resting conditions, 
these dendritic cells secreted on average about 0.05 fg cell-1 hr-1 of IL-6 (Fig. 
1). Given that the molecular weight of the main form of IL-6 is 23.7 kDa 16, this 
equals about 1,300 IL-6 molecules cell-1 hr-1. We then stimulated the cells with 
LPS for 24 hours. During this period, cells secrete more IL-6 which accumulates 
in medium in an almost linear fashion for over 24 hours 3. Overnight stimulation 
of the DCs with LPS increased the IL-6 secretion on average roughly 40-fold 
to approximately 46,000 molecules cell-1 hr-1 (Fig. 1). Thus, a resting dendritic 
cell on average releases an IL-6 molecule approximately every 3 s. Upon LPS 
stimulation, this number increases to about 13 IL-6 molecules per second.
Next, we determined cellular heterogeneity in our dendritic cell populations 
by determining the number of cells that produced IL-6. It is well established 
that even within one cell type, major differences in protein expression and 
cytokine secretion can be present 17–19. Therefore, we estimated the percentage 
of IL-6 producing dendritic cells upon LPS stimulation by flow cytometry 
combined with immunolabeling of intracellular IL-6. Only a minor population of 
approximately 10% of the dendritic cells showed intracellular pools of IL-6, and 
this accumulation was low and only observable 4-6 hours after LPS stimulation 
(Fig. 2A-B), indicating that most IL-6 was secreted rapidly after synthesis. 
Based on immunofluorescence staining of endogenous IL-6, IL-6 accumulated 
at the Golgi region and (less) at recycling endosomes (Fig. 2C), as reported 
previously 6. To prevent the secretion and accumulate all produced IL-6 within 
the cells, we repeated the flow cytometry experiments in presence of Brefeldin 
A which prevents cytokine secretion by disrupting ER-Golgi trafficking 20. This 
enabled us to estimate the percentage of cells within our population that 
is capable of IL-6 secretion. Brefeldin A treatment resulted in both a higher 
IL-6 signal and a higher fraction of approximately 42% of all cells showing 
intracellular pools of IL-6 (for 6 hours LPS stimulation; Fig. 2). After 6 hours, 
the intracellular accumulation decreased, possibly due to degradation. When 
we correct the average IL-6 secretion rate for the fraction of IL-6 producing 
cells (approximately 42% of the population; Brefeldin A condition in Fig. 2B), 
we find that LPS-stimulated cells on average secrete roughly 30 IL-6 molecules 
per second. However, based on the spread of intensities of the IL-6 signals in the 
flow cytometry experiments (Fig. 2A), the variation in IL-6 production among 
the cell population is large and ranges for over an order of magnitude. 
Figure 1. IL-6 secretion by dendritic cells.
(A) The total cellular secretion of IL-6 by dendritic cells measured by ELISA with and without overnight 
stimulation with LPS. Datapoints: individual donors. (B) Same as panel A, but now divided through 
the total number of cells and the time in order to calculate the average IL-6 secretion per cell per hour.
To obtain a rough estimate of the number of IL-6 molecules per secretory 
vesicle, we estimated the rate of exocytotic events from dendritic cells. For this, 
we overexpressed IL-6 C-terminally fused to GFP (IL-6-GFP) from the strong 
cytomegalovirus (CMV) promotor. This construct was used previously to study 
intracellular trafficking of IL-6 in RAW264.7 macrophages 6. As reported in this 
study, and similar to endogenous IL-6 (Fig. 2C), we observed accumulation of 
IL6-GFP in the Golgi apparatus and recycling endosomes of dendritic cells (Fig. 
3). Exocytosis of vesicles containing IL-6-GFP was then measured by total 
internal resonance fluorescence (TIRF) microscopy. Since GFP is quenched in 
the acidic environment of exocytotic vesicles 21, exocytosis of IL-6 results in a 
sudden ‘burst’ of fluorescence. This burst rapidly decreases in intensity as IL-6-
GFP diffuses away and/or gets photobleached (Fig. 4A-B; Suppl. Movie 1). As 
TIRF microscopy is capable of imaging relatively thin optical sections at the 
surface of the coverslip (i.e., at the ventral (lower) plasma membrane) without 
interference from cytosolic fluorescence, it allows to record time-lapse movies 
of exocytosis events, which are apparent from fluorescence bursts and this is a 
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widely used technique to study exocytosis (reviewed in 22). Unstimulated 
dendritic cells displayed on average approximately ~0.0013 bursts sec-1 µm-2 of 
IL-6-GFP (Fig. 4C). This rate increased on average about 2-fold to approximately 
0.0027 bursts sec-1 µm-2 upon overnight stimulation with LPS, likely due to the 
increased expression of trafficking proteins 6,8 and the rerouting of intracellular 
trafficking 3. These are coarse estimates, with a ten-fold variation among cells 
(Fig. 4C). Moreover, the intensity distributions fitted reasonably well with a 
Poisson distribution with the lowest intensity peak in the histogram 
corresponding to a single IL-6-GFP molecule (Fig. 4D). Extrapolating the fit to 
zero fluorescence intensity allowed to estimate the fraction of vesicles not 
containing the IL-6-GFP reporter. From this fitting, we estimate that secretory 
vesicles contained on average about 0.7 ± 0.2 IL-6-GFP molecules, and that 
approximately 49% of the vesicles did not contain an IL-6-GFP molecule (Fig. 4D). 
Thus, this suggests that we did not detect about half of the exocytic events 
Figure 2. IL-6 production by dendritic cells is heterogeneous.
(A) Representative flow cytometry plots showing the distribution of intracellular IL-6 in unstimulated 
cells or cells stimulated with LPS for 6 hours with or without Brefeldin A (BrefA). SSC: side scatter. (B) 
Quantification of the percentage of IL-6 positive cells from panel A following LPS stimulation over time 
in presence (green) or absence (blue) of Brefeldin A. Shown is mean ± SEM (≥3 donors). (C) Confocal 
images of LPS-activated dendritic cells immunostained for the SNARE VAMP3 (green in merge) and 
IL-6 (magenta). Arrowhead: cell positive for IL-6. Yellow regions in intensity distributions: overlap of 
VAMP3 and IL-6 intensities. Scale bar, 10 µm.
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because these vesicles did not contain IL-6-GFP.  Lastly, we cannot exclude that 
IL-6-GFP overexpression could overwhelm the normal secretion mechanism 
leading to deviations in the burst rates, although we did not observe a correlation 
between burst rates and expression levels of IL-6-GFP.
Figure 3. Overexpressed IL-6-GFP accumulates in Golgi and recycling endosomes. 
Confocal images of dendritic cell transfected with IL-6 fused to GFP (IL-6-GFP; green in merge) and 
immunostained for the Golgi marker GM130 or the recycling endosomal marker transferrin receptor 
(TfR; magenta). Yellow regions in intensity distributions: overlap of IL-6 GFP and GM130 or CD71 
intensities. Scale bar, 10 µm.
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Because of the limited imaging depth of TIRF microscopy, we could only measure 
exocytic events at the ventral membrane and not at the dorsal membrane. We 
recently showed that a post-fusion complex of the SNARE VAMP3 (responsible 
for IL-6 release 3,6,23) is present at the dorsal membrane of dendritic cells, 
suggesting that exocytosis does take place at this side 3. This is in line with 
findings in macrophages where no evidence was found for polarized secretion 
of IL-6, whereas tumor necrosis factor α (TNFα) was secreted predominantly 
at the phagocytic cup 6. Moreover, secretion measured with TIRF microscopy is 
representative of the total exocytosis in adrenal chromaffin cells, and exocytosis 
does not differ between the ventral and dorsal membranes 24. Nevertheless, it 
could be possible that IL-6 secretion in dendritic cells is (partly) polarized and 
has a preference for the ventral or dorsal membrane. To account for this, we 
determined different scenarios of fully polarized and non-polarized secretion 
Figure 4. Vesicle release rate at the ventral membrane of dendritic cells.
(A) Stills from time-lapse TIRF microscopy of dendritic cell overexpressing IL-6-GFP. Details of three 
exocytosis events indicated by the arrowheads are shown. Color of the arrowheads are matched with 
kymographs. Kymographs are aligned to the maximum intensities of the bursts (t = 0). Scale bar, 10 
µm. See also Suppl. Movie 1. (B) Quantification of the fluorescence signals shown in panel A over time. 
Yellow shaded areas: occurrence of exocytotic events. (C) IL-6-GFP burst rates per µm2 of imaged 
ventral cell surface area per second of IL-6 GFP exocytosis. Data points show individual cells combined 
from three donors. (D) Blue: fluorescence intensity distribution of IL-6-GFP bursts for a representative 
donor. Purple solid line: fit with Poisson distribution with an average of 0.7 IL-6-GFP molecules per 
burst. The fit was extrapolated to zero fluorescence intensity to quantify the fraction of vesicles not 
containing the IL-6-GFP reporter (~49%). 
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in our calculations and first determined the average apparent surface areas 
of the ventral and dorsal plasma membranes by confocal imaging. Here, we 
immunolabeled dendritic cells for the membrane marker CD9 (Fig 5A–B) 25–27. We 
then estimated the apparent total surface areas from 3-dimensional confocal 
z-stacks of dendritic cells by the method of the spatial grid [28,29]. With this 
method, the surface area is approximated from the number of intersection 
points of the cell surface with a grid of virtual probes. Here, we took advantage 
of the convex shape of dendritic cells which means that each virtual probe only 
passes through the cell a single time (i.e., no internal angles >180o). Because 
each probe only intersects the cell surface twice, we can estimate the apparent 
total surface area Aapp from the projected surface areas in three dimensions AXY, 
AZX and AZY (Fig. 5C) with (Eqn. 2):
   Aapp = 4/3 (Axy + Axy + Ayz).    (2)
Note that Axy is equal to the ventral (glass adherent) membrane surface area, 
and the dorsal membrane surface area can be calculated from the difference 
between Aapp and Axy. Unstimulated cells had an average total apparent surface 
area of approximately Aapp = ~4,035 ± 277 µm
2 (dorsal membrane: 2,260 ± 135 
µm2; ventral membrane: 1,775 ± 155 µm2 (± SEM from 3 different donors)) and 
this area did not change upon stimulation with LPS (Aapp = 3,858 ± 181 µm
2; 
dorsal membrane: 2,185 ± 110 µm2; ventral membrane: 1,673 ± 143 µm2; Fig. 
5D). We obtained similar results with fluorescently-labeled phalloidin which 
stains the (cortical) actin cytoskeleton (Suppl. Fig. 1A-E). Note that these values 
indicate the apparent surface areas as estimated from confocal microscopy, 
and these values will be substantially lower than the total surface area, because 
membrane ruffling is not accounted for. Due to the limited (i.e., diffraction 
limited) resolution of confocal microscopy, membrane curvature arising from 
ruffling cannot be properly resolved and this leads to an underestimation of the 
total membrane surface area. 
147146
Secretory vesicles of immune cells contain only a limited number of interleukin 6 moleculesChapter 6
6
Figure 5. Apparent imaged surface areas of dendritic cells.
(A) Confocal z-stack of a dendritic cell adhered to a cover slip and immunolabeled for the membrane marker 
CD9. The yellow dashed lines indicate the positions of the monograph (XY) relative to the orthogonal 
projections (XZ and YZ). (B) Average intensity z-projections from the cell in panel A. (C) Projected surface 
areas from the cell shown in panel A. Scale bar, 10 µm. The apparent imaged surface area from the cell in 
panels A – C was 2,744 µm2. (D) Frequency distributions of the total (gray filled), ventral (pink) and dorsal 
(blue) apparent surface areas of all measured cells for the control and LPS stimulated conditions (combined 
for 3 donors). Bar graphs: average apparent membrane surface areas (± SEM). 
To correct for this membrane ruffling, we recorded 3-dimensional super-
resolution stimulation emission depletion (STED) microscopy image stacks of 
dendritic cells labeled with a fluorescent cholesterol analog 12–15 (Fig. 6A). The 
extent of membrane ruffling was estimated from these image stacks by tracing 
the ventral and dorsal membranes in multiple cross-sections (Fig. 6B). Correction 
factors for membrane ruffling were then calculated as the square of the ratio of 
the lengths of the traces from STED over the smooth plane curves from confocal 
microscopy (Fig. 6C). The dorsal membranes were strongly ruffled, leading to an 
approximately 3.6-fold underestimation of the surface area by diffraction-limited 
confocal microscopy. In contrast, the ventral membrane was only somewhat 
ruffled and the surface area was only underestimated by 7%. This means that the 
corrected average area of membrane surface of a glass-adherent unstimulated 
dendritic cell is approximately 8,136 µm2 for the dorsal and 1,899 µm2 for the 
ventral membrane (Fig. 6D). For LPS-stimulated dendritic cells, the surface areas 
are 7,866 µm2 for the dorsal and 1,789 µm2 for the ventral membrane (Fig. 6D).
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Figure 6. Quantification of membrane ruffling by super-resolution microscopy.
(A) Representative surface projection of a live dendritic cell labeled with a fluorescent cholesterol 
analog and imaged by 3-dimensional STED microscopy. Note the increased resolution of STED 
compared to diffraction-limited confocal imaging. (B) Orthogonal section as indicated in yellow in 
panel A and traces of the dorsal and ventral membranes. Scale bar, 5 µm. (C) Correction factor to 
account for ruffling in the apparent membrane areas, calculated as the square of the ratios between 
membrane traces from STED over the smooth plane curves from confocal microscopy. (D) Average 
membrane areas from figure 5D, but now corrected for membrane ruffling.  
By multiplying the burst rates per imaged surface area from the TIRF microscopy 
with the total surface areas from the confocal z-stacks, we were able to obtain 
a rough estimate of the average burst rate per cell per second. In case of 100% 
polarized secretion only at the ventral membrane, the average burst rate 
increased from approximately 2.5 bursts cell-1 sec-1 to 4.8 bursts cell-1 sec-1 upon 
LPS stimulation (Fig. 7A; burst rate × corrected ventral membrane surface area). In 
case exocytosis also occurs at the dorsal site and is completely non-polar, the burst 
rates would be higher and increase from 13 bursts cell-1 sec-1 to 26 bursts cell-1 sec-1 
upon LPS stimulation (burst rate × corrected total membrane surface area). As we 
estimated (Fig 1; by ELISA) that unstimulated dendritic cells on average secrete 
roughly one IL-6 molecule per three seconds, this means that on average only 
about 1 in 7.5 (for 100% ventral release) or 39 (non-polar release) secretory vesicles 
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contains an IL-6 molecule (Fig. 7B). For LPS-stimulated dendritic cells that secrete 
13 IL-6 molecules per second, average vesicles contain on average roughly 0.5 (for 
non-polar release; half of the vesicles empty) to 3 (100% ventral) IL-6 molecules. 
However, it should be considered that this is a coarse and average estimate, and 
because of the large variation in IL-6 production, burst rates, and cell surface areas, 
this number is expected to vary substantially among cells and vesicles. 
Figure 7. Quantitative estimation of the number of IL-6 molecules per exocytotic event.
(A) Burst rates per cell per second of IL-6-GFP corrected for the average total surface area of the cells 
assuming (left; pink) 100% secretion at the ventral membrane and (right; purple) completely non-
polarized secretion (average ± SD). (B) Estimates of the average number of IL-6 molecules secreted 
per exocytotic event for 100% ventral or completely non-polarized secretion. No error bars are shown, 
because of the large variation in IL-6 production, burst rates, and cell surface areas among cells, donors 
and vesicles that cannot be accounted for (see main text).
Discussion
In this study, we estimated the number of IL-6 molecules released per secretory 
vesicle from dendritic cells derived from human blood. We estimated that each 
secretory vesicle of an LPS-stimulated monocyte-derived dendritic cell contains on 
average between about ~0.5 and 3 molecules of IL-6. The lower estimate is assuming 
completely non-polarized secretion, as suggested by a macrophage study where 
there was no evidence found for polarized secretion of IL-6 in macrophages, whereas 
TNFα was predominantly secreted at the nascent cup of phagosomes 6. The higher 
estimate is for the case that IL-6 is exclusively released at the ventral membrane, 
which we consider unlikely given that we recently showed 3 the presence of VAMP3 
at the dorsal membrane of post-fusion cis-SNARE complexes (i.e., the SNARE for 
IL-6 release 3,6,23). In the case where release of IL-6 would be higher at the dorsal 
than the ventral membranes, we underestimate the rate of exocytic events and the 
average number of IL-6 molecules per vesicle will be even lower. 
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Of course, our estimates are based on a large number of assumptions. Most 
importantly, we assumed that we labeled every secretory vesicle that potentially 
can release IL-6 by overexpression of IL-6-GFP. Fitting the fluorescence intensity 
distributions of the GFP bursts with Poisson distribution indicated that this might 
not be the case, and that we miss about half of the exocytosis events because the 
vesicle does not carry an IL-6-GFP reporter protein. Because of this, the fraction of 
vesicles containing IL-6 might be overestimated approximately 2-fold accordingly. 
If, on the other hand, the overexpression of IL-6-GFP or the GFP-tag distorts the 
intracellular trafficking somehow, this might lead to an under- or overestimation of 
the number of vesicles. Moreover, the large spread among cells in IL-6 production, 
surface area and burst rate may lead to large deviations in the number of IL-6 
molecules per vesicle. Thus, we fully acknowledge that our estimate can be 
substantially improved in future studies and it should only be regarded as a coarse 
approximation of the number of IL-6 molecules per secretory vesicle. 
Nevertheless, this is the first quantitative estimate of the number of molecules 
of a cytokine in a secretory vesicle and we believe it at least provides an order 
of magnitude of on average 0.1 – 10 molecules of IL-6 per vesicle. This number is 
surprisingly low, compared to for instance the 1,790 glutamate molecules present 
on average in a neurotransmitter vesicle from neurons 30 and the about 500,000 
insulin molecules per vesicle from pancreatic beta cells 31,32. Our results show that 
as IL-6 does not accumulate in most cells (Fig. 2B), the exocytotic machinery is 
not the limiting factor for release of IL-6, and this can assure the rapid secretion 
of IL-6 following cellular activation. The low average number of IL-6 molecules 
per vesicle, combined with the finding that IL-6 does not accumulate in most 
cells, demonstrates that transcription and translation, and not the subsequent 
trafficking, are the bottleneck for IL-6 secretion for the majority of cells. However, 
for the remaining minority of cells (~10%), IL-6 accumulates in Golgi showing that 
trafficking is the bottleneck. A quantitative understanding of cytokine production 
and release is essential for our understanding of immune function and may aid in 
the design of new immunostimulatory or inhibitory drugs.
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Supplementary information
Supplementary figure 1. Apparent surface area of dendritic cells by phalloidin staining.
(A) Confocal z-stack of a dendritic cell adhered to a cover slip and labeled with phalloidin conjugated 
to Alexa Fluor 647. The yellow dashed lines indicate the positions of the monograph (XY) relative to 
the orthogonal projections (XZ and YZ). (B) Average intensity z-projections from the cell in panel A. 
(C) Projected surface areas from the cell shown in panel A. The scale bar depicts 10 µm. The apparent 
surface area from the cell in panels A– C was 2,285 µm2. (D) Frequency distributions of the total 
(gray filled), ventral (pink) and dorsal (blue) apparent surface areas of all measured cells for the 
control and LPS stimulated condition (combined for 3 donors). (E) Average apparent surface areas of 
unstimulated and LPS-stimulated cells. Unstimulated cells had an average total apparent surface area 
of approximately 3,817 ± 530 µm2 and LPS stimulated cells 4,161 ± 637.3 µm2.
Legend to Supplementary Movie 1. 
Representative time lapse movie of TIRF microscopy of dendritic cell expressing IL-6-GFP. Frame 
interval is 200 ms. See main figure 4.
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Immune cell communication at the immunological synapse
Communication among immune cells and between immune cells and other cells 
is crucial for proper initiation and function of both the innate and the adaptive 
immune response against pathogens and cancer. This can be mediated by direct 
cell-cell interactions at the immunological synapse or by soluble molecules like 
cytokines and chemokines. Both these processes tailor the immune system to a 
response that should be the most optimal for combating the pathogen or cancer 
encountered. The pathogen or cancer cell on the other hand tries to evade this 
immune response by manipulating the communication pathways between the 
affected cells and the immune system 1,2. An important player in connecting 
the innate and the adaptive immune system is the dendritic cell. This cell is the 
main antigen presenting cell as it is able to activate naive T cells by presentation 
of endogenous antigens on major histocompatibility complex (MHC) class I 
molecules to CD8+ cytotoxic T lymphocytes (CTLs) and exogenous antigens on 
MHC class II molecules to CD4+ helper T lymphocytes 3. In addition, dendritic 
cells can cross-present exogenous antigens via MHC class I molecules to CTLs, 
which gives them a key role in the immune response against cancer cells 3,4. 
Activation of T cells requires the formation of an immunological synapse in the 
lymph node 5. Here, a large number of naive T cells scan dendritic cells for cognate 
antigens that matches their T cell receptor (TCR) via formation of transient 
short-lived synapses 6–8. When the dendritic cell encounters a T cell with a TCR 
that has sufficient affinity for the MHC-peptide complex, a more stable synapse 
is formed. This synapse formation, and thereby the potency to activate the T 
cells, not only depends on the affinity between the TCR and the MHC-peptide 
complex, but also on the presence of co-stimulatory receptors and cytokines 
9. Thus, the signals provided by the dendritic cells at the immune synapse are 
key for initiating strong T cell responses. In chapter 2 of this thesis, I described 
the molecular mechanisms underlying polarized membrane trafficking on the 
dendritic cell side of these immunological synapses.
As further explained in this chapter, the interface between dendritic cells and 
naive T cells is highly organized, and this is important for the initiation of T cell 
responses. A central conclusion in this review is that synapse formation leads to 
polarized delivery of certain cytokines (interleukin 12; IL-12) and MHC molecules 
at the immune synapse, and that this delivery requires a tight spatiotemporal 
regulation of membrane trafficking events in dendritic cells.
SNARE complex formation in cytokine secretion by dendritic cells
Insight in the spatiotemporal regulation of membrane trafficking is not only 
important at the immunological synapse between T cells and dendritic cells. 
Therefore, the first aim of this thesis was to decipher the molecular processes 
underlying spatiotemporal regulation of membrane trafficking events leading 
to cytokine release in dendritic cells. I focused on the secretion mechanisms 
of the cytokine interleukin 6 (IL-6), because this cytokine is a major player in 
the immune response. It has both pro- and anti-inflammatory properties and 
is involved in a wide range of immune diseases and cancer progression 10–12. 
Additionally, IL-6 promotes the activation, growth, proliferation and survival of 
many different cell types 13. Its production by immune phagocytes is triggered by 
different types of molecules, including stress hormones, cytokines and ligands 
for pathogen recognition receptors (PRRs) 14. 
The final step in IL-6 secretion is membrane fusion, a highly coordinated and 
specific process which releases IL-6 in the extracellular space. We identified 
the soluble-N-ethylmaleimide-sensitive-factor accessory-protein receptors 
(SNARE) proteins responsible for IL-6 release. SNARE proteins function by 
forming a coiled-coil SNARE complex consisting of four α-helical SNARE motives, 
provided by 3 or 4 different SNARE proteins. SNARE complex formation requires 
one R-SNARE motif (named after an arginine located in the center of the SNARE 
complex) and three Q-SNARE-motives (with glutamine at the center instead) 15. 
Based on their position in the SNARE bundle, Q-SNAREs can be grouped into 
three subgroups, called Qa, Qb, and Qc. Some members of the SNARE protein 
family contain both a Qb and a Qc motif (called Qbc-SNAREs). As there are 36 
members of the SNARE protein family present in human cells (9 R, 14 Qa, 5 Qb, 
6 Qc, 4 Qbc SNAREs) a high number of different SNARE complexes is possible 
16. Although SNAREs are functionally redundant and promiscuous, it is believed 
that they contribute to the specificity of organellar trafficking and that specific 
membrane fusion steps are catalyzed by specific sets of SNARE proteins 16–19. 
The importance of SNARE proteins, specifically in the immune system, is also 
apparent from the observations that SNAREs are often hijacked by bacteria and 
parasites thereby manipulating membrane fusion in the host cell 20. Therefore, 
in the past two decades a great body of work has been dedicated to determine 
the complex preferences of SNARE proteins in membrane trafficking. 
SNARE complexes are often identified by co-immunoprecipitation, which can 
yield information about protein-protein interactions, but does not give insight 
in the subcellular localization of the SNARE complexes within the cell. To obtain 
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such spatial information, co-localization of various SNAREs is visualized by 
microscopy with immunolabeling of endogenous proteins or with fluorescently 
tagged SNAREs in overexpression systems 16,21. Although these techniques 
are able to give information on SNARE localization within the cell, this is 
often not conclusive because their localization is often not limited to specific 
compartments, due to their dynamic behavior. In addition, SNARE proteins 
often have multiple trafficking functions within the cell 19. Another limitation 
is that conventional microscopy techniques are not able to show complex 
formation between SNAREs, as the mere presence of a SNARE does not directly 
imply a trafficking function. Thus, the subcellular localization of SNAREs does 
not give insight in the functional engagement of observed SNAREs in fusion.
Measurement of SNARE complex formation in living cells
by FRET-FLIM 
To overcome these limitations, I developed a novel microscopy approach 
allowing for the direct visualization of SNARE complex formation in living 
cells. In chapters 3 and 4, the development and rationale of this technique, 
based on Förster resonance energy transfer (FRET) coupled to fluorescence 
lifetime imaging microscopy (FLIM), are described. For this technique we 
fluorescently tagged different SNARE proteins with a donor fluorophore or 
an acceptor fluorophore fused to their extracellular C-termini. Excitation of 
the donor fluorophore normally leads to photon emission, observable as a 
fluorescent signal. However, when the donor and the acceptor fluorophore are 
very close together (Förster distance; <10 nm) the energy induced by excitation 
is transferred from the donor to the acceptor fluorophore, with a red-shifted 
fluorescent signal that we can detect. This process decreases the fluorescent 
lifetime of the donor fluorophore faster than when only photons are emitted and 
this decay time can also be measured. Chapter 3 provides a detailed step by step 
protocol and methodological information to perform FRET-FLIM measurements 
of SNARE complex formation in living cells and demonstrates how to analyze 
the acquired data to obtain quantitative measurements of SNARE complex 
formation with organellar resolution. 
In chapter 4, the FRET-FLIM method was used to show that syntaxin 3 and 
syntaxin 4 are both able to form complexes with VAMP3 and VAMP8 in dendritic 
cells. Compared to syntaxin 4, there seems to be a preference for syntaxin 3 in 
SNARE complex formation. In addition, we elucidated new spatial information 
that shows that syntaxin 3 and VAMP3 mainly associate at the plasma membrane, 
while VAMP8 complexes were more abundant at intracellular compartments. 
This is in line with the known roles of VAMP3 and VAMP8, as VAMP3 is associated 
with early endosomes and recycling endosomal compartments that fuse with 
the plasma membrane 16,22,23, while VAMP8 is more associated with early and late 
endosomal and lysosomal compartments 19,24–26. However, this distinction is not 
black and white, and VAMP8 has been shown to be an exocytic SNARE in many 
different cell types 19 and is for instance found on recycling endosomes of T cells 
and necessary for their lytic granule release 27,28. Another observation from our 
FRET-FLIM experiments was that upon LPS stimulation, the complex formation 
of syntaxin 4 with VAMP3 increased significantly. This was not observed for 
syntaxin 3 or for any combination with VAMP8. The levels of SNARE proteins did 
not change upon LPS stimulation, which could indicate that protein trafficking 
is rerouted within the dendritic cell upon TLR4 stimulation in human dendritic 
cells. Since we showed in chapter 4 that siRNA knockdown of VAMP3 resulted 
in lower secretion of IL-6, our results suggest that this rerouting is required for 
efficient release of IL-6. 
A possible mechanism for this rerouting could be found in accessory molecules 
involved in SNARE-mediated membrane fusion. Munc18b is known to bind 
syntaxin 3, but also is able to bind syntaxin 11 with a 20 times higher affinity 29. 
We observed a steep increase in syntaxin 11 expression after LPS stimulation 
(unpublished data), while we did not observe this for syntaxin 3. This might 
explain the preference for syntaxin 4 instead of syntaxin 3 in LPS-stimulated 
dendritic cells, as it is proposed that syntaxin 11 has a more regulatory than 
fusion-mediating role 30. In this case, the higher expression of syntaxin 11 
would lead to a sequestration of Munc18b preventing its binding to syntaxin 3. 
Another possibility could be that synaptotagmin XI, a calcium-sensor involved in 
SNARE-mediated fusion, could also be involved in this rerouting as it described 
to negatively regulate IL-6 and TNFα secretion 31 and is expressed by dendritic 
cells (unpublished data). 
The observation that syntaxin 4 and VAMP3 are involved in cytokine secretion 
is in line with previous studies performed in mouse macrophages and human 
synovial sarcoma cells 23,32,33. On the other hand, VAMP3 also forms a complex 
with syntaxin 3 at the plasma membrane and it might well be that this also 
contributes to IL-6 secretion, since this Qa-SNARE has been implicated in IL-6 
secretion in bone-marrow derived mouse dendritic cells 22. A still open question is 
which SNARE protein(s) contribute the Qb and Qc motifs to the SNARE complex 
for IL-6 release in dendritic cells. From human synovial sarcoma cells it is known 
that RNA silencing of SNAP-23 or VAMP3 decreases the secretion of IL-6 (and 
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TNFα) upon combined stimulation with IL-1β and Ca2+ 33. SNAP-23 is well known 
to mediate exocytosis from many different cell types 19,34–36 and is therefore a 
likely candidate for IL-6 secretion at the plasma membrane of dendritic cells. 
In support with such an exocytic role, SNAP-23 is proposed as the Qbc-SNARE 
for the secretion of TNFα, another cytokine which also traffics via recycling 
endosomes 32,33,37. However, TNFα can be secreted in a polarized fashion at the 
phagocytic cup of nascent phagosomes in macrophages, whereas IL-6 seems to 
be released in a non-polarized fashion 23. Because of these diverging trafficking 
pathways, it could also be possible that TNFα and IL-6 are secreted by the 
action of different SNARE complexes. A combination of FRET-FLIM with siRNA 
knockdown could be used to identify the Qbc- or Qb- and Qc-SNAREs for IL-6 
release from dendritic cells.
A limitation of the FRET-FLIM technique is that it only gives insight in the 
interactions of two SNARE proteins, but it does not cover the entire SNARE 
complex as a SNARE complex consists of three (with Qbc-SNAREs) or four 
(separate Qb- and Qc-SNAREs) different SNARE proteins. Moreover, SNARE 
complexes are regulated by interactions with a wide range of accessory molecules 
like SM proteins or synaptotagmins that FRET-FLIM does not give information 
on 38. It would be very interesting to extent the FRET-FLIM technique to a three-
color FRET system, employing three spectrally shifted fluorescent proteins. 
Such a technique would enable determination of the interactions between three 
different proteins 39,40. For instance, by not only adding an acceptor fluorophore 
(e.g. RFP) to a Qa-SNARE and a donor fluorophore (GFP) to an R-SNARE, but 
also adding a Qb- or Qc-SNARE with an even further red-shifted fluorophore 
(e.g., RFP657), this will allow to resolve SNARE complexes containing all three 
SNARE proteins 41. Employing a three-color based FRET-FLIM setup will also 
allow to distinguish different SNARE complexes within a cell. For instance, by 
using syntaxin-3 conjugated to the donor fluorophore GFP, VAMP3 conjugated 
to RFP that can function as an acceptor for GFP and as a donor for RFP657, and 
syntaxin-4 conjugated to the acceptor fluorophore RFP657, SNARE complexes 
of syntaxin-3 with VAMP3 and of syntaxin-4 with VAMP3 can be simultaneously 
visualized. Although technically challenging, this approach would make it 
possible to determine the complex formation between all SNARE proteins 
involved in membrane trafficking with subcellular resolution, increasing our 
knowledge on the spatiotemporal regulation of membrane trafficking. 
A second improvement of the FRET-FLIM approach could be achieved by 
increasing the sensitivity of the setup. As explained in chapter 4, the limited 
number of photons we recorded with our current setup are insufficient to fit 
single pixels with a two-component exponential decay function. The reason is 
that such a model has too many fitting parameters (two fluorescent lifetimes and 
two amplitudes), and the error in one of these parameters has a large influence on 
all of the other fitting parameters. We therefore generated fluorescent lifetime 
images by fitting with only a single component exponential decay function with 
only two fitting parameters (one amplitude and one lifetime). However, when a 
sufficient number of photons can be obtained during FRET-FLIM measurements, 
it might be possible to fit the lifetime images with a two-component exponential 
decay function. This would allow quantitative estimation of the percentage of 
bound SNAREs at various organelles and not only at the whole cell level. A higher 
number of photons could be recorded by using more sensitive detectors, such 
as avalanche photodiodes instead of photon multiplier tubes, more photostable 
fluorophores than mCitrine and mCherry, or by the use of anti-fading agents 
such as oxygen scavengers.
A promising future application of FRET-FLIM is to measure complexes of 
endogenous SNAREs. In chapter 3 and 4, we visualized SNARE complex 
formation of overexpressed recombinant SNAREs labeled with donor and 
acceptor fluorescent proteins. However, overexpression of SNAREs to non-
physiologically high levels might lead to artifacts. In addition, the percentage 
of SNARE complex formation is probably underestimated in our current 
experiments, as the cells still contain endogenous (unlabeled) SNARE proteins 
which compete with the labeled SNAREs for complex formation. The specificity 
and sensitivity of the FRET-FLIM technique could thus be further increased by 
labeling of endogenous SNARE proteins with fluorescent proteins by genetic 
modification. This would prevent complex formation between overexpressed 
labeled and endogenous unlabeled SNAREs. Such endogenous tagging could be 
obtained in cell lines by using CRISPR-Cas9 42.
In chapter 4 we focused on SNARE proteins involved in the final steps of 
membrane fusion necessary for IL-6 secretion. Less is known about the SNAREs 
necessary for trafficking events upstream to IL-6 secretion at the plasma 
membrane. In previous studies a role for syntaxin 7, Vti1b, and syntaxin 6 
was suggested for Golgi apparatus to endosome trafficking 23,37,43. FRET-FLIM 
could be used to measure if these SNAREs actually form SNARE complexes at 
the Golgi apparatus in live cells. A major challenge for this is that the use of 
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an overexpression system might lead to accumulation of fluorescently tagged 
proteins at the Golgi apparatus, as Golgi maturation cannot cope with the high 
protein synthesis due to strong viral promotors. This could lead to a high number 
of background SNARE complexes formed at the Golgi apparatus, that might 
not be functionally involved in membrane transport. The use of endogenously 
tagged proteins, as possible with CRISPR-Cas9 described above, would resolve 
this problem. 
In our studies, we focused on IL-6 because this cytokine is a central player in 
the immune system and is a key mediator of the pro-inflammatory acute 
phase response. However, this is not the only cytokine that is secreted during 
an inflammatory response. In addition, immune receptors need to traffic from 
and towards the plasma membrane both in resting immune cells and during 
inflammation. The secretion of these cytokines and plasma membrane delivery 
and retrieval of these receptors has been addressed in several studies 44–47. IL-
10 secretion in macrophages can occur via two pathways, one comparable to 
IL-6 and TNFα secretion via the Golgi apparatus and VAMP3 positive recycling 
endosomes, while for unclear reasons the other pathway transports IL-10 from 
the Golgi apparatus directly to the plasma membrane 48. IL-12 on the other hand 
is secreted in a polarized manner to T cells via VAMP7 positive late endocytic 
vesicles instead of VAMP3 positive recycling endosomes 49. The release of TNFα 
can also be polarized at the phagocytic cup during phagocytosis, although non-
polarized secretion is also possible 23,37. The high degree of overlap between 
certain cytokine trafficking pathways and clear differences between other 
cytokines indicate a high degree of spatiotemporal regulation that we are 
only starting to unravel. The divergence of the characteristics of endosomal 
compartments increases this complexity, as these are not uniform organelles 
but consist of different regions with different protein compositions 23. For 
instance, in macrophages it is shown that IL-6 and TNFα both traffic via recycling 
endosomes to the plasma membrane, but that their spatial overlap in these 
compartments is only partly with a fraction of IL-6 and TNFα residing in separate 
regions of recycling endosomes 23. Such compartmentalization on the one hand 
and co-trafficking on the other is likely important for the differential release 
of IL-6, TNFα and other cytokines, as it allows the spatiotemporal control of 
trafficking of these different cargo proteins.
Furthermore, not only cytokines, but also immune receptors need to be actively 
transported to and recycled from the cell periphery via the endosomal network, 
and their trafficking pathways are mostly unknown. A major question is how 
these receptors, and especially luminal cargo molecules such as cytokines, are 
sorted to the right trafficking organelle. Some studies show that IL-15, IL-11 and 
possibly IL-6 traffic bound to one of their receptor subunits 50–52, suggesting that 
the receptor may act as a cargo adaptor. However, whether this is the case, and 
how cytokines and receptors reach the correct trafficking vesicle carrying the 
correct SNAREs and Rab GTPases still remains to be elucidated.
Regulation of IL-6 trafficking and signaling in dendritic cells
Regulation of the pro-inflammatory response is very important to prevent 
extensive and unnecessary tissue damage and is regulated by membrane 
trafficking, making SNARE proteins a key target for interfering in the immune 
response. In chapter 4, I showed that VAMP3 influences the secretion of IL-
6, a pleiotropic cytokine mainly known for its pro-inflammatory functions. 
IL-6 is an activator of the acute phase response and activates the innate and 
adaptive immune system to effectively combat pathogens 13. However, too 
much IL-6 could be dangerous as during septic shock, an excessive systemic 
pro-inflammatory response, IL-6 levels in the serum can become very high and 
this leads to increased patient mortality due to tissue damage and multi-organ 
failure 53–57. In addition, in many autoimmune diseases, IL-6 levels are higher than 
in the healthy population and this directly relates to chronic inflammation 58,59. 
The signaling pathways underlying IL-6 effector functions are broadly studied 
but still incompletely understood. IL-6 first binds IL-6 receptor alpha subunit 
(IL-6RA) and subsequently forms a complex with the signal transducing subunit 
glycoprotein 130 (gp130) 60. Janus tyrosine kinases (JAK) phosphorylate gp130 
and subsequently signal transducer and activator of transcription (STAT) and 
mitogen-activated protein kinase (MAPK) signaling systems are activated 10,11,61. 
Interestingly, IL-6 producing cells, such as dendritic cells, monocytes, B cells and 
macrophages, have the special characteristic that they are able to secrete IL-6, 
but also express the IL-6 receptor complex which makes them prone to autocrine 
signaling and thus responsive to their own signaling 62. How IL-6 production 
and signaling are regulated in the same cell is not completely understood. The 
second aim of this thesis therefore was to determine the influence of the Toll-
like receptor 4 (TLR4) ligand lipopolysaccharide (LPS), an outer membrane 
lipid of gram negative bacteria and a potent initiator of IL-6 production, on IL-6 
synthesis, trafficking and signaling in dendritic cells. 
In chapter 5 we describe that in dendritic cells IL-6 traffics via the Golgi 
apparatus and recycling endosomes to the plasma membrane, similar to 
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observations made in macrophages 23. IL-6RA mainly localizes in intracellular 
compartments of the dendritic cell. With confocal and TIRF microscopy we 
showed that overexpressed IL-6 and IL-6RA co-localize within in the cell and co-
migrate to the plasma membrane, as previously described in mouse dendritic 
cells 63. Intracellular transport of soluble cytokines is still poorly understood 
and the observations described in this thesis could suggest that IL-6RA 
facilitates organellar trafficking and sorting of soluble IL-6. This is in line with 
data obtained in macrophages, where immune-gold labeled IL-6 appeared in 
close proximity to the luminal membrane interface of endosomes, suggesting 
an interaction with IL-6RA 23. Such a transport mechanism where a soluble 
cytokine is intracellularly sorted by its receptor was previously described for IL-4 
secretion in eosinophils, where IL-4RA is located at tubovesicular structures and 
co-localizes with IL-4 upon eosinophil stimulation by eotaxin 64. In neutrophils, 
IL-6RA showed a similar localization pattern as IL-4RA, further supporting a 
transportation function for this receptor subunit in IL-6 release 64. The possible 
role of IL-6RA in the trafficking of IL-6 might provide a mechanistic explanation 
for the differential sorting of IL-6 from TNFα to specific regions of recycling 
endosomes in macrophages and possibly neutrophils 23,45,64. This would clarify 
the sorting function of recycling endosomes in membrane trafficking, as it 
allows cargo transportation from recycling endosomes in different directions: 
to the plasma membrane, but also to late endosomes or lysosomes 65. However, 
this might also be regulated by post-translational modification or regulation of 
SNAREs, or modifications on other membrane trafficking proteins 66–68.
If IL-6RA mediates the intracellular trafficking of IL-6 and co-migrates 
together with IL-6 to the plasma membrane, the question remains how IL-6 is 
eventually released from its receptor at the plasma membrane. This secretion 
of IL-6 could be comparable to release of TNFα, IL-15 and IL-11, which are 
cleaved by metalloproteases at the plasma membrane 50,51,69,70. In line with 
this, previous studies show that IL-6RA in complex with IL-6 can be cleaved 
from the plasma membrane by ADAM10 or ADAM17 71. This could effectively 
potentiate cells in the vicinity that express gp130 (but not IL-6RA), comparable 
to IL-11 50. It might also be that IL-6 simply dissociates from IL-6RA due to the 
neutral extracellular pH, whereas it binds to the receptor in acidic intracellular 
organelles, like receptor-bound insulin 72. A third possibility might simply relate 
to the dissociation constant between IL-6 and IL-6RA. In endosomal vesicles the 
effective concentration of IL-6 is high, as only few molecules in a small vesicle 
lead to a concentration higher than the dissociation constant of about 10 nM 14,73. 
In contrast, the concentration in the extracellular space may be lower, and after 
IL-6 dissociates from IL-6RA it can diffuse away from the cell surface. In this 
respect, IL-15RA differs from IL-6, as in contrast to IL-6 which can be present 
in the blood as a free cytokine, IL-15RA always remains bound to the soluble 
receptor IL-15 in the circulation 52,74,75.
Co-trafficking of IL-6RA in complex with IL-6 in dendritic cells might facilitate 
signaling. Well described is trans-signaling, where soluble IL-6RA with IL-6 can 
bind to gp130 expressed by cells that do not have IL-6RA, thereby activating 
the IL-6 signaling cascade 76. This way of signal transduction is thought to be 
mainly pro-inflammatory and trans-presentation of an IL-6-IL-6RA complex on 
the surface of dendritic cells is responsible for pathogenic Th17 differentiation 
13,63. Moreover, we show that the IL-6 receptor complex does not signal at the 
plasma membrane, but needs to be internalized and signals at endosomal 
compartments, similar to STAT3 signaling in hepatocytes and other types of 
receptors like receptor tyrosine kinases and TLRs 77–79. Signaling at endosomal 
compartments might provide a main advantage, as receptors can be directly 
recycled back to the plasma membrane when more activation is necessary, but 
also directly to the lysosomal compartments for degradation when signaling 
should be terminated 78.
Our results reveal an additional role for IL-6 signaling in dendritic cells. As 
dendritic cells are able to produce IL-6, which together with IL-6RA resides in 
endosomal compartments, we show that newly synthesized IL-6 in transit to 
the plasma membrane already leads to STAT3 signaling. Without sufficient 
levels of exogenous IL-6 in the medium of LPS stimulated dendritic cells, we 
still observed phosphorylation of STAT3. This was supported by the observation 
that siRNA silencing of VAMP3, a SNARE protein involved in IL-6 release (see 
chapter 4), leads to increased LPS-mediated STAT3 phosphorylation. These 
findings illustrate the tight interplay between the trafficking and synthesis of 
IL-6 in dendritic cells. Because we observed large variability in IL-6 production 
and receptor expression among cells, it would be interesting to confirm self-
signaling of IL-6 in single-cell analysis, for example with microfluidics 80.
In chapter 5, we discussed the two major signaling cascades regulating IL-6 
synthesis and secretion, the STAT3 and the TLR signaling pathways. From 
previous studies we know that on the one hand TLR stimulation promotes IL-6 
production and this IL-6 can activate STAT3 signaling 81–84, while on the other 
hand STAT3 signaling interferes with TLR signaling, as IL-6 pre-treatment 
decreases LPS-mediated dendritic cell activation and maturation 85 and STAT3 
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activation is inhibited by LPS-mediated TLR stimulation 84. This inhibition of 
STAT3 activation by TLR signaling is due to suppressor of cytokine signaling 3 
(SOCS3) recruitment to the STAT3 signaling complex 86. Although we did not 
see a clear association between SOCS3 expression and STAT3 phosphorylation, 
probably because of the high instability of SOCS3 protein 87, a clear reduction 
of STAT3 activation was observed when SOCS3 degradation was prevented 
by a proteasome inhibitor. We argue that as a result, there is a mutual cross-
inhibition between the STAT3 and the TLR4 signaling pathways. These 
interfering pathways may well explain the sometimes activating and sometimes 
inhibitory role of both pathways 88,89. For instance, IL-6 was originally believed to 
promote activation of dendritic cells 90, and although it has later been shown to 
have the opposite effect and block activation 85,91,92, surprisingly it is still widely 
used for activation of dendritic cells in immunological studies 93–95.
A contradicting finding from our chapter 5 was the strong donor variation in the 
cellular levels of IL-6RA and gp130 upon LPS stimulation. For some donors, we 
observed strong increases in expression levels by flow cytometry and Western 
blot, whereas for other donors we observed no effects or even a decrease. 
This opposes the previously described decrease in the levels of IL-6RA and 
gp130 in dendritic cells upon LPS treatment 84, although this study described 
mRNA levels instead of protein levels and examined only a limited number of 
donors. The high donor-variability in IL-6RA and gp130 levels might be caused 
by genetic variation among donors, or by differences in pre-activation of the 
immune system before cell isolation. However, a key question is how important 
such differences in receptor levels are, as expression levels might not directly 
relate to the level of STAT3 phosphorylation and low numbers of IL-6 receptor 
complexes might already suffice for potent STAT3 activation. In chapter 6 of my 
thesis, I attempted to gain a more quantitative understanding of IL-6 synthesis 
and secretion.
Quantification of IL-6 production by dendritic cells
As discussed above, the synthesis and secretion of IL-6 by dendritic cells is 
tightly spatiotemporally regulated by membrane trafficking and self-signaling 
of newly produced IL-6. However, this IL-6 signaling will only occur when the 
concentration of IL-6 is high enough to efficiently bind to the IL-6 receptor 
complex. Therefore, we aimed to quantify the number of IL-6 molecules that 
resides in exocytic vesicles of dendritic cells. In chapter 6, by using quantitative 
microscopy we estimate that an LPS-activated dendritic cell on average releases 
approximately 0.5 - 3 IL-6 molecules per secretory vesicle, compared to less than 
0.1 molecules per vesicle in resting dendritic cells. In addition, TIRF microscopy 
revealed that the rate of secretion is also substantially lower (approximately 
2-fold) in resting cells compared to LPS-activating cells. Moreover, for most 
cells IL-6 does not accumulate in intracellular compartments but is immediately 
secreted after synthesis. This indicates that for the majority of dendritic cells, 
the transcription and translation, but not the trafficking, is the limiting factor of 
IL-6 production after LPS stimulation. However, there was a large variability in 
secretion rates, cell surface areas and in the production of IL-6 among cells, with 
60% of them not producing any detectable IL-6 at all. This could be explained by 
the fact that monocyte-derived dendritic cells are a relatively heterogeneous cell 
population consisting of different cell types at different stages of their lifecycle. 
This makes it possible that the amount and mechanism of IL-6 secretion differs 
widely among these cells, and future studies are needed to address this cellular 
heterogeneity. 
Conclusion and future perspectives
In this thesis I described the molecular mechanisms involved in IL-6 regulation, 
production and secretion in dendritic cells. In figure 1 a schematic representation 
of these processes is presented. When dendritic cells encounter pathogens 
or cancer cells pattern recognition receptors induce gene transcription 
of pro-inflammatory cytokines and regulatory proteins. In my studies I 
used LPS as a model pathogenic stimulus triggering the canonical pattern 
recognition receptor TLR4. This induces synthesis of IL-6, which traffics from 
the endoplasmic reticulum (not shown in the figure) to the Golgi apparatus 
where it is sorted into endosomal compartments that also contain IL-6RA. This 
newly synthesized IL-6 can, even prior to its secretion, activate the signalling 
cascade that phosphorylates and activates STAT3 via self-signaling within the 
dendritic cell. Vesicles carrying only a few molecules of IL-6 along with the 
IL-6 receptor traffic to and eventually fuse with the plasma membrane for IL-6 
release. Fusion of these vesicles with the plasma membrane is mediated by the 
SNARE proteins VAMP3 (R-SNARE) and syntaxin 4 (STX4; Qa-SNARE) together 
with a yet unidentified Qbc-SNARE protein, releasing IL-6 in the extracellular 
space. Concomitantly, IL-6 in the extracellular environment of the dendritic 
cell can bind to the IL-6 receptor complex, which is then endocytosed. Upon 
endocytosis of this complex the signaling cascade is activated, again leading to 
STAT3 phosphorylation. Phosphorylation of STAT3 can block new synthesis of 
IL-6, thereby regulating the inflammatory response. In addition to this negative 
feedback loop, TLR signaling induces expression of SOCS3, a well-known 
inhibitor of STAT3 signaling. These complex signaling cascades and feedback 
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loops result in the regulation of IL-6 synthesis and limit its production following 
acute infection. This is likely important because next to an effective immune 
response, IL-6 can be a dangerous player in sepsis 53,55–57,96 and also in cancer and 
auto immune diseases 91,97–101. 
A key question is whether the mechanisms of IL-6 production and self-signaling I 
described in my thesis are general and also present in other immune cells or apply 
to other cytokines and their receptors. That this might be the case is supported 
by the finding that many cell types that produce a cytokine also express the 
cognate receptor for this cytokine. This makes them not only prone to autocrine 
signaling, but also to self-signaling if the receptors would encounter the cytokines 
within intracellular compartments. A better understanding of the signaling and 
trafficking cascades underlying production of IL-6 and other cytokines, hormones 
and chemokines would enable a better understanding on how they tailor immune 
responses. For IL-6, especially the trans-signaling of IL-6-IL-6RA complexes 
involved in pro-inflammatory responses 60,63 and the exact role of inhibitory 
molecules like SOCS3 58,86,102 remain interesting areas of research. In conclusion, 
the role of intracellular localization and involvement of SNARE proteins in the 
regulation of IL-6 signaling and secretion by dendritic cells, as demonstrated in 
my thesis, make membrane trafficking a novel target for therapeutic strategies 
aimed at improving or reducing IL-6-mediated immune responses, which could 
be valuable in anti-cancer therapy or in the treatment of auto immune diseases. 
Figure 1. Regulation of IL-6 synthesis and secretion in dendritic cells.
LPS binding to TLR4 initiates transcription and translation of IL-6. Next, IL-6 is transported via the 
Golgi apparatus to recycling endosomes. Together with IL-6RA, IL-6 traffics to the plasma membrane 
in vesicles originating from recycling endosomes. These vesicles can fuse with the plasma membrane 
in a process mediated by a SNARE complex containing VAMP3 and STX4. Extracellular IL-6 can bind 
to the IL-6 receptor at the plasma membrane, which is subsequently taken up by the dendritic cell. 
Following both IL-6 synthesis and endocytosis, IL-6 can associate with the IL-6 receptor complex in 
recycling endosomes. This can lead to self- and paracrine signaling via phosphorylation of STAT3 (pY-
STAT3), inhibiting further transcription and translation of IL-6. This negative feedback loop is inhibited 
by TLR4 signaling that initiates transcription and translation of SOCS3, an inhibitor of pY-STAT3.
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Het immuunsysteem
Ons lichaam wordt door het immuunsysteem continue beschermd tegen 
ongewenste indringers zoals bacteriën en virussen (pathogenen) en gevaar 
van binnenuit zoals transformatie van eigen cellen tot kankercellen. Het 
immuunysteem bestaat uit fysieke barrières, zoals de huid en slijmvliezen, en uit 
een groot aantal witte bloedcellen, ook wel immuuncellen genoemd, dat samen 
ten strijde trekt tegen het gevaar. De eerste verdedigingslinie bestaat uit fysieke 
barrières en de aspecifieke immuuncellen. Zij maken geen onderscheid in het 
type indringer, maar kunnen de indringer uitschakelen door deze in zich op te 
nemen (dit heet fagocytose) en ze vervolgens af te breken. Hiernaast alarmeren 
ze ook de cellen van het adaptieve immuunsysteem door het uitscheiden van 
verschillende stofjes, cytokinen genoemd. Deze cytokinen passen als een 
sleutel in het slot op zogenoemde receptoren op B of T cellen, de immuuncellen 
van het adaptieve systeem. Dit zet een complexe signaleringscascade aan 
waardoor de B of T cel geactiveerd wordt. Bij de activatie van deze adaptieve, 
specifieke immuuncellen spelen ook de stukjes van de afgebroken indringer 
een rol. Elke B of T cel heeft unieke receptoren op het celoppervlak (ook wel 
celmembraan genoemd) die één specifiek stukje van de indringer kan herkennen. 
Sommige aspecifieke immuuncellen kunnen de afgebroken stukjes van de 
indringer, antigenen, op het celoppervlak presenteren. Dit worden antigeen-
presenterende cellen (APC) genoemd en zij zijn de belangrijkstee schakel tussen 
het aspecifieke en adaptieve immuunsysteem. Het antigeen op het celoppervlak 
past vervolgens bij een B of T cel precies op de receptor. Deze specifieke B of T 
cel vermenigvuldigt zich dan razendsnel en kan heel specifiek de indringer of de 
kankercel aanvallen en opruimen. 
Communicatie tussen immuuncellen 
Goede communicatie over de locatie en kenmerken van de indringer tussen 
de APC en de B en T cellen is dus essentieel voor een optimale aanval van het 
immuunsysteem. In hoofdstuk 2 beschrijf ik hoe de communicatie tussen 
een dendritische cel (DC; de meest efficiënte en veelzijdige APC) en een T cel 
verloopt. Communicatie kan over grote afstand plaatsvinden, maar ook door 
middel van direct fysiek contact tussen de DC en de T cel. Het contactoppervlak 
tussen deze twee cellen wordt de immunologische synaps genoemd. De manier 
waarop receptoren en cytokinen precies op het goede moment naar de goede 
kant van het celmembraan van de APC worden getransporteerd is belangrijk 
voor goede T cel activatie. Hierbij moet de T cel niet alleen het antigeen op 
het celmembraan van de DC herkennen met zijn receptor, er moeten ook nog 
verschillende ondersteunende connecties tussen receptoren op de DC en de T 
cel worden gemaakt. De moleculaire mechanismen die ten grondslag liggen 
aan de regulatie van al deze connecties zijn voor T cellen vrij goed onderzocht, 
maar voor DCs nog niet. Op basis van beschreven onderzoek stel ik dat de 
immunologische synapse vanuit het DC perspectief waarschijnlijk vergelijkbaar 
is met de mechanismen in de T cel, maar dat de eiwitten die belangrijk zijn bij dit 
proces mogelijk verschillen.
Het belang van SNARE eiwitten in cytokine secretie
De moleculaire organisatie achter ‘de goede cytokine op het juiste moment 
op de juiste plek’ wordt spatio-temporale regulatie genoemd. Dit is niet alleen 
belangrijk voor de communicatie tussen verschillende cellen, maar ook voor de 
communicatie van verschillende eiwitten binnenin een cel. In mijn onderzoek 
heb ik daarom bestudeerd hoe de regulatie en het transport van de cytokine 
interleukine 6 (IL-6) in dendritische cellen is georganiseerd. IL-6 wordt in de 
cel geproduceerd en vervolgens in kleine blaasjes, organellen genoemd,  via 
een uitgebreid transportnetwerk vervoerd naar het celmembraan waar het 
wordt uitgescheiden. De allerlaatste stap in dit proces is de fusie van het IL-6 
gevulde organel met het celmembraan. Voor dit proces, en alle andere fusies 
van verschillende organellen in de cel, moeten zogenaamde SNARE eiwitten 
op het organel en op het celmembraan een complex van vier SNARE eiwitten 
vormen. Er zijn 36 verschillende SNARE eiwitten, die in een cel op verschillende 
plekken en momenten complexen van verschillende samenstelling vormen. 
Het is daardoor vrij ingewikkeld om te bepalen welke SNARE eiwitten precies 
betrokken zijn bij de laatste fusiestap van het organel met het celmembraan. 
In het verleden was het niet mogelijk om in levende cellen tegelijkertijd de 
complexformatie en de locatie van SNARE eiwitten in de cel te bepalen. In dit 
proefschrift beschrijf ik een methode die we hebben ontwikkeld waarbij dit wel 
mogelijk is. Dit doen we met behulp van microscopie. Door een fluorescent 
label aan een SNARE eiwit vast te maken kunnen we deze eiwitten, die we in 
levende cellen met het blote oog niet kunnen zien, onder de microscoop toch 
onderscheiden. Wanneer twee SNARE eiwitten met elk een ander fluorescent 
label op minder dan 10 nanometer (= 0.00001 milimeter) afstand van elkaar zijn 
(en dus waarschijnlijk een complex vormen) kunnen we dat met een speciale 
microscoop meten. Deze techniek noem je ‘fluorescence lifetime imaging 
microscopy’ (FLIM). De principes en het protocol van deze methode zijn 
beschreven in hoofdstuk 3. 
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Vervolgens hebben we deze FLIM techniek in hoofdstuk 4 toegepast om te 
onderzoeken welke SNARE eiwitten in DCs een complex kunnen vormen en 
of er voorkeur is voor een bepaalde combinatie. Hierbij hebben we  gefocust 
op de SNARE eiwitten STX3, STX4, VAMP3 en VAMP8. Het blijkt dat STX3 en 
VAMP3 bijvoorbeeld vaker een complex vormen op het celmembraan dan in het 
midden van de cel, halverwege het transportnetwerk. Verder blijkt dat wanneer 
de DC wordt blootgesteld aan kleine stukjes bacterie (LPS) er meer complexen 
worden gevormd tussen STX4 en VAMP3, dan wanneer er geen LPS aanwezig is. 
Wanneer we het VAMP3 eiwit in de DC vervolgens uitschakelen, wordt er minder 
van de cytokine IL-6 uitgescheiden. Dit is belangrijk omdat IL-6 een belangrijke 
cytokine is die andere cellen waarschuwt voor gevaar.
Regulering van IL-6 signalering in dendritische cellen
Bij gevaar zorgt een toename van IL-6 productie en secretie in een DC voor het 
waarschuwen van immuuncellen in de omgeving en daarmee voor een efficiënte 
immuunreactie. Dit moet strak gereguleerd worden, omdat een te heftige 
immuunreactie schade aan gezond weefsel kan veroorzaken. 
DCs kunnen niet alleen IL-6 produceren en uitscheiden, maar ze bevatten zelf 
ook de receptor om door IL-6 geactiveerd te worden. In  hoofdstuk 5 beschrijf 
ik hoe LPS de productie, het transport en de communicatie binnenin de cel van 
IL-6 en de IL-6 receptor beïnvloeden. 
Het blijkt dat na productie IL-6 en de receptor elkaar al tegenkomen in specifieke 
organellen en vervolgens samen hun weg vervolgen naar het celmembraan. Dit 
vertelt ons iets over de manier waarop IL-6 wordt getransporteerd binnen in de 
cel, namelijk samen met zijn receptor. Wanneer IL-6 vervolgens is uitgescheiden, 
kan het binden aan een IL-6 receptor op een andere DC, maar de communicatie 
(we noemen dit signalering) begint pas wanneer dit complex is opgenomen in 
de cel. Het blijkt dat signalering al plaatsvindt tijdens het transport van nieuw 
gevormd IL-6 en de IL-6 receptor in een organel  via het eiwit STAT3, wat op 
zijn beurt zorgt voor een afname in IL-6 productie. Er is dus een duidelijke 
samenwerking en balans tussen transport en productie van IL-6 in een DC.
Kwantificatie van interleukine 6 in de dendritische cel
Signalering tussen IL-6 en de IL-6 receptor vind alleen plaats wanneer de 
concentratie IL-6 binnen of buiten de cel hoog genoeg is om elkaar te kunnen 
vinden en een complex te vormen. In hoofdstuk 6 heb ik geprobeerd om met 
behulp van verschillende microscopie technieken een schatting te maken 
hoeveel IL-6 eiwitten er in een organel zitten wanneer de cytokine wordt 
uitgescheiden. Het bleek dat er relatief weinig IL-6 eiwitten in een organel 
zitten, ondanks dat er bij een infectie snel veel IL-6 wordt uitgescheiden door 
dendritische cellen. Dit komt doordat het aantal organellen met IL-6 dat fuseert 
met het celmembraan verdubbeld, wanneer een DC wordt blootgesteld aan een 
infectie.
Conclusie
In mijn proefschrift heb ik de moleculaire mechanismen beschreven die 
betrokken zijn bij de regulatie, productie en secretie van IL-6 in dendritische 
cellen. Wanneer een DC wordt blootgesteld aan een bacterie wordt IL-6 
geproduceerd. In specifieke organellen komt het de IL-6 receptor tegen, 
waardoor de signalering van STAT3 in de cel wordt geactiveerd. Wanneer deze 
organellen het celmembraan bereiken, fuseren zij met behulp van de SNARE 
eiwitten STX4 en VAMP3, waardoor IL-6 wordt uitgescheiden. Op hetzelfde 
moment is de DC ook in staat IL-6 van andere DCs op te nemen met behulp 
van de IL-6 receptor die zich inmiddels ook op het celmembraan bevindt. Na 
opname van IL-6 wordt de signalering van STAT3 opnieuw geactiveerd, waardoor 
nieuwe productie van IL-6 wordt tegengehouden. De complexe signalering 
en bijbehorende feedback in de cel zorgen ervoor dat de immuunreactie in 
proportie blijft met de dreiging en onnodige schade aan gezond weefsel wordt 
voorkomen. De conclusie van mijn proefschrift is dan ook dat de locatie en rol 
van SNARE eiwitten en daarmee het transportnetwerk in de dendritische cel 
belangrijk is voor de regulatie van IL-6 productie, secretie en signalering en 
daarmee voor een effectieve immuunreactie bij infectie of kanker. 
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